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Prelude – learning and memory 
There are many different definitions of learning and memory, some extensive and complex 
and others straightforward and easily comprehensible. In its simplest form, learning is a 
mechanism by which we acquire new information, and memory is the mechanism by which 
we retain and possibly retrieve that information. As simple as these definitions may appear, 
they are the basis for any species to survive, adapt, reproduce and finally succeed in even the 
harshest environment. When Charles Darwin first proposed his theory of natural selection in 
1859 it was controversial and highly debated. Nowadays it is largely accepted by its 
overwhelming evidence and rather intuitive to most. The ability to learn about the 
environment, store that information and then retrieve and utilize it, presents an invaluable 
competitive advantage, which can be appreciated when looking at human evolutionary 
history. First fossils of the human species (genus: Homo) date back about two to three million 
years (Schrenk et al., 2007), which is relatively little compared to most other species living 
on earth. In those two to three million years humans have undoubtedly changed and adapted 
to their environment, but they also took control of their environment and shaped it to their 
needs. Humans have colonized almost all the land masses of the earth regardless of the 
climate, have created complex social structures, harnessed the power of fire and electricity, 
and more than anything humans have overcome their own limitations by technological and 
no less medical advances. Thus, humans have used their ability to learn and memorize to 
effectively predict the future and accordingly shape their environment to a favorable 
outcome. By being able to share and pass on acquired knowledge, not genetically but socially, 
humans have surpassed the learning abilities of any other species, allowing every generation 
to further the knowledge of the previous. It was therefore almost inevitable that humans 
would ultimately reach a stage at which they would inquire the very nature of their own 
abilities. While early human societies often considered the heart being the seat of thought, 
emotion and no less the soul, recent times revealed that it is the brain that holds our memories 
and governs our abilities to learn. This organ of about 1.5 kg (Herculano-Houzel, 2009) has 
become the study object and fascination of many generations of researchers coming from so 
different fields as biology, philosophy, psychology, chemistry and others. 
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How is information stored in the brain? 
In the beginning of the 20th century Richard Semon brought forward his Mneme or Engram 
theory of how information is stored in the brain. In short, he postulated that when 
experiencing an event, certain sub-populations of brain cells would store this information by 
being excited simultaneously and then undergoing physical and/or chemical changes. 
Retrieval of that information could then be achieved by reactivation of one or more of the 
original cells that were active while encoding the memory (Semon, 1904). Most of Semon’s 
work, which goes far beyond the short paragraph above, has gone unnoticed, and although 
he may have been false in some of his assumptions by following Lamarckian reasoning, one 
can clearly see foresight on his behalf of what the following century would uncover. 
In the middle of the 20th century Donald Hebb elaborated on the engram theory and 
its underlying mechanisms, taking the current knowledge on synaptic connections into 
account. As others before him, he postulated that repeated activity of two or more neurons 
together would cause lasting cellular changes that would increase the efficacy of synapses 
between them, thereby allowing the storage of information (Hebb, 1949). What set Hebb’s 
postulate apart from that of others, is that he emphasized the causality, arguing that synaptic 
connections would grow stronger only when presynaptic activity precedes and triggers the 
activity in postsynaptic neurons. It took about 20 years before the Hebbian rule, as it is now 
known, was confirmed experimentally when Lomo and Bliss (1973) showed that a strong, 
repetitive stimulation of neurons in the hippocampus of rabbits, led to long-term potentiation 
(LTP) of synaptic strength that lasted for up to 10 hours. Another 20 years later several 
research groups demonstrated that the opposite of what Hebb postulated, non-correlated 
activity of neurons leading to a decrease of synaptic strength, also holds true (Dudek and 
Bear, 1992; Fujii et al., 1991; Malenka, 1994). In short, they showed that a prolonged, but 
weak sub-threshold stimulation of hippocampal neurons leads to decreased synaptic strength, 
a phenomenon that was named long-term depression (LTD). Both, long-term potentiation 
and long-term depression are forms of synaptic plasticity and much of what we know today 
about how we learn, store and retrieve information, comes from studying their underlying 
molecular mechanisms. 
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Synaptic plasticity 
Synapses undergo changes. Synaptic connections can be weakened or strengthened in an 
activity-dependent manner. The process of constant synaptic change is considered to be the 
basis of the brain’s ability to store information and is called synaptic plasticity (Holtmaat and 
Svoboda, 2009). LTP and LTD are the most extensively studied forms of functional synaptic 
plasticity, but functional plasticity is often accompanied by structural synaptic changes, i.e. 
changes in spine morphology (size and length increase/decrease) and changes in spine 
numbers (Caroni et al., 2012; Matsuzaki et al., 2004; Nagerl et al., 2004). These structural 
synaptic alterations were often viewed as a mere consequence of processes involved in 
synaptic plasticity, e.g. gene expression and protein synthesis, and most observations to date 
are indeed correlative and not of causative nature. In recent years, however, numerous studies 
have pointed to a more pivotal role of morphological synaptic changes in learning and 
memory. In order to understand how synaptic structure relates to synaptic function and vice 
versa, the following paragraphs will introduce cause and effect in (post-)synaptic plasticity 
in more detail. 
 
Receptor-mediated plasticity 
Synapses are the communication terminals of neurons. They present the bridge between the 
axon of one neuron (presynaptic) and the dendrite of another neuron (postsynaptic). When 
an action potential arrives at an axonal terminal, it will trigger the influx of calcium ions 
through voltage-dependent calcium channels, inducing the exocytosis of neurotransmitters. 
These bind to specific neurotransmitter receptors allowing the flux of ions, leading to a 
postsynaptic depolarization or hyperpolarization of the membrane, thereby exerting 
excitatory or inhibitory effects on the postsynaptic side. In case of an excitatory synapse the 
neurotransmitter is generally glutamate. Glutamate can bind to three types of receptors: 
(i) AMPA (α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid), (ii) NMDA (N-
methyl-D-aspartate) and (iii) kainate receptors, which all are (transmitter-) ligand-gated ion 
channels. Under basal conditions glutamate binding will lead to a flux of Na+ and K+ ions via 
AMPA receptors, while NMDA receptors remain impervious due to a Mg2+ block. Only when 
the postsynaptic membrane is sufficiently depolarized, Mg2+ dissociates from the receptor 
and allows an influx of Ca2+ ions (Hammond, 2001; Kandel et al., 2000). That Ca2+ influx is 
 General Introduction 
 15 
assumed to be the initiator of synaptic plasticity. When entering the postsynaptic cell it sets 
a number of signaling processes in motion, which will finally lead to a LTP state of the 
synapse. Via binding to the protein calmodulin, Ca2+ activates the calcium/calmodulin-
dependent protein kinase 2 (CaMKII), protein kinase C (PKC) and protein kinase A (PKA), 
all of which are able to phosphorylate AMPA receptors (Barria et al., 1997; Boehm et al., 
2006; Nayak et al., 1998). AMPA receptor phosphorylation leads to an increase of 
conductance in two ways: (i) additional AMPA receptors are incorporated in the post-
synaptic membrane (Schnell et al., 2002) and (ii) the conductance of individual AMPA 
receptors is increased (Derkach et al., 1999; Derkach et al., 2007). In addition, activation of 
the aforementioned kinases causes a downstream effect that induces increased synthesis of 
synaptic proteins (Miller et al., 2002; Sutton and Schuman, 2006), which further strengthens 
synapses. 
The second most studied form of synaptic plasticity is LTD. As with LTP, LTD 
induction can also be dependent on NMDA receptors and calcium influx. Whereas LTP 
requires large amounts of calcium, LTD is triggered by lower calcium levels (Artola and 
Singer, 1993; Nabavi et al., 2013). In general, LTP increases the number and transmission 
efficacy of AMPA receptors. LTD in contrast is reported to trigger the opposite: AMPA 
receptors are dephosphorylated in a NMDA receptor- and calcium-dependent manner and 
subsequently removed from the synaptic membrane by endocytosis leading to synaptic 
weakening (Mansuy, 2003; Winder and Sweatt, 2001). 
 
Synaptic structure-related plasticity 
In parallel to functional synaptic changes via endo- or exocytosis of receptors on the 
postsynaptic membrane and direct modulation of their conductance properties, the 
morphology of spines is also altered. Changes in spine head size have been observed as well 
as changes in length and thickness of spine necks (Engert and Bonhoeffer, 1999; Fifkova and 
Anderson, 1981). In addition, the spine density changes after stimulation (Leuner and Gould, 
2010). Interestingly, structural and functional processes appear to be interdependently 
connected. Induction of LTP not only triggers recruitment of AMPA receptors into the 
postsynaptic membrane, but also causes outgrowth of new spines, growth of spine pairs and 
triplet spines and an increase in spine size (Harris et al., 2003; Toni et al., 1999). The increase 
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in spine head size is already visible as quickly as 10 seconds after stimulation and can reach 
a maximum of more than 200 % within 1 - 5 minutes thereafter. As with LTP, spine 
enlargement can be inhibited by blocking NMDA receptors or by inhibiting calmodulin 
(Matsuzaki et al., 2004). Reversely, when blocking spine size enlargement by suppressing 
actin polymerization, LTP is also suppressed (Fukazawa et al., 2003; Krucker et al., 2000; 
Matsuzaki et al., 2004). It is thus clear that structural and functional synaptic plasticity are 
mutually interdependent processes of a plasticity response that share similar inductive 
mechanisms and are both required for the expression of plasticity. 
It is interesting to note that both structural and functional changes associated with 
LTP require protein synthesis (Tanaka et al., 2008; Yang et al., 2008), and that the Ca2+ influx 
through NMDA channels triggered by LTP induction, not only activates gene transcription, 
but also mRNA translation (Luscher and Malenka, 2012; West et al., 2002). This protein 
synthesis not only occurs somatically, but also dendritically from mRNAs that are located in 
or near spines (Luscher and Malenka, 2012). The concept of local protein synthesis has 
become crucial in our understanding of synaptic plasticity, and will be further explained in 
the following paragraphs. 
 
mRNA transport granules 
Neurons are highly polarized cells, with dendritic trees and axons often extending far from 
the cell body. This specialized cellular architecture presents a unique challenge, i.e., how to 
supply each of the sometimes thousands of synapses with the correct proteins at times of high 
demand?  
In 1982 Steward and Levy showed that polyribosomes are present at the base of 
spines in hippocampal granule cells (Steward and Levy, 1982). With that finding speculation 
arose that local translation of mRNAs may be the means to locally and temporally regulate 
the abundance of specific proteins in neurons. In the following decades more evidence on 
local protein synthesis was gathered. Many different mRNAs, such as Map2 (Garner et al., 
1988), CaMKIIα (Burgin et al., 1990), Shank (Bockers et al., 2004) and others were found 
localized in or near synapses of mouse neurons. Recent studies suggest that the number of 
different protein coding mRNAs in axons and dendrites is in the thousands (Cajigas et al., 
2012; Zivraj et al., 2010). In fact, Lécuyer et al. (2007) showed that in Drosophila embryos 
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71 % of all expressed genes were found to encode mRNAs highly localized in non-nuclear 
subcellular compartments (Lecuyer et al., 2007), suggesting that local mRNA translation is 
not an isolated phenomenon in mammalian neurons, but a general mechanism to specifically 
regulate localization of proteins.  
In neurons, localized RNAs are often transported in RNA granules containing 
mRNAs and a multitude of proteins, many of which are RNA-binding proteins (Kiebler and 
DesGroseillers, 2000; Knowles et al., 1996; Kohrmann et al., 1999). At least three different 
kinds of RNA granules can be found in dendrites: (i) stress granules carrying RNAs of stress 
response proteins such as HSP70, (ii) processing bodies (P-bodies) that regulate RNA 
degradation and (iii) ribonucleoprotein particles (RNPs) that transport and store mRNAs for 
local translation (Liu-Yesucevitz et al., 2011). Most common of the three are RNP granules, 
which are also referred to as mRNA transport granules. They transport the majority of 
mRNAs. Stress granules and P-bodies on the other hand are rarely observed and appear only 
after induction of metabolic stress, e.g. heat, oxidative stress, osmotic stress (Anderson and 
Kedersha, 2009). Most RNP granules in neurons are stationary and only a small percentage 
is mobile at any given moment (Buchan, 2014). Neuronal activity, however, is able to 
increase targeted movement of RNP granules into dendrites (Bramham and Wells, 2007). 
They are able to move in anterograde as well as retrograde directions along microtubules 
employing different kinesin motor proteins (Kanai et al., 2004; Knowles et al., 1996). The 
composition of RNP particles varies depending on brain region and developmental stage (Di 
Liegro et al., 2014). They generally consist of mRNAs, proteins for translation initiation and 
elongation, regulators of mRNA structure and function, ribosomal subunits, and other RNA-
binding proteins many of which are assumed to repress mRNA translation while in transport. 
The most prominent and most researched RNP proteins are FMRP, PURA, STAUFEN, ZBP1 
and TLS, all of which were shown to have an effect on synaptic plasticity and/or spine 
morphology (Bramham and Wells, 2007; Kanai et al., 2004; Kiebler and Bassell, 2006). Of 
these proteins FMRP has received special interest. Loss of FMRP, due to a mutation in its 
gene FMR1, leads to a severe form of mental retardation called fragile X syndrome (Bagni 
and Greenough, 2005). FMRP is assumed to locally control translation of a number of 
proteins such as CaMKIIα, ARC and MAP1B. On a cellular level, loss of FMRP in neurons 
results in a reduction of mature spines and an excess of long filopodial like spines (Zalfa et 
al., 2006; Zalfa et al., 2003). Interestingly, the loss two other aforementioned RNP proteins, 
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TLS and STAUFEN 2, results in similar spine morphology abnormalities. Loss of TLS leads 
to an increase in thin spines and a reduction of mushroom spines, whereas loss of 
STAUFEN 2 increases filopodia and reduces spine number (Fujii et al., 2005; Goetze et al., 
2006). As argued above, alterations in spine density, size and shape require structural changes 
that are mediated by the actin skeleton. Conveniently, messenger ribonucleoprotein (mRNP) 
complexes are known to transport beta-actin mRNA, bound and translationally inhibited by 
protein ZBP1 (Zipcode Binding Protein 1) (Eom et al., 2003; Kiebler and DesGroseillers, 
2000). Upon stimulation, ZBP1 can be phosphorylated leading to beta-actin mRNA release, 
which triggers its local translation (Huttelmaier et al., 2005; Zhang et al., 2001), supplying 
spines with extra building material to increase in size.  
 
Synaptic protein synthesis and breakdown 
Many studies have shown that protein synthesis is an essential mechanism regulating protein 
content of synapses and thereby affecting synaptic strength and learning (Fonseca et al., 
2006a; Frey et al., 1988; Huang et al., 1996). However, synaptic plasticity is not driven by 
protein synthesis alone, and how could it? Logic dictates that constant synthesis of proteins 
in a limited space, even when only activity-driven, will eventually lead to crowding if a 
counter measure is not in place. That counter measure has been identified as protein 
degradation mediated by the ubiquitin proteasome system. In 2006, Fonseca et al. 
demonstrated that LTP is not solely dependent on protein synthesis, but also on protein 
degradation. They showed that blocking the proteasome led to as much a decrease in LTP as 
when blocking translation. Only when inhibiting protein synthesis and degradation at the 
same time, LTP was restored. This led them to conclude that synaptic protein degradation is 
essential for synaptic plasticity, counterbalancing protein synthesis and keeping protein 
levels in balance. 
Protein degradation is generally achieved by post-translational modifications, 
meaning that proteins are modified by the attachment of cellular recognition tags that direct 
them to proteasomal degradation (Hershko and Ciechanover, 1998). Given their importance 
in synaptic plasticity, I will now first discuss the nature of these modifications in more detail.  
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Post-translational modifications 
Only a few years ago the human genome project finished its efforts to sequence the human 
genome in its entirety (International Human Genome Sequencing, 2004). While analysis of 
the sequences advanced, it became clear that our genome does not contain an anticipated 
50,000 to 90,000 genes (Antequera and Bird, 1993; Fields et al., 1994), but a mere 20,000 to 
25,000 genes (International Human Genome Sequencing, 2004). This rather low number 
brought into question how so few proteins are able to fulfill the complexity of everyday 
cellular tasks in human cells. In comparison, the house mouse (Mus musculus) and the thale 
cress (Arabidopsis thaliana) have approximately the same number of genes (Arabidopsis 
Genome, 2000; Mouse Genome Sequencing et al., 2002). The phenomenon of alternative 
splicing was quickly identified as a means to increase protein diversity without the need to 
increase the number of genes. In alternative splicing, non-coding and coding parts of the pre-
mRNA are excised to produce different mature mRNAs, often resulting in different isoforms 
of the same protein, potentially fulfilling a different or altered function (Black, 2003; 
Graveley, 2001; Maniatis and Tasic, 2002). In recent years, driven by technological 
advances, post-translational modifications (PTMs) have been identified to immensely 
contribute to structural and functional diversity of proteins (Jensen, 2004). PTMs are 
chemical modification of amino acids of proteins that are introduced during or after 
translation. These modifications can involve (i) structural changes, e.g. proteolytic cleavage 
and the formation of di-sulfide bridges, (ii) chemical changes such as amino acid conversions, 
(iii) the addition of functional groups, e.g. acetylation and alkylation, and (iv) the addition of 
other proteins and peptides, e.g. sumoylation, neddylation and ubiquitylation (Han and 
Martinage, 1992b). Most of these modifications are mediated by enzymatic activity and occur 
at specific amino acid sequences in the target proteins (Han and Martinage, 1992a; Han and 
Martinage, 1992b; Han and Martinage, 1993). The total number of types of post-translational 
modifications is estimated between 200 and 400 and all of them are able to change the 
structure and/or function of a protein (Farley and Link, 2009; Zhao and Jensen, 2009). In 
addition most proteins can be modified at more than one site, allowing for numerous 
combinations of PTMs to regulate protein function in many different ways. Some of the most 
common and also most studied PTMs include phosphorylation, acetylation, methylation, 
glycosylation, palmitylation, sumoylation and ubiquitylation (Khoury et al., 2011). Many, if 
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not all, PTMs affect synaptic proteins and have an impact on learning and memory in one 
way or another. A few of them will be briefly described in the following paragraphs, whereas 
ubiquitylation, which is especially relevant for this thesis will be explained in detail in the 
next section. 
Phosphorylation is the reversible addition of a phosphate group to a serine, 
threonine, tyrosine or arginine residue (Han and Martinage, 1992b). Phosphorylation is 
mediated by kinases and can be reversed by phosphatases (Hunter, 1995). It is the 
experimentally most often identified modification of proteins with an extremely high 
turnover rate (Khoury et al., 2011). Phosphorylation is best known for its involvement in the 
activation and inactivation of enzyme activity and the modulation of molecular interactions 
in signaling pathways (Seo and Lee, 2004). It plays a major role in synaptic plasticity by 
controlling the activity state and function of numerous synaptic proteins, e.g. NMDA 
receptors, AMPA receptors, CaMKII and others (Lee, 2006). Dysregulation of 
phosphorylation is also assumed to be a trigger in the development of neurodegenerative 
diseases such as Parkinson’s disease, where it precedes synuclein accumulation and Lewy 
body formation (Anderson et al., 2006). 
Acetylation is the second most common protein modification. It occurs N-terminally 
or at lysine residues of amino acid sequences. It is estimated that 80 - 90% of all proteins in 
eukaryotes are acetylated (Walsh, 2006; Walsh et al., 2005). Acetylation is known to regulate 
many different cellular functions, including DNA recognition, gene regulation, protein-
protein interaction and protein stability (Choi and Howe, 2009; Wang et al., 2011), but it is 
most prominently known as a histone modification enhancing transcriptional activity. By that 
means, acetylation also has a strong effect on synaptic plasticity, in particular late phase LTP 
and long-term memory, both of which are transcription-dependent (Sharma, 2010). 
Sumoylation is a protein-based protein modification. SUMO (Small Ubiquitin-like 
MOdifier) is a collective term for three SUMO paralogues (SUMO 1, 2 and 3) of about 11.6 
kDa that can be attached to lysine residues of other proteins (Martin et al., 2007). All three 
paralogues are abundantly expressed in the brain (Geiss-Friedlander and Melchior, 2007) and 
until recently they were considered to be mainly nuclear protein modifiers (Mahajan et al., 
1997; Matunis, 1996). Several studies showed that cellular structures, such as dendrites, 
axons and synapses are also enriched in SUMO protein and in sumoylated proteins (Luo et 
al., 2013). Sumoylation can affect synaptic efficacy by altering protein-protein interaction, 
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and the activity and localization of modified proteins such as GluK2, CB1 and Arc in neurons 
(Lee et al., 2014; Martin et al., 2007). Sumoylation is dynamically regulated and was shown 
to be required for the normal expression of LTP and LTD (Tang et al., 2005; Wilkinson et 
al., 2008). Reversely, LTP induces an increase of SUMO1 in spines (Jaafari et al., 2013). 
Recently, it has been speculated that sumoylation plays a role in the development of 
neurodegenerative diseases, and inclusion bodies typical for Parkinson’s disease and 
Alzheimer’s disease are often SUMO immunoreactive (Dawson and Dawson, 2003; Dorval 
et al., 2007; Li et al., 2003). 
 
Ubiquitylation 
Ubiquitylation is the most common and most studied post-translational modification 
employing an entire protein as a modifier (Khoury et al., 2011). It plays a key role in many 
aspects of cellular life such as transcription, protein stability and intracellular transport 
(Hochstrasser, 2009). It is however mostly associated with its critical role in protein 
degradation. Ubiquitylation is the reversible attachment of ubiquitin, an 8.5 kDa protein, to 
a lysine residue of another protein (substrate) (Hershko, 1983; Hershko and Ciechanover, 
1998). It is a process that demands the consecutive action of at least three different enzymes 
to finally attach one or multiple ubiquitin moieties to a lysine of the substrate protein (Streich 
et al., 2013). The three enzymes involved are: (i) an E1 ubiquitin-activating enzyme which 
covalently binds ubiquitin in an ATP-dependent manner, (ii) an E2 ubiquitin-conjugating 
enzyme which receives the activated ubiquitin from E1, and (iii) an E3 ubiquitin-protein 
ligase, which either directly transfers or facilitates the transfer of activated ubiquitin from E2 
to the substrate protein (Figure 1). Two major types of ligases have been identified: HECT 
(Homologous to the E6-AP Carboxyl Terminus) and RING domain (Really Interesting New 
Gene domain) ligases (Pickart, 2004; Pickart and Eddins, 2004). Whereas E3 ligases of the 
HECT family form a thiol ester intermediate with ubiquitin and then directly transfer it to 
substrate proteins, E3 RING ligases do not directly transfer ubiquitin, instead they form a 
complex by interacting with a ubiquitin carrying E2 enzyme and the prospective substrate, 
thereby facilitating and catalyzing the transfer of ubiquitin (Hershko, 2005; Hershko et al., 
2000; Pickart, 2004). Ubiquitin itself harbors 7 lysines (K6, K11, K27, K29, K33, K48, and 
K63) in its amino acid sequence, each of which can also be ubiquitylated, allowing the 
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formation of large ubiquitin chains. The type of ubiquitin chain and the number of ubiquitins 
then decide the fate of the substrate (Strieter and Korasick, 2012). Among other functions, 
mono-ubiquitylation for example is known to trigger endocytosis, change in localization and 
lysosomal degradation of proteins (Haglund and Dikic, 2012; Mosesson et al., 2009; Polo, 
2012), whereas linear poly-ubiquitylation employing K48, and to a lesser degree K63, is 
generally known to target substrate proteins to the 26S proteasome for degradation (Hershko 
and Ciechanover, 1998). E3 ligases play a pivotal role in determining substrate specificity. 
This is reflected by the fact that the human genome alone encodes for 617 different E3 ligases 
(Li et al., 2008). E3 ligases usually only target a few very specific proteins, whereas E2 
conjugating enzymes catalyze the ubiquitin transfer to the substrate and decide which of the 
ubiquitin lysines will be targeted for elongation (Berndsen and Wolberger, 2014; Strieter and 
Korasick, 2012). 
It is worth noting that ubiquitylation is a highly dynamic and moreover reversible 
process (Reyes-Turcu et al., 2009). Ubiquitins attached to substrates can efficiently and 
specifically be removed or poly-ubiquitin chains be trimmed by de-ubiquitylation enzymes 
(DUBs). To date there are about 100 DUBs known (Komander et al., 2009), which is 
relatively few when compared to the more than 600 known E3 ligases (Li et al., 2008). 
However, considering that each DUB only needs to recognize certain consensus sites of 
ubiquitin-protein or ubiquitin-ubiquitin links, deubiquitylation can certainly be viewed as a 
very powerful antagonist of ubiquitylation. 
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Figure 1. Ubiquitylation cascade. 
The ubiquitylation cascade begins 
with ATP-dependent charging of the 
E1 enzyme and results in the 
formation of a thioester bond between 
the ubiquitin C-terminus and the E1 
active site cysteine. Ubiquitin is 
transferred to the E2 active site 
cysteine. An E3 ligase catalyzes the 
transfer of the ubiquitin from the 
active site cysteine of the E2 to a 
primary amine group on a lysine side 
chain or protein N-terminus. There 
are two main classes of E3 ligases: 
RING E3 ligases, which bind to both 
E2-Ub-thioester and substrate and 
thereby catalyze the ubiquitin 
transfer, and HECT ligases, which 
have active site cysteines and 
catalyze substrate ubiquitination in a 
two-step reaction involving 
formation of a thioester with the 
HECT followed by attack of the 
substrate lysine or N-terminus on the 
E3-Ub-thioester to form an 
isopeptide (or peptide) linkage 
between the ubiquitin C-terminus and 
lysine (or the protein N-terminus). 
Illustration and caption adjusted with 
permission from Berndsen and 
Wolberger (2014). 
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Ubiquitin ligases and the ubiquitin proteasome system in neurons 
Ubiquitylation and several components of the ubiquitin proteasome system have been found 
to play a major role in plasticity, learning and memory, as well as in numerous 
neurodegenerative diseases (Dantuma and Bott, 2014; Mabb and Ehlers, 2010; Whalley, 
2012). A common feature of diseases such as Alzheimer’s, Parkinson’s, and Huntington’s is 
an aggregation/accumulation of certain proteins in the brain, mostly identified postmortem 
as amyloid plaques, Lewy bodies, neurofibrillary tangles and others. Accumulated proteins 
are often found to be highly ubiquitylated (Glickman and Ciechanover, 2002). Although it is 
still a matter of debate whether these ubiquitin-rich protein accumulations are cause or effect 
of the underlying diseases, it certainly demonstrates the involvement of the ubiquitin-
proteasome system. For example mutations in the PARK2 gene coding for the E3 ubiquitin 
ligase Parkin are responsible for about 50 % of all familial cases of Parkinson’s disease and 
for 10 – 20 % of juvenile Parkinson’s disease cases (Sandebring and Cedazo-Mínguez, 2012; 
Takahashi et al., 1994; Walden and Martinez-Torres, 2012). Another prominent example is 
the ubiquitin-protein ligase E3A (UBE3A) that, when defective in humans, causes Angelman 
syndrome, a neurodevelopmental disorder that is characterized by developmental delay and 
severe intellectual disabilities (Clayton-Smith and Laan, 2003; Kishino et al., 1997). Mouse 
models mimicking Angelman syndrome do not display such a severe phenotype, yet exhibit 
some deficits in LTP and learning (Bruinsma et al., 2015; Jiang et al., 1998; Silva-Santos et 
al., 2015). Although UBE3A and Parkin have been investigated extensively over the last 
decades and many ubiquitylation substrates suggested, it is not entirely clear to date what 
causative role, if any, they play in the development of Parkinson’s disease and Angelman 
syndrome, respectively. 
Many synaptic proteins, e.g. PSD-95, GKAP and SHANK, undergo activity 
dependent ubiquitylation (Ehlers, 2003; Mabb and Ehlers, 2010) and a small number of 
synaptic ubiquitin ligases have been identified. The number of identified synaptic E3 ligases 
is still growing, yet the identification of their substrates has proven to be rather difficult. A 
few ligase-substrate pairs, however, have successfully been identified and their role in 
plasticity and learning established. Ubiquitin ligase FBX2 for instance binds to the NR1 
subunit of NMDA receptors and increases NR1 ubiquitylation in an activity-dependent 
manner (Kato et al., 2005). The presynaptic ubiquitin ligase SCRAPPER was shown to bind 
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and regulate RIM1, a presynaptic protein that is involved in vesicle release. SCRAPPER 
thereby indirectly regulates synaptic transmission (Takagi et al., 2012; Yao et al., 2007). 
Whereas overexpressing SCRAPPER in mice appears to have no effect on learning and 
behavior, knocking Scrapper out was lethal. Heterozygous SCRAPPER knockout mice 
however are viable and show increased freezing in a contextual fear memory paradigm (Yao 
et al., 2011). Another ubiquitin ligase, MDM2, was shown to bind and ubiquitylate PSD-95 
in response to NMDA receptor activation (Colledge et al., 2003). 
 
RING ligases and the TRIM protein family 
E3 Ring ligases are the most diverse family of ligases that all share a common protein 
structure containing an N-terminal RING finger domain. The RING motif was first 
discovered when sequence databases were searched for the N-terminal domain of a gene 
termed really interesting new gene 1 (RING1) and it consists of a conserved stretch of 
cysteine and histidine residues that bind two zinc ions. The RING domain is generally 
believed to confer ubiquitylation function to proteins that contain it (Deshaies and Joazeiro, 
2009). While HECT ligases form a temporary thioester intermediate with ubiquitin before 
transfer to the substrate, RING ligases do not come in direct contact with ubiquitin, but rather 
bring the ubiquitin bound E2 and the substrate in proximity by binding to both, and thereby 
facilitate the ubiquitin transfer. The specificity of the reaction is provided by the E3 RING 
ligases pairing the E2s and their respective substrates (Glickman and Ciechanover, 2002; 
Hegde, 2010). RING finger E3 ligases can generally be divided into two groups: (i) large 
multisubunit RING finger E3 ligase complexes like SCF (Skp1/Cullin/Fbox) or APC/C 
(anaphase-promoting complex/cyclosome) that utilize multiple adaptors, cullin domains and 
RING domains to recruit substrates and ubiquitylate them, and (ii) single-subunit RING 
finger E3 ligases that contain the RING domain and substrate recognition sites in the same 
protein (Deshaies and Joazeiro, 2009; Mabb and Ehlers, 2010). One of the largest families of 
single-subunit RING finger E3 ligases are the TRIM (tripartite motif) proteins. TRIM family 
members have been shown to exert functions in a diversity of cellular processes, from 
development to antiviral immune responses, to finally playing a role in certain forms of 
cancer (Boulay et al., 2009; Pertel et al., 2011; Rajsbaum et al., 2014; Uchil et al., 2013). Yet, 
not in all cases is the specific function of a TRIM family member associated with its ubiquitin 
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ligase activity, nor has E3 ligase activity been demonstrated for every TRIM protein (Ozato 
et al., 2008). TRIM proteins are also known as RBCC motif-containing proteins, because the 
N-terminal region contains in addition to the RING domain one or two B-box domains and a 
coiled-coil region (Figure 2) (Meroni and Diez-Roux, 2005). The B-box domains also bind 
zinc ions and it is assumed that they contribute to the E3 ligase function, as was shown for 
TRIM18 (Han et al., 2011). The coiled-coil domain is required for homo- or 
heterodimerization and oligomerization, and it was shown to play an important role in cellular 
localization (Reymond et al., 2001). The coiled-coil domain is followed by a variable 
C-terminus that is used to classify TRIM proteins into subfamilies according to their domain 
composition (Reymond et al., 2001; Short and Cox, 2006). The number of subfamilies varies 
depending on domain classification and stringency. The most recent classification recognizes 
11 subfamilies (Figure 2) (Ozato et al., 2008).  
 
 
Figure 2 TRIM protein family. All members of the TRIM family contain the RBCC motif, consisting 
of a RING domain (R), 1 or 2 B-Box domains (B1, B2), and a coiled-coil domain (CC). TRIM protein 
family members are further grouped into 11 subfamilies according to their C-terminal composition. The 
RING domain is generally associated with the ability to facilitate ubiquitin transfer to substrate proteins. 
Coiled-coil domains are required for homo- and heterodimerization and oligomerization. TRIM3 
belongs to subfamily VII, together with TRIM2, TRIM32 and TRIM71. All four members of this 
subfamily share a C-terminal NHL domain (NHL). Other illustrated domains are: ADP ribosylation 
factor-like (ARF), bromodomain (BR), C-terminal subgroup one signature (COS), fibronectin type 3 
(FN3), filamin-type immunoglobulin (FIL), meprin and tumour-necrosis factor receptor-associated 
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factor homology (MATH), plant homeodomain (PHD), transmembrane (TM), splA kinase and 
ryanodine receptors domain (PRY, SPRY). Figure and caption adjusted with permission from Ozato et 
al. (2008).  
 
TRIM3 and the TRIM-NHL subfamily 
The TRIM-NHL subfamily of TRIM proteins, consisting of TRIM2, TRIM3, TRIM32 and 
TRIM71, share a stretch of 5 - 6 NHL repeats (first identified in protein NCL-1, HT2A and 
Lin-41) downstream of the RBCC domain (Slack and Ruvkun, 1998). TRIM32 is highly 
expressed in skeletal muscle (Horn et al., 2004; Kudryashova et al., 2005) and involved in 
two different human disorders, (i) limb-girdle muscular dystrophy type 2H (LGMD2H) and 
(ii) Bardet-Biedl syndrome (BBS). LGMD2H is caused by mutations in the NHL domain, 
whereas BBS is caused by an amino acid substitution in B-box 2 (Chiang et al., 2006; Cossee 
et al., 2009; Saccone et al., 2008). TRIM32 is an ubiquitin ligase that was shown to 
ubiquitylate many different proteins, e.g. X-linked inhibitor of apoptosis (XIAP) (Ryu et al., 
2011), protein inhibitor of activated STAT (PIASy) (Albor et al., 2006) and muscle actin 
(Kudryashova et al., 2005). It was also recently shown that the NHL domain of TRIM32 
positively regulates microRNA (miRNA) activity and plays a role in developmental timing 
and asymmetric cell division (Hammell et al., 2009; Schwamborn et al., 2009). TRIM71 is a 
close family member of TRIM32 and it was shown to associate and ubiquitylate AGO2 
(Argonaute RISC Catalytic Component 2), a central protein in RNA mediated gene silencing 
(Rybak et al., 2009). 
TRIM2 and TRIM3 are very similar and abundantly expressed in the brain (El-
Husseini, 1999; Ohkawa et al., 2001). Both proteins interact with myosin V (Ohkawa et al., 
2001; Reymond et al., 2001), yet a role in endosomal trafficking has not been demonstrated. 
TRIM2 further interacts with and ubiquitylates neurofilament light chain (NF-L). Trim2 
knockout mice are viable and born without apparent brain defects (Balastik et al., 2008). 
However they develop juvenile onset ataxia and exhibit spontaneous seizures. Brains of 
Trim2 knockout mice show neurodegeneration from four months of age on, which is caused 
by increased levels of NF-L, leading to swollen axons and subsequent loss of neurons in the 
retina, cerebellum and spinal cord (Balastik et al., 2008). In a recently reported case of a 
patient with early-onset axonal neuropathy, two mutations in the Trim2 gene as well as 
neurofilament accumulations were identified (Ylikallio et al., 2013), strengthening the 
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evidence that TRIM2 targets neurofilament light chain for degradation. TRIM3 is the subject 
of this thesis, and will be extensively introduced in the next paragraph. 
 
Tripartite motif-containing protein 3 (TRIM3) 
TRIM3, also called BERP (Brain Expressed Ring finger Protein), was first discovered in a 
RT-PCR (reverse transcription polymerase chain reaction) mRNA analysis of rat brain in 
1999 (El-Husseini). It has the N-terminal RBCC motif (RING, B-box, coiled-coil) and a C-
terminal domain consisting of six NHL repeats. With TRIM2 and TRIM32 it shares an 
immunoglobulin filamin-type (IG-FLMN) domain downstream of the RBCC motif. TRIM3 
is highly expressed in the brain, particularly in cerebellum and hippocampus. Low levels of 
TRIM3 mRNA were also detected in other organs, e.g. lung, heart, liver and kidney (El-
Husseini, 1999). When expressed in PC12 cells, TRIM3 localizes to the cytoplasm in a 
punctate pattern, but when a truncated TRIM3 protein lacking the NHL domain was 
expressed, cells remained small upon stimulation by nerve growth factor, formed clustered 
aggregates and failed to differentiate (El-Husseini, 1999), indicating that TRIM3 might play 
a role in cell differentiation. Another role for TRIM3 in intracellular transport or trafficking 
has also been suggested. Yeast-two-hybrid analysis showed that TRIM3 interacts with 
myosin Vb and alpha-actinin 4 (El-Husseini et al., 2000; El-Husseini, 1999). Yan et al. (2005) 
subsequently showed that TRIM3, alpha-actinin 4 and myosin V, together with the protein 
Hrs, form the cytoskeleton-associated recycling or transport (CART) complex, which is 
required for the efficient constitutive recycling of transferrin receptors and epidermal growth 
factor receptors in HeLa cells (Yan et al., 2005). Although these studies were all performed 
in non-neuronal cells, they might shed some light on the possible neuronal functions of 
TRIM3, as myosin Va and Vb were recently shown to be important motor proteins delivering 
AMPA receptor-containing cargo vesicles in neurons (Correia et al., 2008; Wang et al., 
2008), and alpha-actinin plays a role in AMPA receptor transport in dendritic spines (Schulz 
et al., 2004). Recently, it was also reported that TRIM3 interacts with the orphan motor 
protein KIF21B, and that loss of TRIM3 reduces the motility of KIF21B in neurons (Labonte 
et al., 2013). Finally, Kanai et al. (2004) showed that TRIM3 is one of the major protein 
constituents of neuronal RNA transport granules associated with motor protein KIF5. 
Although these studies seem to suggest that TRIM3 is involved in cellular transportation, a 
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direct role for TRIM3 in the trafficking and/or recycling of AMPA receptors, or any other 
dendritic or synaptic cargo, has never been established. 
Raheja et al. (2014) demonstrated convincingly that TRIM3 is indeed a RING 
domain ubiquitin ligase. In 2010 Hung et al. showed that TRIM3 is synaptically localized in 
neurons, and that overexpression of TRIM3 leads to a significant decrease in GKAP and 
SHANK1A levels in cultured cortical rat neurons. Importantly, the observed decrease was 
RING domain dependent. Overexpressing TRIM3 also caused a significant decrease in spine 
head width in cultured neurons, which would be in accordance with a decrease of synaptic 
scaffold proteins such as GKAP or SHANK. Although GKAP was suggested to be the direct 
ubiquitylation substrate of TRIM3, the two proteins were not shown to interact, and these 
very same authors subsequently showed that activity-dependent removal of GKAP from 
synapses in vivo does not likely depend on TRIM3 (Shin et al., 2012). 
Ohkawa et al. (2001) showed that Trim3 gene expression is coupled to activity. In 
order to trigger seizures, they lowered the seizure threshold of mice with the GABAA receptor 
antagonist pentylenetetrazole (PTZ) or with glutamate receptor agonist kainate. They 
observed that evoked seizures with both compounds increased mRNA expression of Trim3, 
but also of Trim2. In 2010 Cheung et al. demonstrated that Trim3 deficient mice show 
increased resistance to PTZ-induced seizures, indicating that TRIM3 confers sensitivity to 
PTZ in mice. They argue that the PTZ insensitivity of Trim3 deficient mice results from 
reduced surface expression of γ2-subunit-containing GABAA receptors, which also resulted 
in a decrease of miniature inhibitory postsynaptic currents. However, they failed to show a 
causal relationship between TRIM3 and GABA receptor surface expression. 
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Aim and outline of this thesis 
The data presented in the introduction demonstrate that TRIM3 is a synaptically localized 
RING E3 ligase in the brain. Over the last decade TRIM3 has been investigated by several 
research groups, yet its role in neurons and especially at synaptic sites remains elusive. This 
study was aimed at understanding the precise role of TRIM3 in hippocampal and cerebellar 
function by making use of a newly generated Trim3 knockout mouse and investigating it in 
a multidisciplinary manner. In Chapter 2 a detailed analysis is provided of the 
morphological, cell physiological and behavioral phenotype of Trim3 knockout mice. 
Chapter 3 explores the possibility that TRIM3 is involved in mRNP trafficking. Chapter 4 
focuses on the identification of TRIM3 ubiquitylation substrates in the hippocampus and in 
the cerebellum, and in Chapter 5 one of the identified substrates, ACTG1, is studied in more 
detail. Finally, in Chapter 6 I summarize and discuss all data, and provide a working model 
in which TRIM3 and ACTG1 together contribute to the normal expression of hippocampal 
synaptic plasticity. 
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Abstract 
Post-translational protein modifications play an important role in cellular function. 
Ubiquitylation is one of the most common protein modifications. Poly-ubiquitylation in 
particular is a tightly controlled process targeting specific substrate proteins for subsequent 
proteasomal degradation. This specificity is achieved by E3 ubiquitin ligases recognizing and 
modifying only a certain set of substrate proteins. In recent years a number ubiquitin ligases 
were shown to regulate synaptic function and plasticity. Here, we show that TRIM3 is a 
synaptically localized E3 ligase in the hippocampus and the cerebellum. Trim3 knockout 
mice show no morphological abnormalities in the hippocampus or the cerebellum, and 
anxiety, locomotion and motor coordination are unaffected. In contrast, hippocampal fear 
memory acquisition, long-term potentiation and spine densities are significantly enhanced in 
Trim3 knockout mice. Our findings put forward TRIM3 as a synaptic E3 ligase that regulates 
hippocampal plasticity, learning and memory.  
Introduction 
Proteins can be viewed as molecular machines fulfilling a certain function in the cell. But as 
with the best machine, it is of no use, if it cannot be properly controlled. In the protein world, 
post-translational modifications are what switches, dials, buttons and levers are to real 
machines. The number of identified types of modifications ranges between 200 and 400, 
depending on which source is consulted (Farley and Link, 2009; Zhao and Jensen, 2009), all 
of which are able to change the function and fate of a protein in one way or another. The most 
common and also most studied post-translational modifications include phosphorylation, 
glycosylation, palmitylation, sumoylation and ubiquitylation (Khoury et al., 2011). The 
latter, ubiquitylation, is the main subject of this chapter. 
Ubiquitylation is the attachment of ubiquitin, an 8.5 kDa protein, to a lysine residue 
of another protein, the substrate. This modification requires the consecutive activity of at 
least three different enzymes, an E1 ubiquitin-activating enzyme, which covalently binds 
ubiquitin in an ATP-dependent manner, an E2 ubiquitin-conjugating enzyme which receives 
activated ubiquitin from E1, and an E3 ubiquitin-protein ligase, which either directly transfers 
or facilitates the transfer of activated ubiquitin from E2 to the substrate protein. Substrate 
proteins, when poly-ubiquitylated, will be targeted to the proteasome for degradation 
 The ubiquitin ligase TRIM3 affects hippocampal synaptic plasticity and learning in mice 
 33 
(Hershko and Ciechanover, 1998). E3 ligases play a key role in this process. They on the one 
hand recognize a specific substrate and a matching E2-carrying ubiquitin, and on the other 
hand catalyze ubiquitin transfer to the substrate (Berndsen and Wolberger, 2014). This 
specificity is reflected by the fact that the human genome encodes for 617 E3 ligases (Li et 
al., 2008). Recent studies show that a number of ubiquitin E3 ligases are found in or near 
synapses and that they target proteins involved in synaptic plasticity, learning and memory 
(Lin et al., 2011; Mabb et al., 2014; Takagi et al., 2012; Yao et al., 2007). Yet, a direct causal 
link between E3 ligase expression and learning behavior has not been established. 
 TRIM (tripartite motif) proteins are a large family (> 70 members in humans 
according to the HUGO Gene Nomenclature Committee) of structurally related proteins 
which all share an N-terminal RBCC (RING finger / B-box / coiled coil) region. TRIM 
proteins have a typical modular structure comprising multiple protein-protein interaction 
domains, and many have RING finger-dependent E3 ubiquitin ligase activity (Joazeiro and 
Weissman, 2000; Meroni and Diez-Roux, 2005; Reymond et al., 2001). Nine subfamilies of 
TRIM proteins are defined based on the nature of their C-terminal domains (Short and Cox, 
2006). TRIM2, TRIM3 and TRIM32 form a subfamily that is characterized by a C-terminal 
IG-FLMN domain followed by six NHL repeats. TRIM2 and TRIM3 are structurally closely 
related and are predominantly expressed in the brain with largely overlapping expression 
patterns (El-Husseini, 1999; Ohkawa et al., 2001). TRIM32 is more distantly related and 
primarily expressed in skeletal muscle (Kudryashova et al., 2005). The NHL repeat domain 
of these proteins mediates interaction with myosins; TRIM2 and TRIM3 interact with 
unconventional class V myosins (El-Husseini, 1999; Ohkawa et al., 2001), whereas TRIM32 
interacts with skeletal muscle Myosin II (Kudryashova et al., 2005). Myosins, however, are 
not ubiquitylation targets but rather are involved in determining subcellular localization. 
TRIM2 ubiquitiylates neurofilament light chain (NF-L) (Balastik et al., 2008), and TRIM32 
ubiquitylates muscle actin (Kudryashova et al., 2009) and c-Myc in neuronal progenitors 
(Schwamborn et al., 2009). Hung et al. (2010) demonstrated that TRIM3 is indeed an E3 
ubiquitin ligase, a finding that was later confirmed by Raheja et al. (2014) showing that 
TRIM3 ubiquitylates p21 in an in vitro assay. 
 Recently, Trim2 and Trim32 knockout mice were generated and analyzed (Balastik 
et al., 2008; Kudryashova et al., 2009), but neither protein seems a likely candidate E3 ligase 
for synaptic plasticity and learning processes. In this study we employed biochemical, 
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electrophysiological, behavioral and imaging techniques aimed to establish a potential role 
for TRIM3 in synaptic plasticity.  
 
Material and Methods 
Animals 
Trim3-/- mice were maintained on a C57BL/6J background. In all experiments wildtype 
littermates were used as controls. Mice were individually housed on sawdust in standard 
Makrolon type II cages (26.5 cm long, 20.5 cm wide and 14.5 cm high) enriched with 
cardboard nesting material and a plastic tube under 12/12h dark/light cycle with access to 
water and food ad libitum. All animal experiments were approved by the animal ethics 
committee of the VU University Amsterdam, The Netherlands. 
Immunohistochemistry 
Mice were intracardially perfused with ice-cold paraformaldehyde (4 % in PBS, pH 7.4). 
Brains were removed, postfixed, embedded in gelatin (Mallinckrodt Baker, USA) and 
cryostat-sectioned at 40 µm. For immunostaining the following antibodies were used: 
Calbindin D28k (Swant, Bellinzona, Switzerland; 1:20,000) and TRIM3 (BD Biosciences, 
USA; 1:1,000). The antigens were visualized using VECTASTAIN ABC standard kit (Vector 
Laboratories, USA) or with secondary fluorescent Alexa Fluor 488 conjugated antibodies 
(Invitrogen, USA; 1:400). Nissl staining was used for gross morphological characterization 
of brain slices. 
Golgi-Cox staining 
Golgi-cox staining was performed using the FD Rapid GolgiStain Kit (FD 
NeuroTechnologies, USA). After staining, brains were microtome-sectioned at 100 µm. 
Neurons were photographed at 100 x magnification, and Z-stacks were generated using 
Image Pro Plus 6.2 software (Media Cybernetics Inc., USA). Morphological features were 
quantified using ImageJ 1.40g software (NIH, USA). 
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Immunofluorescence and confocal microscopy 
Hippocampi were dissected from E18 wildtype mice, collected in Hanks balanced salts 
solution (HBSS; Sigma-Aldrich, USA) buffered with 7 mM HEPES (Invitrogen, USA) and 
incubated for 30 min in HBBS containing 0.25 % trypsin (Invitrogen, USA) at 37° C. After 
washing, neurons were triturated with fire-polished Pasteur pipettes, counted and plated in 
Neurobasal medium (Invitrogen, USA) supplemented with 2 % B - 27 (Invitrogen), 1.8 % 
HEPES, 1 % glutamax (Invitrogen, USA), 1 % Pen Strep (Invitrogen, USA) and 0.2 % 
14.3 mM β-mercapto-ethanol. Cultures were plated on glass coverslips coated with poly-D-
lysine (Sigma-Aldrich, USA) and treated with 5 % heat-inactivated horse serum (Invitrogen, 
USA). Neurons were plated at a seeding density of 250 cells/mm2. Half of the medium was 
replaced with fresh medium every week. After 14 days in culture, neurons were fixed using 
4 % paraformaldehyde and 10 % saccharose in PBS (pH 7.4). Neurons were stained with 
BERP (611732; BD Biosciences; 1:1,000) and MAP2 (AB5543, Abcam, 1:5,000) antibodies. 
Antigens were visualized using Alexa Fluor 488 and 568 (Molecular Probes; 1:400). 
Confocal microscopy was performed using a Zeiss LSM 510 (Zeiss, Germany). 
Cellular fractionation 
Brain tissue was obtained from C57BL/6 mice. Animals were sacrificed by cervical 
dislocation. Cortex, cerebellum and hippocampus were dissected and stored at -80° C. 
Cellular fractionation was performed as previously described (Klemmer et al., 2009). In brief, 
hippocampi were homogenized in a glass Potter homogenizer containing 5 ml of ice-cold 
homogenization buffer (320 mM sucrose in 5 mM HEPES, pH 7.4) at 900 rpm with 12 up 
and down strokes. Cell debris and nuclei were removed by centrifugation at 1,000 g for 10 
min. The supernatant was centrifuged at 16,000 g for 30 min to obtain P2 fraction or at 
100,000 g for 2 h to obtain crude synaptosome (P2 + M, Pellet 2 + microsomes) fraction 
enriched in synaptosomes and microsomes. For synaptosome and synaptic membrane 
isolation cleared homogenate was loaded on a sucrose gradient consisting of 0.85 M and 
1.2 M sucrose. After ultracentrifugation at 100,000 g, 4° C for 2 h the synaptosome fraction 
was recovered at the interface of 0.85/1.2 M sucrose. Synaptosomes were then diluted with 
an equal volume of 5 mM HEPES buffer (pH 7.4) and brought to 15 ml using homogenization 
buffer, centrifuged at 25,000 g for 30 min. The pellet was resuspended in HEPES buffer and 
osmotically shocked while stirring slowly on ice for 15 min. The resulting synaptic 
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membrane fraction was recovered by ultracentrifugation using the sucrose step gradient as 
outlined above. Protein concentrations were measured using Bradford Protein-Assay 
(Bio-Rad Laboratories, USA) and equal amounts of protein were separated on a 10 % SDS-
PAGE gel and transferred to PVDF membranes (Bio-Rad Immuno-Blot PVDF membrane, 
Bio-Rad Laboratories). Blots were blocked by immersing in 5 % nonfat dry milk in PBS-T 
(PBS plus 0.05 % Tween) for 1 h. Blots were then incubated with antibodies for BERP 
(611732, BD Biosciences, 1:250) and PSD-95 (73-028, Neuromab, 1:10) for 1 h at room 
temperature or overnight at 4° C, followed by a 1 h incubation with a secondary antibody 
conjugated to alkaline phosphatase. Proteins were visualized by ECF treatment (24 µl ECF 
substrate/cm2) and scanned using an FLA-5000 scanner (Fujifilm, Japan).  
Cell culture 
Human embryonic kidney cells (HEK293) were maintained in Dulbecco’s modified Eagle 
medium supplemented with 10 % fetal bovine serum and 1 % Penicillin-Streptomycin (all 
from Life Technologies Thermo Fisher Scientific Inc., USA) at 37° C and 5 % CO2. Cells 
were transfected with myc-TRIM3, myc-ΔRBCC-TRIM3 or mock-transfected at 60 – 80 % 
confluence using polyethylenimine (PEI). After 48 h cells were washed with ice cold PBS 
and subsequently lysed in SDS-containing loading buffer. Samples were separated on 
4 – 20 % gradient SDS-PAGE gel (Criterion TGX Stain-Free Gel, Bio-Rad Laboratories) and 
then transferred to PVDF membranes (Bio-Rad Immuno-Blot PVDF membrane, Bio-Rad 
Laboratories). Blots were blocked by either immersing the membrane in 5 % nonfat dry milk 
in TBS-T (TBS plus 0.025 % Tween) or 0.5 % BSA in TBS-T (TBS plus 0.025 % Tween) 
for 1 h. Blots were then incubated with antibodies for Actin (sc65634, Santa Cruz, 1:10,000) 
and Ubiquitin (BML-PW8810, Enzo Life Sciences, 1:100) for 1 h at room temperature or 
overnight at 4° C, followed by 1 h incubation with a secondary antibody conjugated to HRP. 
Proteins were visualized by ECL treatment (SuperSignal West Femto Chemiluminescent 
Substrate, Thermo Scientific) and scanned using the Odyssey Fc imager (Li-Cor, USA). 
Spontaneous synaptic transmission 
Mice of age 22 - 38 days were decapitated and brains rapidly removed and dissected in ice-
cold carbogenated (95 % O2/5 % CO2) slicing solution (110 mM choline chloride, 26 mM 
NaHCO3, 10 mM D-glucose, 11.6 mM Na-ascorbate, 7 mM MgCl2, 3.1 mM Na-pyruvate, 
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2.5 mM KCl, 1.25 mM NaH2PO4, 0.5 CaCl2). Horizontal hippocampal slices (300 µm) were 
prepared as previously described (Dawitz et al., 2011). Slices were stored for at least 1 h in 
a submerged-style holding chamber containing carbogenated artificial cerebrospinal fluid 
(aCSF; 125 mM NaCl, 26 mM NaHCO3, 10 mM D-glucose, 3 mM KCl, 2.5 mM MgCl2, 1.6 
mM CaCl2 and 1.25 mM NaH2PO4). Slices were then transferred to a recording chamber and 
perfused continuously with carbogenated aCSF (as in the holding chamber, but with 1.5 mM 
MgCl2). CA1 pyramidal neurons were identified on the basis of cell soma location and basic 
firing properties recorded using the whole-cell patch-clamp technique. For recording 
excitatory synaptic currents patch pipettes (borosilicate glass, 3-5 MΩ resistance) were filled 
with 148 mM K-gluconate, 1 mM KCl, 10 mM HEPES, 4 mM Mg-ATP, 4 mM 
K2-phosphocreatine, 0.4 mM GTP and 0.2 % biocytin, adjusted with KOH to pH 7.3. For 
inhibitory currents, intracellular solution contained 70 mM K-gluconate, 70 mM KCl, 10 mM 
HEPES, 4 mM Mg-ATP, 4 mM K2-phosphocreatine, mM 0.4 GTP and 0.2 % biocytin, 
adjusted with KOH to pH 7.3. Neurons were allowed to stabilize for at least five minutes 
after a whole-cell configuration was achieved. For all measurements, eight-minute gap-free 
recordings were made at -70 mV holding potential in voltage-clamp mode. Spontaneous 
excitatory postsynaptic currents (sEPSCs) were measured in the presence of GABAa receptor 
blocker gabazine (10 µM), spontaneous inhibitory postsynaptic currents (sIPSCs) in the 
presence of glutamate receptor blockers DAPV (50 µM) and CNQX (10 µM). EPSCs and 
IPSCs were detected using Mini analysis software (Synaptosoft, USA). Amplitude, 
frequency, rise- and decay times of excitatory and inhibitory currents were measured and 
statistical significance was determined using a two-tailed t-test. 
Spine analysis 
Hippocampal slices were prepared from 8 - 10 weeks old mice and CA1 neurons recorded as 
described above. Cells were kept in whole-cell configuration for 10 - 15 min to fill with 
biocytin, after which a Giga-seal was obtained when retracting the pipette. After retraction 
of the pipette, slices were immediately fixed in 4 % paraformaldehyde in PBS for 1 - 2 days 
at 4° C. Slices were then washed four times for > 10 min in PBS and incubated with 0.5 % 
Triton X-100 in PBS, after which they were incubated for two days with 1:500 streptavidin-
Alexa 488 conjugate (Life Technologies, Thermo Fisher Scientific, USA) and 0.1 % Triton 
X-100 in PBS. To-Pro-3 (Life Technologies) was added at 1:10,000 for the last 10 min of 
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incubation to counterstain for nuclei. Slices were then washed four times for > 15 min in PBS 
and mounted in Mowiol on glass slides. Labeled cells were imaged using a Nikon Ti-E A1R 
(Nikon, Tokyo, Japan) confocal microscope using a 10 x 0.45 NA air objective to check the 
position of the cells in CA1. Spines were imaged using a 100x 1.49 NA oil immersion 
objective at a resolution of 80 (x) x 80 (y) x 125 (z) nm/pixel. Approximately 80 µm of the 
first oblique dendrite and 80 µm of the first basal dendrite (either clockwise or counter 
clockwise from the apical dendrite) were imaged. For each labelled neuron one oblique and 
one apical dendrite were analyzed using NeuronStudio software (v0.9.92) (Rodriguez et al., 
2008). Automatic dendrite tracing and spine recognition were used and spine densities were 
calculated. Statistical significance was determined using a two-tailed t-test. 
 
Long-term potentiation 
A planar multi-electrode recording setup (MED64 system; Alpha Med Sciences, Tokyo, 
Japan) was used to record field excitatory post-synaptic potential (fEPSP) and to elicit LTP 
as previously described (Shimono et al., 2002). Animals were decapitated and brains were 
rapidly removed and placed in ice-cold slice buffer (124 mM NaCl, 3.3 mM KCl, 1.2 mM 
KH2PO4, 7 mM MgSO4, 0.5 mM CaCl2, 20 mM NaHCO3 and 10 mM glucose; constantly 
gassed with 95 % O2/5 % CO2). Coronal hippocampal slices were prepared using a vibrating 
microtome at 400 µm and then placed in a chamber containing aCSF (124 mM NaCl, 3.3 mM 
KCl, 1.2 mM KH2PO4, 1.3 mM MgSO4, 2.5 mM CaCl2, 20 mM NaHCO3 and 10 mM 
glucose; constantly gassed with 95 % O2/5 % CO2). Slices were allowed to recover for one 
hour and then placed on 8 x 8 multi-electrode arrays containing P5155 probes (Alpha Med 
Sciences; inter-electrode distance 150 µm) pre-coated with polyethylenimine (PEI; Sigma-
Aldrich, USA). After addition of 500 µl aCSF the array was placed in a moist chamber that 
was constantly gassed with 95 % O2/5 % CO2 for at least one hour before recording. Correct 
placement of the electrodes at the CA3 – CA1 region was done manually, monitored by a 
microscope (SZ61; Olympus, Japan). During recording, slices were constantly perfused with 
oxygenated aCSF containing 10 µM glycine at a flow rate of 2 ml/min at room temperature. 
fEPSPs were recorded from multiple electrodes in the stratum radiatum of CA1. An external 
concentric bipolar electrode (CBCBG75; FH-Company, Bowdoin, ME) in the Schaffer 
collateral pathway was used as the stimulating electrode using a homemade model 440b 
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isolated Bipolar Current Stimulator. Based on the stimulus–response curve, a stimulation 
intensity was used that evoked fEPSPs with a magnitude of 50 % of the maximum response 
(usually ~100 µA). After allowing a stable baseline of 10 min, LTP was evoked by a 
2 x 100 Hz stimulus of 1 s each with a 15 s interval and fEPSP responses were recorded for 
1 h after the tetanus. LTP was expressed as the change in the slope of the fEPSP relative to 
baseline and averaged for multiple electrodes (usually 5) located in the stratum radiatum. 
Statistical significance was determined using a two-tailed t-test on the fEPSP change from 
10 – 20 min or 20 - 30 min after LTP induction. 
 
Open field test 
Mice were introduced into a corner of the white square open field (50 x 50 cm, walls 35 cm 
high) illuminated with a single white fluorescent light bulb from above (130 lx), and 
exploration was tracked for 10 min (12.5 frames/s; EthoVision 3.0, Noldus Information 
Technology, The Netherlands). EthoVision was used to calculate the total distance traveled 
as well as the time spent and the number of entries into the center square area (20 x 20 cm). 
The SEE software (Strategy for the Exploration of Exploration; (Kafkafi and Elmer, 2005) 
was used to smoothen path shape and calculate specific measures of locomotor behavior. 
SEE uses the distribution of speed peaks to parse the locomotor data and to slow local 
movements (so-called lingering episodes) and progression segments.  
Light-Dark box 
Mice were introduced into the dark compartment (< 10 lx; 25 x 25 x 30 cm, length x width x 
height) of a light-dark box and the lit was closed. After one minute the bright light was 
switched on, and the door to the brightly lit compartment (320 lx; same dimensions) was 
opened. Exploratory behavior of eight mice was video tracked simultaneously for 10 min 
(12.5 frames/s, EthoVision 3.0, Noldus Information Technology). The number of transitions 
into, and the total time spent in the light compartment were calculated using the hidden zone 
feature in EthoVision with the border of crossing into the light compartment defined two cm 
away from the door in the light compartment. 
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Elevated plus maze 
Mice were introduced into the closed arm of an elevated plus maze (EPM, arms 30 x 6 cm, 
walls 35 cm high, elevated 50 cm above the ground), all facing the same closed end of the 
arm. The EPM was illuminated with a single white fluorescent light bulb from above (130 lx) 
and exploratory behavior was video tracked for five min (12.5 frames/s, EthoVision 3.0, 
Noldus Information Technology, The Netherlands). The border between center and arm 
entries was defined at two cm into each arm, producing the number of entries and total 
duration in the open arms, closed arms and the center platform. 
Rotarod 
Motor performance was tested using a rotarod device as previously described (van Hagen et 
al., 2007). In short, mice were placed on a rotating rod, and the latency to fall off the rod was 
recorded as a measurement of motor performance. Mice were initially trained to stay on a 
stationary rod and on a rod at a constant rotational speed of two rpm. Next, their latency to 
drop off was measured with increasing rotational speed (from 2 to 12 rpm in 2 min) during 
four different sessions. 
Fear conditioning 
Fear conditioning experiments were carried out as described (Misane et al., 2005; Stiedl et 
al., 2000) using a computerized fear conditioning system (TSE, 303410, Bad Homburg, 
Germany). In brief, mice were placed in an acrylic cage mounted into a constant illuminated 
(450 lux) fear conditioning box. After a 180 s exploration period, mice received a 2 s foot 
shock (0.7 mA) delivered through a metal floor grid. Mice were returned to their home cages 
30 s after termination of the shock. Activity, exploration and freezing (lack of movement 
aside from respiration and heart beat) were measured automatically via infrared lasers before, 
during and after the shock. Contextual fear memory was measured as the time spent freezing 
after re-exposure of the animals to the conditioned context at various time points after 
receiving the shock. 
  
 The ubiquitin ligase TRIM3 affects hippocampal synaptic plasticity and learning in mice 
 41 
Results 
TRIM3 is a synaptic E3 ubiquitin ligase expressed in hippocampus and 
cerebellum 
We first aimed to confirm that TRIM3 is an ubiquitin ligase. We generated expression 
constructs for full length TRIM3, and for mutant TRIM3 lacking the RING/B-box/coiled-
coil domain (ΔRBCC- RIM3; Figure 1A). When we expressed these constructs in HEK293 
cells and immunoblotted the cell lysates for ubiquitin, we observed a strong increase in high-
molecular weight ubiquitin staining specifically in TRIM3-expressing cells (Figure 1B). 
These findings indicate that TRIM3, but not ΔRBCC-TRIM3, has ubiquitin ligase activity, 
and confirm previous work by Hung et al. (2010), who showed that TRIM3 can poly-
ubiquitylate the protein GKAP in vitro. These same authors also showed that TRIM3 protein 
is enriched in biochemically isolated light membrane fractions from the cortex, suggesting 
synaptic localization. When we performed biochemical enrichment on hippocampal tissue 
and analyzed the different fractions for the presence of TRIM3, we observed a similar 
distribution, with relatively high TRIM3 protein levels in the microsome fraction and in the 
synapse (Figure 1C). TRIM3 staining on brain sections subsequently showed that TRIM3 is 
most strongly expressed in two brain regions, the hippocampus and the cerebellum. In the 
hippocampus TRIM3 is expressed throughout the CA region, but less in the dentate gyrus 
(Figure 1D). The TRIM3 antibody clearly also labeled the dendrites of CA pyramidal cells 
(Figure 1E). In the cerebellum TRIM3 protein is localized in the granular layer, the molecular 
layer and in the deep cerebellar nuclei (Figure 1F - H). A double staining for TRIM3 and 
Calbindin, a Purkinje cell marker, confirmed that TRIM3 is specifically expressed in 
molecular and granule cell layer, but not in Purkinje cells. TRIM3 protein staining in the 
cerebellum opposes that of TRIM2, which is absent in molecular and granular cell layer, but 
present in Purkinje cells. Absence of staining in Trim3-/- sections confirmed the specificity of 
the antibody (Figures 1D’ - H’). We also stained cultured hippocampal neurons for TRIM3 
and observed a punctate labeling in MAP2-positive dendrites, consistent with microsomal 
and/or synaptic localization and with the previous findings of Hung et al. (2010). Together 
these data confirm that TRIM3 is a synaptic ubiquitin ligase. 
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Figure 1 TRIM3 is a synaptically localized ubiquitin ligase expressed in hippocampus and 
cerebellum. (A) Schematic diagram of full-length TRIM3 and ΔRBCC-TRIM3 constructs. Deletion of 
the RBCC domain abolishes E3 ligase activity (Hung et al., 2010). R, RING; B, B-box; CC, coiled-
coil; ABP280, actin-binding protein 280 repeat; NHL repeat, NCL-1/HT2A/LIN-41 repeat. (B) TRIM3 
induces poly-ubiquitylation in HEK293 cells. Lysates from HEK293 cells expressing full length 
TRIM3 or ΔRBCC-TRIM3 and mock-transfected cell lysates were subjected to WB analysis using an 
anti-ubiquitin (Ub) antibody. Increased poly-ubiquitylation is evidenced by a strong increase in high-
molecular weight ubiquitin staining. Actin staining is shown as loading control. (C) TRIM3 is enriched 
in microsomal and synaptic fractions. Biochemical fractionation of hippocampal tissue followed by 
Western blot (WB) analysis showed that TRIM3 protein is enriched in the postsynaptic density fraction 
and in microsomes. Synaptic enrichment is evidenced by PSD95 staining. 
(D - H) Immunohistochemistry showed that TRIM3 protein is highly expressed in hippocampus and 
cerebellum. (D - E) In the hippocampus TRIM3 staining is found throughout the CA regions, but less 
in the dentate gyrus (DG) (D). TRIM3 was primarily detected in CA pyramidal cell bodies, but also in 
dendrites (arrows in E). (F - H) In the cerebellum TRIM3 protein is expressed in the granule layer (GL) 
and molecular layer (ML), but not in the Purkinje cell layer (PCL). (G) In the molecular layer, TRIM3 
labeling is strongest at the pial surface (arrows). (H) Trim3/Calbindin immunofluorescence double 
staining (red = TRIM3, green = calbindin) confirms the absence of TRIM3 protein in Purkinje cells. 
(D’ - H’) Staining of hippocampal and cerebellar sections from Trim3-/- animals confirmed the 
specificity of the TRIM3 labeling. (I - K) Immunocytochemistry revealed a punctuate staining of 
TRIM3 in dendrites of cultured primary hippocampal neurons. Neurons were cultured for 14 days and 
then labeled with antibodies against MAP2 (green; I) and TRIM3 (red; J). The overlay image clearly 
revealed TRIM3-positive puncta inside MAP2-positive dendrites (K).  
 
Trim3-/- mice have a hippocampal memory and plasticity deficit 
Having confirmed that TRIM3 is a synaptically localized ubiquitin ligase in the 
hippocampus, we next tested whether loss of TRIM3 causes memory and plasticity deficits. 
We recently generated a Trim3-/- mouse (Labonte et al., 2013), which we here used for 
detailed morphological and functional analyses. Nissl staining revealed normal hippocampal 
morphology (Figure 2A), and Golgi-Cox staining did not indicate major differences in the 
dendritic morphology of CA1 and CA3 pyramidal neurons (Figures 2B - C) and dentate gyrus 
granule neurons (Figure 2D) between Trim3-/- mice and wildtype controls. The gross 
morphology and layering of the cerebellum are also intact in Trim3-/- mice (Figures 2E - F). 
Purkinje cell specific Calbindin staining further confirmed the integrity of the Purkinje cell 
layer (Figure 2H) and Golgi-Cox staining of Purkinje cells (Figure 2G) and cerebellar granule 
cells (Figure 2I) did not reveal major differences in cellular morphology. 
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Figure 2 Trim3-/- mice exhibit no brain morphological abnormalities (A) Nissl staining showed 
normal gross morphology of the hippocampus in Trim3-/- mice (A) compared with wildtype controls 
(A’) at four months of age. (B - D) Golgi-cox staining showed normal cellular morphology of CA1 (B) 
and CA3 (C) pyramidal neurons and of granule neurons in the dentate gyrus (D) in Trim3-/- mice 
compared with wildtype controls (B’ - D’). CA; cornu amonis; DG, dentate gyrus. (E - F) Cerebellar 
morphology is normal in Trim3-/- mice. (E) Nissl staining showed normal gross morphology of the 
cerebellum (H) Calbindin staining confirmed normal appearance of the Purkinje cell layer. 
(G - I) Golgi-cox staining showed normal cellular morphology of Purkinje cells (G) and cerebellar 
granule neurons (I). 
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Behavioral analysis of Trim3-/- mice did not reveal important alterations in basal 
performance. We specifically assessed anxiety, locomotor behavior and motor coordination 
using open field, dark-light box, elevated plus maze and rotarod tests. In all tests, three 
months old Trim3-/- mice and wildtype controls scored comparable on all test parameters 
(Table 1). In a contextual fear memory task, however, we observed that Trim3-/- mice showed 
enhanced memory acquisition (Figure 3). Fear memory was measured as the amount of 
freezing that animals showed in an environment in which they had previously experienced a 
mild foot shock (Misane et al., 2005). Freezing was measured independently at 2 h (short-
term memory) and at 24 h (long-term memory) after the shock using separate cohorts of 
animals (Figure 3A). At 24 h, Trim3-/- mice and wildtype littermates showed a similar 
increase in freezing behavior (Figure 3B), indicating that long-term memory consolidation 
occurred equally well in both genotypes. However, at 2 h after the shock Trim3-/- mice 
showed significantly higher freezing levels compared with wildtype controls (p < 0.05, 
n = 8/10, WT 16.6 ± 2.8, KO 28.4 ± 5.1 % freezing) (Figure 3B). Notably, the level of 
freezing in Trim3-/- mice was already at the level that was observed for both genotypes at 
24 h after the shock. These data indicate that a fully consolidated fear memory is expressed 
much earlier in Trim3-/- mice compared with wildtype controls. 
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WT (n = 12)           KO (n=12) 
Mean ± SE             Mean ± SE    p-value  
Table 1. Behavioral analysis of Trim3 knock-out mice.        
    
Test / test measure unit     
 Open Field - Ethovision          
 Number of entries into the center area  84.83 ± 4.07 91.67 ± 6.36 0.375  
 Time spent in the center area s 314.5 ± 18.0 308.0 ± 18.4 0.803  
 Total distance traveled 5602 ± 264 5819 ± 345 0.622  
 Open Field - SEE analysis - velocity          
 Lingering progression threshold speed cm/s 12.05 ± 0.61 12.89 ± 0.83 0.418  
 Median of move segment max speed cm/s 24.03 ± 0.69 25.01 ± 1.00 0.425  
 Quantile 95 of move segment max speed cm/s 35.80 ± 0.89 35.54 ± 1.03 0.850  
 Lingering mean speed cm/s 1.65 ± 0.10 1.66 ± 0.10 0.988  
 Median of lingering segment max speed cm/s 3.17 ± 0.40 2.28 ± 0.60 0.231  
 Open Field - SEE analysis - acceleration          
 Latency to max half speed s 8.65 ± 3.84 5.88 ± 1.62 0.513  
 Median segment acceleration to max speed cm/s2 15.77 ± 0.69 15.44 ± 0.57 0.715  
 Open Field - SEE analysis - other          
 Number of progression segments segments 143.3 ± 10.7 142.0 ± 10.2 0.934  
 Median length of progression segments cm 24.73 ± 0.96 28.40 ± 2.08 0.123  
 Median duration of progression segments s 1.55 ± 0.05 1.63 ± 0.07 0.369  
 Quantile 5 of duration of progression segments s 0.55 ± 0.03 0.57 ± 0.04 0.755  
 Quantile 95 of duration of progression segments s 3.38 ± 0.10 3.62 ± 0.14 0.172  
 Number of stops per distance segments/cm 0.03 ± 0.00 0.03 ± 0.00 0.386  
 Time proportion of lingering episodes   0.59 ± 0.03 0.58 ± 0.03 0.651  
 Median radius of turn cm 77.69 ± 3.74 81.05 ± 3.41 0.513  
 Median turn rate degrees/s 14.06 ± 0.58 13.83 ± 0.48 0.761  
 Light-Dark Box          
 Number of entries into the light compartment  29.50 ± 3.30 38.00 ± 3.67 0.099  
 Time spent in the light compartment s 301.1 ± 17.2 305.2 ± 16.7 0.863  
 Elevated Plus Maze          
 Number of entries into the closed arms  22.00 ± 1.93 23.50 ± 1.81 0.576  
 Number of entries into the open arms  28.42 ± 2.94 32.75 ± 2.66 0.287  
 Number of entries into the middle  25.92 ± 2.53 29.58 ± 2.18 0.284  
 Time spent in the closed arms s 419.8 ± 15.0 395.7 ± 7.9 0.171  
 Time spent in the open arms s 159.7 ± 12.6 175.2 ± 8.3 0.315  
 Time spent in the middle s 84.64 ± 7.37 110.07 ± 7.87 0.028  
 Total distance moved cm 1552 ± 86 1608 ± 76 0.632  
 Rotarod          
 Latency to fall (session 1) s 163 ± 17 172 ± 23 0.761  
 Latency to fall (session 2) s 217 ± 21 213 ± 20 0.892  
 Latency to fall (session 3) s 238 ± 20 208 ± 24 0.351  
 Latency to fall (session 4) s 224 ± 27 224 ± 20 0.999  
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Figure 3 Contextual fear memory is enhanced in Trim3-/- mice. (A) Hippocampal memory 
performance was measured in a contextual fear memory task. Animals received a mild foot shock 
(unconditioned stimulus; US) in a novel context (conditioned stimulus; CS). Memory retrieval was 
tested either 2 h (short-term memory; STM) or 24 h (long-term memory; LTM) after conditioning by 
re-exposing animals to the shock-associated context (CS) and measuring the amount of freezing. STM 
and LTM were tested in two independent cohorts of mice. (B) Freezing behavior was significantly 
increased in Trim3-/- mice compared with wildtype littermates when re-exposed to the conditioned 
context 2 h after receiving the shock (STM), but not at 24 h (LTM), indicating enhanced consolidation 
of fear memory (means ± SEM, two-tailed t test, *p < 0.05, n = 8/10 per genotype). 
 
  Trim2-/- mice show a strong age-dependent neurodegenerative phenotype (Balastik 
et al., 2008). Because TRIM3 and TRIM2 are very similar, we wanted to exclude the 
possibility that the behavioral phenotype of Trim3-/- mice is also due to neurodegeneration 
and thus performed morphological and behavioral analyses in an independent cohort of eight 
month old animals. Gross hippocampal morphology was not affected in Trim3-/- mice at eight 
months of age (Supplemental Figure S1) and basal behavioral analyses did not reveal 
important alterations either (Supplemental Table S1). Importantly, enhanced memory 
consolidation after contextual fear conditioning was still observed in Trim3-/- mice at this age 
(Supplemental Figures S1 B - C), indicating that this phenotype is robust and unique, and not 
the result of other major morphological or behavioral alterations. 
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 We then asked whether there are structural or physiological impairments in Trim3-/- 
mice that might explain the observed enhancement of fear memory consolidation. 
Spontaneous synaptic activity measurements in acute hippocampal slice preparations did not 
reveal significant differences between genotypes in either EPSC (Figure 4A) or IPSC (Figure 
4B) amplitude (EPSC, WT: 12.11 ± 0.55, KO: 13.13 ± 1.01; IPSC, WT: 40.6 ± 5.1, 
KO: 33.71 ± 3.99 [pA]), frequency (EPSC, WT: 3.34 ± 0.95, KO: 1.98 ± 0.83; IPSC, 
WT: 12.37 ± 1.81, KO: 9.52 ± 2.14 [Hz]), rise time (EPSC, WT: 1.82 ± 0.14, 
KO: 1.96 ± 0.15; IPSC, WT: 1.50 ± 0.06, KO: 1.42 ± 0.05 [ms]) or decay time (EPSC, 
WT: 6.52 ± 0.47, KO: 6.85 ± 0.43; IPSC, WT: 16.26 ± 0.97, KO: 14.84 ± 1.12 [ms]). 
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Figure 4 Hippocampal LTP, but not basal transmission, is increased in Trim3-/- mice. 
(A - B) Spontaneous excitatory (A) and inhibitory (B) synaptic transmissions are unaffected in 
Trim3-/- mice. Excitatory synaptic currents (mEPSC) (A) and inhibitory synaptic currents (mIPSCs) (B) 
were recorded from acute hippocampal slices. Frequency, amplitude, rise time and decay time of both 
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excitatory and inhibitory currents were unaffected in Trim3-/- mice compared to wildtype controls 
(means ± SEM, n = 6/8 for EPSCs, n = 10 for IPSCs). (C - F) Hippocampal LTP is enhanced after 
tetanus stimulation. (C) LTP was induced in acute hippocampal slices using a single stimulation 
electrode in the Schaffer collateral pathway and field excitatory postsynaptic potentials (fEPSPs) were 
recorded using an 8 x 8 multi-electrode array (black dots) in the CA1 area. (D) Example fEPSP traces 
from a wildtype control and a Trim3-/- mouse (D’) before (grey) and after (black) tetanus stimulation 
indicate stronger potentiation in Trim3-/- mice. (E) Averaged fEPSP data show enhanced LTP in 
Trim3-/- animals compared to wildtype mice, in particular in the first 30 min after theta burst stimulation 
(TBS). (F) Quantification of the average amount of potentiation at 10 - 20 min and 20 - 30 min after 
TBS showed a significant increase in Trim3-/- mice compared to wildtype controls (means ± SEM, two-
tailed t test, *p < 0.05, n = 12/13 per genotype). 
 
Hippocampal long-term potentiation (LTP), however, was significantly enhanced in 
slices from Trim3-/- mice compared with wildtype controls. LTP was induced in acute 
hippocampal slices by theta burst stimulation of the Schaffer collateral pathway using a single 
stimulation electrode, and recorded in CA1 using an 8x8 multi-electrode array (Figure 4C). 
Potentiation was readily detected in slices from both genotypes (Figure 4D), but Trim3-/- 
slices showed on average a stronger potentiation compared with wildtype controls 
(Figure 4E). This increase in LTP was significant at 10 - 20 min and at 20 - 30 min after 
induction (10 – 20 min: WT 144 ± 4.8, KO 171.2 ± 9.6 %; 20 – 30 min: WT 146.1 ± 4.6, 
KO 171.7 ± 10.4 %) (Figure 4F). We next filled hippocampal CA1 neurons in slices from 
Trim3-/- mice and wildtype controls with biocytin and collected high-resolution confocal 
images of the first basal and oblique dendrite of each neuron (Figures 5A - E). Automated 
quantification of spine densities revealed that Trim3-/- dendrites on average have a higher 
spine density compared with wildtype control dendrites (WT 1 ± 0.03, KO 1.13 ± 0.06 %; 
1.76 ± 0.05 spines/µm in WT and 1.99 ± 0.10 spines/µm in Trim3-/-) (Figure 5F). Spine head 
diameter (Figures 5G - H) and spine length (Figures 5I - J) on the other hand were unaffected 
in Trim3-/- mice (diameter, WT 0.36 ± 0.01 µm, KO 0.36 ± 0.01 µm; length, WT 0.77 ± 0.02 
µm and KO 0.81 ± 0.02 µm). Together these data indicate that increased LTP and increased 
spine densities in the hippocampus may provide the physiological and the structural basis for 
enhanced fear memory consolidation in Trim3-/- mice. 
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Figure 5 Spine density is increased in Trim3-/- mice, while spine length and spine head diameter 
are unaffected. (A - B) Example of a confocal image of a patched hippocampal CA1 pyramidal cell 
filled with biocytin and stained with streptavidin-Alexa 488. (A) The image shows the location of cell 
bodies the in the hippocampus in red. Scale bar, 200 µm. (B) Zoom of (A) showing the first basal and 
oblique dendrite (boxed). Scale bar, 100 µm. (C - D) Maximum intensity z-projections from confocal 
stacks (resolution 80 x 80 x 125 nm/pixel, xyz) of the first basal and the first oblique dendrite of each 
cell were selected for spine density measurements. Images correspond to the boxes in (B). 
(E) Representative images of dendrite segments from Trim3-/- mice and wildtype controls used for 
analysis. Scale bar, 10 µm (overview) and 2 µm (enlargement). (F) Average spine density was 
significantly higher in Trim3-/- mice compared to wildtype controls (means ± SEM, two-tailed t test, *p 
< 0.05, n = 6/11 per genotype). (G - H) Analysis of spine head diameter revealed no differences 
between wildtype animals and Trim3-/- mice. (G) Average spine head diameter did not differ between 
wildtype and Trim3-/- mice. (H) Cumulative frequency plot of spine head diameters of wildtype and 
Trim3-/- mice revealed no differences. (I) Spine length was slightly, but not significantly, increased in 
Trim3-/- mice (means ± SEM, two-tailed t test, p ˃ 0.05, n = 6/11). (J) Frequency distributions of spine 
length did not differ between Trim3-/- and wildtype mice. 
 
Discussion 
In this study we aimed to elucidate the role of TRIM3 in learning and memory. We were able 
to demonstrate that TRIM3, like its two closest relatives TRIM2 and TRIM32, is an E3 
ubiquitin ligase (Balastik et al., 2008; Hung et al., 2010; Kudryashova et al., 2005) and that 
in accordance with Raheja et al. (2014) the ability of TRIM3 to ubiquitylate is RING domain-
dependent. TRIM3 is highly expressed in the brain, predominantly in the hippocampus and 
the cerebellum. The observed TRIM3 protein expression patterns are in accordance with 
Trim3 mRNA expression reported previously (El-Husseini, 1999). Interestingly, we 
additionally observed dendritic TRIM3 protein staining of hippocampal pyramidal cells, 
suggesting postsynaptic localization, which is confirmed by biochemical enrichment analysis 
showing relatively high levels of TRIM3 in synaptic fractions. In the cerebellum however, 
high levels of TRIM3 staining were observed in the granular and molecular layers, indicating 
that the protein is synthesized in granule neurons and localized pre-synaptically in granule 
cell axons terminating on Purkinje cell dendrites in the molecular layer. Thus, the subcellular 
localization of TRIM3 may be different in the cerebellum compared with the hippocampus. 
The expression pattern of TRIM3 in the cerebellum is strikingly different from that of its 
paralogue TRIM2, which is highly expressed in Purkinje cells (Balastik et al., 2008; Ohkawa 
et al., 2001). Only in the deep cerebellar nuclei TRIM2 and TRIM3 expression appears to 
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overlap. TRIM2 mutant mice have a strong and progressive neurodegenerative phenotype 
(Balastik et al., 2008). At the age of 6 weeks TRIM2 mutant mice start to show intention 
tremor and gait ataxia due to the degeneration of cerebellar Purkinje cells, and at later stages 
they have episodes of spontaneous generalized seizures. Purkinje cell degeneration appears 
to be due to axonal swellings caused by the accumulation of neurofilament light chain 
protein, which was identified as the TRIM2 substrate. In strong contrast, Trim3-/- mice are 
morphologically and behaviorally indistinguishable from their wildtype littermates up to the 
age of 12 months. Locomotion and motor coordination were unaffected, and these mice did 
not develop seizures, nor did they show signs of neurodegeneration. Based on these findings 
we conclude that TRIM2 and TRIM3 have very different functions in the cerebellum. They 
are not only expressed in different cell types and at different subcellular locations, but also 
the neurodegenerative phenotype of TRIM2 mutant mice is not recapitulated in Trim3-/- mice. 
The exact cerebellar phenotype of Trim3-/- mice is at this moment still elusive, and we cannot 
exclude that fine motor skills or motor learning functions are affected. 
In the hippocampus, TRIM2 and TRIM3 expression overlap completely, yet their 
specific contribution to hippocampal function has not been studied. We therefore decided to 
find evidence for a role of TRIM3 in the hippocampus. Trim2 and Trim32 knockout mice 
have both been thoroughly investigated, but no behavioral abnormalities were reported. 
Trim3-/- mice, in contrast to Trim2-/- mice, did not present with a neurodegenerative 
phenotype, which lead us to assume that also their behavior would hardly be affected. Indeed, 
observed basal behavior of our Trim3-/- mice was normal. Contextual fear conditioning on 
the other hand revealed a most striking and very specific phenotype. Trim3-/- mice showed 
fully consolidated fear memory already two hours after fear conditioning. This result was 
also reproducible in older mice. Interestingly we identified two underlying phenomena, 
alterations in spine density and LTP, which could potentially cause such a specific phenotype 
on a cellular level. Trim3-/- mice have significantly higher spine density in hippocampal 
pyramidal cells. Over the last two decades numerous studies suggested high spine densities 
to be direct correlates of different sorts of learning (Knafo et al., 2004; Moser et al., 1994; 
O'Malley et al., 1998). Following that reasoning, it is rational to assume that a stronger fear 
memory in Trim3-/- mice can be formed due to a higher number of spines and likely a higher 
number of functional synapses. In this regard it is worth noting that Hung et al. (2010) did 
not observe a change in spine density after overexpressing TRIM3 in cultured rat 
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hippocampal neurons. They did however observe a significant decrease in spine head width, 
which may indeed present a first step towards spine pruning, eventually resulting in lower 
spine density corroborating our finding. 
The second mechanism potentially underlying increased fear memory in Trim3-/- 
mice is LTP. Cheung et al. (2010) reported a significant decrease in mIPSC amplitude in 
cortical neurons from TRIM3 deficient mice, a finding that we were not able confirm in 
hippocampal pyramidal cells. Recordings of spontaneous activity in slices of Trim3-/- mice 
did not show any differences in amplitude, frequency, rise time and decay time compared 
with recordings from wildtype animals. Intriguingly, we observed significantly enhanced 
LTP in hippocampal slices 10 – 30 minutes after stimulation, suggesting that TRIM3 or one 
of its ubiquitylation substrates plays a role in the induction and early phase of LTP, but not 
in the maintenance. This raises the question of how TRIM3 could directly affect the 
expression of LTP in the hippocampus. It is conceivable that TRIM3 is directly involved in 
AMPA receptor trafficking. The first demonstrated interactors of TRIM3 were myosin V (El-
Husseini, 1999) and alpha-actinin-4. Both are known to be part of the CART complex (Yan 
et al., 2005), which is required for efficient recycling of transferrin receptors and epidermal 
growth factor receptors. Only recently, two studies identified myosin Va and Vb as important 
motor proteins delivering cargo vesicles containing AMPA receptors (Correia et al., 2008; 
Wang et al., 2008) and alpha-actinin was shown to play a role in AMPA receptor transport 
in dendritic spines (Schulz et al., 2004). In addition we had previously demonstrated that 
TRIM3 interacts with KIF21B, another motor protein, and increases its motility (Labonte et 
al., 2013). 
Kanai et al. (2004) showed that TRIM3 is associated with yet another motor protein 
KIF5, which transports TRIM3 as part as of mRNP granules. This indicates that TRIM3 
exerts its function localized, possibly at post-synaptic sites. Interestingly, we also detected 
high levels of TRIM3 in the microsomal fraction, suggesting that TRIM3 may be associated 
with vesicular structures. In line with these observations, TRIM3 is present in punctate 
structures along dendrites of cultured primary hippocampal neurons. The punctate TRIM3 
staining we observed is likely to be TRIM3 as part of these transport granules. Whether or 
how TRIM3 may affect transport granule attributes, i.e. composition, localization and 
mobility is not clear and demands further investigation. 
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To summarize, loss of TRIM3 very specifically increases hippocampus dependent 
fear memory acquisition. This increase most likely results from higher spine density and 
increased LTP. However, at this stage it can only be speculated how, where and by what 
molecular mechanism TRIM3 influences memory consolidation, LTP and spine density. 
These questions need further investigation and will be addressed in the following chapters. 
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Supplementary 
 
Supplemental Table S1. Behavioral analysis of Trim3 knock-out mice at eight months of age.   
  WT (n = 14) KO (n = 12)  
Test / test measure unit Mean ± SE Mean ± SE p-value 
          
Open Field - Ethovision         
 Number of entries into the center area  37.29 ± 3.67 41.08 ± 4.06 0.493 
 Time spent in the center area s 65.0 ± 6.4 85.8 ± 20.0 0.303 
 Total distance traveled cm 4729 ± 341 5290 ± 303 0.238 
          
Open Field - SEE analysis - velocity         
 Lingering progression threshold speed cm/s 12.52 ± 0.67 14.83 ± 0.78 0.034 
 Median of move segment max speed cm/s 21.55 ± 1.10 24.94 ± 1.09 0.040 
 Quantile 95 of move segment max speed cm/s 30.22 ± 1.13 34.18 ± 1.33 0.031 
 Lingering mean speed cm/s 1.77 ± 0.10 1.84 ± 0.14 0.687 
 Median of lingering segment max speed cm/s 4.41 ± 0.40 4.07 ± 0.35 0.540 
          
Open Field - SEE analysis - acceleration         
 Latency to max half speed s 10.71 ± 2.87 13.01 ± 4.07 0.642 
 Median segment acceleration to max speed cm/s2 13.59 ± 0.36 14.55 ± 0.57 0.155 
          
Open Field - SEE analysis - other         
 Number of progression segments segments 112.5 ± 8.3 114.8 ± 6.0 0.828 
 Median length of progression segments cm 23.83 ± 2.03 30.66 ± 1.99 0.026 
 Median duration of progression segments s 1.58 ± 0.08 1.76 ± 0.06 0.075 
 
Quantile 5 of duration of progression 
segments s 0.59 ± 0.05 0.67 ± 0.03 0.238 
 
Quantile 95 of duration of progression 
segments s 3.35 ± 0.15 3.68 ± 0.13 0.119 
 Number of stops per distance 
segments/c
m 0.03 ± 0.00 0.03 ± 0.00 0.109 
 Time proportion of lingering episodes   0.67 ± 0.03 0.63 ± 0.02 0.389 
 Median radius of turn cm 75.43 ± 4.17 83.35 ± 5.29 0.245 
 Median turn rate degrees/s 13.23 ± 0.54 13.45 ± 0.79 0.812 
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Figure S1 Trim3-/- mice at the age of 8 months have normal hippocampal morphology and show 
enhanced contextual fear memory. Nissl staining showed normal gross morphology of the 
hippocampus in eight months old Trim3-/- mice (A) compared with wildtype controls (A’). 
(B) Hippocampal memory performance in a contextual fear memory task. Animals received a mild foot 
shock (unconditioned stimulus; US) in a novel context (conditioned stimulus; CS). Memory retrieval 
was tested either 2 h (short-term memory; STM) or 24 h (long-term memory; LTM) after conditioning 
by re-exposing animals to the shock-associated context (CS) and measuring the amount of freezing. 
STM and LTM were tested in two independent cohorts of mice. (C) Freezing behavior was significantly 
increased in Trim3-/- mice compared with wildtype littermates when re-exposed to the conditioned 
context 2 h after receiving the shock (STM), but not at 24h (LTM), indicating enhanced consolidation 
of fear memory (means ± SEM, two-tailed t test, *p < 0.05, n = 5/7 per genotype). 
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Abstract 
Over the last decades local protein synthesis in neurons has attracted a lot of research. The 
complexity of neuronal cell architecture, the long distances between cell somata and 
synapses, and the plasticity of the system require temporally and spatially controlled protein 
synthesis. The majority of messenger RNAs for local translation travels within messenger 
ribonucleoprotein (mRNP) particles. TRIM3 was shown to be part of RNA binding protein 
Pur-alpha (PURA) -containing mRNP particles. We have previously described the phenotype 
of TRIM3 deficient mice, showing enhanced memory consolidation, enhanced long-term 
potentiation and an increase in spine density. In this chapter we assessed whether observed 
changes of Trim3-/- mice might be explained by a role of TRIM3 in mRNP trafficking. By 
co-immunoprecipitation and overexpression experiments we first determined whether 
TRIM3 interacts with PURA and whether PURA is an ubiquitylation substrate of TRIM3. 
We then investigated mRNP trafficking in cultured neurons and analyzed mobility 
parameters in the presence or absence of TRIM3. We found that TRIM3 and PURA do not 
directly interact, but that they are part of the same mRNP granules. We furthermore found 
that TRIM3 is not essential for mRNP trafficking, but that the loss of TRIM3 increased 
travelled distance and velocity of a long distance sub-population of mRNP particles. We 
conclude that the observed characteristics of TRIM3 deficient mice are not caused by the role 
of TRIM3 in mRNP trafficking. 
 
Introduction 
Neurons are highly polarized cells, with dendritic trees and axons often extending far from 
the cell body. This specialized cellular architecture is on one hand the basis of many unique 
neuronal properties, but it also presents a very unique cellular challenge. How can axons, 
dendrites and even individual synapses be quickly and specifically supplied with all the 
needed proteins at times of high demand? 
A leap towards answering that question came in 1982 when Steward and Levy 
showed that polyribosomes are found at the base of spines in hippocampal granule cells 
(Steward and Levy, 1982), opening the possibility of local mRNA translation into protein. In 
the following decades increasing evidence on local protein synthesis was gathered. Many 
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different mRNAs, such as MAP2 (Garner et al., 1988), CAMKIIα (Burgin et al., 1990), 
SHANK (Bockers et al., 2004) and others were found to be localized in or near synapses of 
murine neurons. Recent studies even suggest that the number of different protein coding 
mRNAs in axons and dendrites is rather in the thousands than in single digits (Cajigas et al., 
2012; Zivraj et al., 2010). In fact, Lécuyer et al. (2007) showed that in Drosophila embryos 
71 % of all expressed genes encode mRNAs that are highly localized in non-nuclear 
subcellular compartments (Lecuyer et al., 2007), suggesting that local mRNA translation is 
not an isolated phenomenon in mammalian neurons, but rather a common theme. 
In neurons, localized RNAs are often transported in messenger ribonucleoprotein 
(mRNP) granules containing mRNAs and a multitude of proteins, many of which are RNA 
binding proteins (Kiebler and DesGroseillers, 2000; Knowles et al., 1996; Kohrmann et al., 
1999). One of the major components of neuronal mRNP granules is the RNA binding protein 
Pur-alpha (PURA) (Elvira et al., 2006; Kanai et al., 2004; Ohashi et al., 2002). PURA was 
shown to be essential for postnatal brain development. Pura knockout mice are normal at 
birth, but develop neurological problems after two weeks and die at the age of four weeks 
(Khalili et al., 2003). Immunohistochemical analysis of these mice revealed decreased neuron 
numbers in the hippocampus, and a profound reduction in synapse formation. Kanai et al. 
(2004) further demonstrated that PURA is essential for mRNA transport. 
In their groundbreaking study, Kanai et al. (2004) identified 42 protein components 
of mRNP granules associated with motor protein KIF5. Using RNA interference they 
determined that not all of these proteins are essential for mRNP trafficking. The knock-down 
of PURA, hnRNP-U, PSF and STAUFEN, each significantly suppressed RNA dispersion in 
dendrites, but dendritic RNA localization was not affected when DDX3 or SYNGRIP were 
knocked down (Kanai et al., 2004). Based on their results, and on available functional data 
from other studies, they classified most mRNP proteins in five different groups: RNA 
transport, protein synthesis, RNA helicases, heterogeneous nuclear ribonucleoproteins and 
other RNA-associated proteins. Interestingly, the same study also identified TRIM2 and 
TRIM3 as part of mRNP granules. TRIM2 and TRIM3 were not studied in detail, and were 
simply classified as ‘other proteins’ with unknown functions. Given the role of TRIM3 in 
regulating plasticity, in particular the increased long-term potentiation (LTP) and spine 
density phenotype observed in Trim3-/- mice (see Chapter 2), we wondered whether this 
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phenotype might be related to the presence of TRIM3 in mRNP granules. The goal of this 
study was to identify a role for TRIM3 in dendritic mRNP trafficking as a possible 
explanation for the observed behavioral, structural and electrophysiological phenotype found 
in Trim3-/- mice as described in chapter 2. 
 
Material and Methods 
Animals 
Trim3-/- mice were maintained on a C57BL/6J background. In all experiments wildtype 
littermates were used as controls. Mice were individually housed on sawdust in standard 
Makrolon type II cages (26.5 cm long, 20.5 cm wide and 14.5 cm high) enriched with 
cardboard nesting material and a plastic tube under 12/12h dark/light cycle with access to 
water and food ad libitum. All animal experiments were approved by the animal ethics 
committee of the VU University Amsterdam. 
 
Synaptic protein isolation and quantification 
Brain tissue was obtained from mice under control conditions (home cage) and two hours 
after contextual fear conditioning (shock; see Chapter 2 for details). Animals were sacrificed 
by cervical dislocation. Cerebellum and hippocampus were dissected and synapse-enriched 
fractions isolated as previously described (Klemmer et al., 2009). Protein concentrations 
were measured using Bradford Protein-Assay (Bio-Rad Laboratories, USA) and equal 
amounts of protein were loaded on a 4 - 20% gradient SDS-PAGE gel (Criterion TGX Stain-
Free Gel, Bio-Rad Laboratories, USA). Total protein amounts were imaged after 
electrophoresis using Criterion Stain Free Imager (Bio-Rad Laboratories, USA). Gels were 
then transferred to polyvinylidene fluoride (PVDF) membranes (Bio-Rad Immuno-Blot 
PVDF membrane, Bio-Rad Laboratories, USA) and membranes were blocked by immersion 
in 5 % nonfat dry milk in TBS-T (TBS plus 0.025 % Tween, pH 7.4) for 1 h. Blots were then 
incubated with anti-PURA (ab79936, Abcam, 1:2,000) for 1 h at room temperature, followed 
by a 1 h incubation with a secondary antibody conjugated to HRP. Proteins were visualized 
by ECL (SuperSignal West Femto Chemiluminescent Substrate, Thermo Scientific, USA) 
and scanned using the Odyssey Fc imager (Li-Cor, USA). Protein quantities were calculated 
 TRIM3 participates in mRNP granules, but is not essential for mRNP granule trafficking 
 63 
by dividing the background corrected signal intensity of each protein band (ImageStudio 
Software v. 2.0.38, Li-Cor, USA) by the background corrected signal intensity of the 
corresponding stain-free gel protein lane (Image Lab 3.0, Bio-Rad, USA). Significance was 
tested using a two-tailed t test. 
 
Cell culture and immunoprecipitation 
Human embryonic kidney cells (HEK293) were maintained in Dulbecco’s modified Eagle 
medium supplemented with 10 % fetal bovine serum and 1 % Penicillin-Streptomycin (all 
from Life Technologies Thermo Fisher Scientific Inc., USA) at 37° C and 5 % CO2. Cells 
were co-transfected with myc-TRIM3 and GFP-PURA, myc-ΔRBCC-TRIM3 and 
GFP-PURA or GFP-PURA alone at 60 – 80 % confluency using polyethylenimine (PEI). 
Starting 12 h after transfection cells were sampled at three hour intervals for 12 hours. Cells 
were washed with ice cold PBS and subsequently lysed in SDS containing loading buffer. 
Samples were then separated and analyzed for PURA expression as described above. For 
immunoprecipitation (IP), HEK293 cells were co-transfected with myc-TRIM3 and 
GFP-PURA at 60 – 80 % confluence. At 48 h after transfection cells were washed with ice 
cold phosphate-buffered saline (PBS) and subsequently lysed in extraction buffer (1 % Triton 
X-100, 150 mM NaCl, 25 mM HEPES pH 7.4) supplemented with protease inhibitors 
(cOmplete Protease Inhibitor Cocktail, Roche Diagnostics) for 1 h at 4° C on a rotator. 
Insoluble material was pelleted at 20,000 g for 20 min and the supernatant used for IP. 
Antibodies used for IP were rabbit anti-PURA (ab79936, Abcam, 1:2,000) and rabbit anti-
TRIM3 (epitope: CLRPGDLPPSPDDVK, GenScript). IPs and input were separated on an 
8 % SDS-PAGE gel and transferred to PVDF membranes (Bio-Rad Immuno-Blot PVDF 
membrane, Bio-Rad Laboratories). Membranes were blocked by immersion in 5 % nonfat 
dry milk in TBS-T (TBS plus 0.025 % Tween, pH 7.4) for one hour, washed and incubated 
with antibodies for GFP (75-131, Neuromab, 1:2,000 ) and TRIM3 
(epitope: CLRPGDLPPSPDDVK, GenScript, 1:1,000) for 1 h at room temperature, followed 
by a 1 h incubation with a secondary antibody conjugated to horseradish peroxidase (HRP). 
Proteins were visualized by ECL (SuperSignal West Femto Chemiluminescent Substrate, 
Thermo Scientific, USA) and scanned using the Odyssey Fc imager (Li-Cor, USA). 
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Co-Immunoprecipitation of TRIM3 from hippocampus and cerebellum 
For an IP experiment 10 mg of synapse-enriched protein fractions (P2 + M) were extracted 
in an equal volume of 2 % Triton X-100, 150 mM NaCl, 25 mM HEPES pH 7.4, protease 
inhibitors (cOmplete Protease Inhibitor Cocktail, Roche Diagnostics) for 1 h on a rotator at 
4° C. Insoluble material was then pelleted at 20,000 g for 20 min at 4°C. The pellet was then 
re-extracted in 1 % Triton X-100, 150 mM NaCl, 25 mM HEPES pH 7.4, protease inhibitors 
for 1 h. Insoluble material was again pelleted at 20,000 g for 20 min. Supernatants from the 
first and second extraction were pooled, centrifuged at 20,000 g for 20 min and the final 
supernatant served as input for IPs. Input from wildtype animals was split in two; one half 
was treated with RNase inhibitors (40 u/ml RiboLock, Thermo Scientific, USA) and the other 
with RNase A (R4642, Sigma-Aldrich). Input from Trim3 knockout animals remained 
untreated. After 24h, 10 µg of anti-TRIM3 (epitope: QAPEGAHDPEDPHPC, GenScript) 
antibody was added to each sample and incubated overnight on a rotator at 4° C. On the next 
day, 30 µl of protein A/G beads (Protein A/G Plus-Agarose, Santa Cruz Biotechnology Inc., 
USA) were washed three times in washing buffer (0.1 % Triton X-100, 150 mM NaCl, 
25 mM HEPES pH 7.4) and added to each IP. Beads were incubated for 120 min on a rotator 
at 4° C, then pelleted at 2.500 g and washed four times in ice-cold washing buffer. TRIM3 
and interacting proteins were eluted by adding SDS containing loading buffer and boiling for 
five min. Samples were separated on SDS-PAGE and immunoblotted for PURA (ab79936, 
Abcam, 1:2,000).  
Time-lapse video microscopy 
Hippocampal primary neurons from Trim3-/- and wildtype mice were cultured on glass 
bottom dishes coated with 5 µg/ml ply-D-lysine. Cells were transfected with GFP-tagged 
PURA at DIV8 - 10. After 15 - 24 h cells were imaged. Imaging was performed in pre-
warmed HEPES buffer with an inverse fluorescence microscope Axiovert 200M (Zeiss, Jena, 
Germany) at 37° C in the incubation chamber (Harnischmacher-Labortechnik, Kassel, 
Germany). MetaVue software (verion 6.2r6, Molecular Devices, Munich, Germany) was 
used to record cells for 5 min at 3 - 5 s intervals. Analysis of various trafficking parameters 
was performed with the Metamorph software. Significance was tested using a two-tailed t 
test. 
  
 TRIM3 participates in mRNP granules, but is not essential for mRNP granule trafficking 
 65 
Results 
 
TRIM3 and PURA interaction and regulation 
To test whether enhanced contextual fear memory and/or the increase in LTP observed in 
Trim3-/- mice might be explained by a role of TRIM3 in mRNP trafficking, we first 
determined whether TRIM3 interacts PURA, one of the major components of mRNP 
particles in neurons (Elvira et al., 2006; Kanai et al., 2004; Ohashi et al., 2002). We performed 
co-immunoprecipitation of TRIM3 from hippocampal and cerebellar synapse enriched 
fractions. To test whether the observed interaction is RNA-dependent, we treated co-
immunoprecipitated fractions either with RNase inhibitors to preserve RNA, or with 
RNase A to break down RNA. Immunoblotting revealed that TRIM3 and PURA interact in 
an RNase-sensitive manner (Figure 1A - B), thus confirming that they indeed co-exist in 
mRNP particles, and that their interaction depends on the presence of RNA. Further evidence 
that TRIM3 and PURA do not directly interact came from co-expression experiments in 
heterologous cells. When we co-expressed TRIM3 and PURA in HEK293 cells and 
immunoprecipitated TRIM3 and PURA, PURA did not co-precipitate with TRIM3 and 
TRIM3 not with PURA (Figure 2A), confirming that the interaction observed in 
hippocampus and cerebellum is not direct. Given the fact that TRIM3 is an ubiquitin ligase 
(Raheja et al., 2014), we hypothesized that TRIM3 may negatively regulate PURA levels by 
ubiquitylation and subsequent proteasomal degradation. We therefore isolated hippocampal 
synaptosomal fractions from wildtype and Trim3-/- mice under basal conditions and two hours 
after contextual fear conditioning, the time point when enhanced memory consolidation was 
observed (see Chapter 2). We found no differences in PURA levels in Trim3-/- mice compared 
with wildtype controls, neither under basal conditions, nor at two hours after fear 
conditioning (Figure 1C - D). Moreover, when we co-expressed TRIM3 and PURA in 
HEK293 cells we observed a stable expression of PURA over time, independent of whether 
full length TRIM3 or ΔRBCC-TRIM3 were expressed (Figure 2B). Taken together these data 
demonstrate that PURA levels are not regulated by TRIM3. 
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Figure 1 TRIM3 is present in PURA containing mRNP particles, but does not directly interact 
with PURA or affect PURA abundance. (A - B) TRIM3 interacts with PURA in an RNA-dependent 
manner. Hippocampal (A) and cerebellar (B) synapse-enriched fractions were prepared and treated 
either with RNase A or with RNase inhibitor. TRIM3 was immunoprecipitated and samples were 
immunoblotted and stained for TRIM3 and PURA. PURA was detected in RNase inhibitor treated 
samples, but not in RNase treated samples. Samples prepared from Trim3-/- mice served as negative 
control for the immunoprecipitation. (C - D) PURA levels are not altered in Trim3-/- mice. 
(C) Hippocampal synapse-enriched fractions were prepared from wildtype and Trim3-/- mice under 
control conditions (home cage, HC) and 2 h after contextual fear conditioning (shock, SH). Samples 
were immunoblotted and stained for PURA (D). Normalized PURA levels were calculated by dividing 
Western blot (WB) signal intensities by the total protein intensities (stain-free gel) and expressed 
relative to wildtype levels. PURA levels did not differ between conditions (means ± SEM, n = 8 per 
genotype, 4 per condition).  
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Figure 2 TRIM3 does not directly interact with PURA or affect PURA abundance in HEK293 
cells. (A) TRIM3 and PURA do not interact when expressed in HEK293 cells. HEK293 cells were co-
transfected with full length TRIM3 and GFP-PURA. Cells were lysed 48 h after transfection. TRIM3 
and PURA were immunoprecipitated from lysates, immunoblotted and stained for TRIM3 and GFP 
(PURA). PURA did not co-immunoprecipitate with TRIM3, and TRIM3 not with PURA. (B) TRIM3 
does not alter PURA levels in HEK293 cells. HEK293 cells were co-transfected with PURA and 
TRIM3, PURA and ΔRBCC-TRIM3, or PURA alone. Starting 12 h after transfection cells were lysed 
at 3 h intervals and lysates were immunoblotted and stained for PURA. No differences in PURA levels 
in TRIM3 expressing cells were observed at any time point. 
 
TRIM3 and mRNP trafficking 
We next asked whether TRIM3 is important for regulating mRNP trafficking. We expressed 
GFP-tagged PURA in cultured hippocampal neurons derived from Trim3-/- mice or wildtype 
controls and quantified the mobility of GFP-positive PURA-containing mRNP particles 
(Figure 3A). The total number of particles observed was not different between genotypes 
(WT: 0.173 ± 0.01 clusters/µm, Trim3-/-: 0.155 ± 0.01 clusters/µm) (Figure 3B), nor was the 
percentage of mobile clusters (WT: 9.76 ± 1.37 %, Trim3-/-: 10.01 ± 1.27 %) (Figure 3C). 
We then separated mobile clusters in clusters that moved > 5 µm over the 90 second imaging 
period (long-distance clusters) and clusters that moved < 5 µm (short-distance clusters). No 
difference was observed in the percentage of long- and short-distance moving clusters 
between genotypes (long distance, WT: 29.56 ± 5.83 %, Trim3-/-: 26.09 ± 5.8 %; short 
distance, WT: 70.44 ± 5.83 %, Trim3-/-: 73.91 ± 5.8 %) (Figure 3D). When we analyzed the 
kinetics of long-distance moving clusters separately, we observed no difference in the total 
distance moved (WT: 13.15 ± 0.86 µm, Trim3-/-: 15.77 ± 1.57 µm) (Figure 3E), and a small 
but significant increase in Trim3-/- neurons compared with wildtype controls in the maximum 
velocity of clusters (WT: 0.72 ± 0.04 µm / s, Trim3-/-: 0.91 ± 0.09 µm/s, p ˂ 0.05) (Figure 3F) 
and the maximum distance they reached, measured from origin (WT: 8.15 ± 0.43 µm, 
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Trim3-/- 10.39 ± 1.16, p ˂  0.05) (Figure 3G). For short-distance moving clusters none of these 
parameters was significantly affected in Trim3-/- neurons (total distance: WT: 9.34 ± 0.53 µm, 
Trim3-/-: 9.62 ± 0.58 µm; max. velocity: WT: 0.4 ± 0.03 µm/s, Trim3-/-: 0.4 ± 0.03 µm/s; max. 
distance to origin: WT: 3.17 ± 0.11 µm, Trim3-/-: 3.12 ± 0.11 µm) (Figures 3H - J). These 
findings indicate that, although present in mRNP particles and possibly affecting some 
kinetic parameters of a subpopulation of particles, TRIM3 is not essential for mRNP 
trafficking. We therefore conclude that TRIM3 likely travels on mRNP particles as cargo in 
order to exert its function at the synapse, possibly in the regulation of local mRNA 
translation. 
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Figure 3 TRIM3 is not essential for mRNP particle trafficking. (A) Hippocampal neurons from 
Trim3-/- and wildtype mice were transfected with GFP-PURA at DIV8 - 10 and time-lapse imaged 
15 – 24 h later. Example images of a mobile GFP-PURA cluster (red arrow) over a time span of 90 s 
are shown. Scale bars, 2 µm. (B - C) Trim3-/- neurons and wildtype control neurons expressed equal 
amounts of PURA clusters (B) and had equal fractions of mobile clusters (C). (D) PURA clusters were 
divided in long-distance clusters that traveled ˂ 5 µm from their site of origin, and short-distance 
clusters that traveled > 5 µm from their site of origin. Trim3-/- neurons and wildtype control neurons 
expressed equal amounts of short-distance and long-distance clusters. (E - G) Long-distance PURA 
clusters show slightly increased kinetics in Trim3-/- neurons. The total distance moved (E) did not 
change, but the maximum velocity (F) and the maximum distance reached from origin (G) were 
significantly increased in Trim3-/- neurons compared to wildtype neurons (means ± SEM, two-tailed 
t test, *p < 0.05, n = 27/40 clusters per genotype). (H - J) Short-distance PURA clusters show unaltered 
kinetics in Trim3-/- neurons. The total distance moved (H), the maximum velocity (I) and the maximum 
distance reached from origin (J) did not differ significantly in Trim3-/- neurons compared wildtype 
neurons (means ± SEM, n = 76/80 clusters per genotype).  
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Discussion 
TRIM3 is an ubiquitin ligase (Raheja et al., 2014) strongly expressed in the hippocampus and 
the cerebellum (Chapter 2). TRIM3 was shown to interact with myosin V (El-Husseini, 1999) 
and alpha-actinin-4 (El-Husseini et al., 2000), and shown to be part of the CART complex 
(cytoskeleton-associated recycling or transport complex) containing Hrs, actinin-4, TRIM3 
(BERP) and myosin V (Yan et al., 2005). Myosin V is known to be involved in various sorts 
of intracellular transport (Reck-Peterson et al., 2000), and Yan et al. (2005) demonstrated 
that the CART complex is required for efficient recycling of transferrin receptors and 
epidermal growth factor receptors. It was furthermore demonstrated that TRIM3 interacts 
with motor protein KIF21B and affects its motility (Labonte et al., 2013). These data together 
led to the assumption that TRIM3 may be involved in cargo transport and trafficking. 
One particular study indicated that TRIM3 is involved in the trafficking of mRNA 
(Kanai et al., 2004). Together with its paralog TRIM2, TRIM3 was found to be part of 
neuronal PURA containing mRNP granules associated with motor protein KIF5 (Kanai et 
al., 2004). These granules transport mRNA and associated translational machinery towards 
synapses (Erickson and Lykke-Andersen, 2011), however, the roles of TRIM proteins in 
these complexes has not been studied yet. We therefore aimed to identify the role of TRIM3 
in mRNP trafficking in neurons. We employed co-immunoprecipitation of TRIM3 from 
synapse-enriched fractions of hippocampus and cerebellum, but also from HEK293 cells 
overexpressing TRIM3 and PURA, to determine protein-protein interactions. We also 
quantified PURA amounts in hippocampal synaptosomes of wildtype and TRIM3 deficient 
mice, as well as in HEK293 cells overexpressing PURA and full length TRIM3 or PURA 
and mutant TRIM3, missing its RING domain essential for ubiquitylation of substrate 
proteins (Deshaies and Joazeiro, 2009; Raheja et al., 2014). We furthermore expressed a 
GFP-tagged PURA in cultured hippocampal neurons and quantified the mobility of 
GFP-positive PURA-containing mRNP particles in the absence and the presence of TRIM3. 
From our TRIM3 immunoprecipitation experiments from synapse-enriched 
fractions of hippocampus and cerebellum we can conclude that TRIM3 is part of the same 
mRNP particles as PURA. Both proteins co-immunoprecipitated under conditions preventing 
RNA degradation. When RNAs were degraded by the addition of RNase A, however, both 
proteins did not longer co-immunoprecipitate, indicating that their interaction is RNA 
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mediated, and not direct. Indeed, when PURA and TRIM3 were co-expressed in HEK293 
cells and then immunoprecipitated, a direct interaction could not be observed. In addition we 
explored the possibility of PURA being a ubiquitylation substrate of TRIM3. If that were the 
case, PURA levels should be increased in TRIM3 deficient animals, or we should be able to 
decrease PURA amounts in heterologous cells when co-expressed with TRIM3. Neither in 
HEK293 cells nor in hippocampal synaptosomal preparations did we detect differences in 
PURA levels between conditions where TRIM3 was either present or absent. Taken together 
our findings indicate that (i) TRIM3 and PURA are indeed part of the same mRNP complex, 
(ii) TRIM3 and PURA do not directly interact, and (iii) PURA is not a likely TRIM3 
substrate.  
Since we did not observe alterations in PURA levels in synaptosome preparations 
from TRIM3 deficient mice, neither under basal conditions, nor upon induction of contextual 
fear memory, we may assume that mRNP granules in total are not affected by the absence of 
TRIM3. It is possible however that TRIM3 affects the trafficking of mRNP granules, for 
instance by modifying the tracks. It has been demonstrated, for instance, that posttranslational 
modification of the microtubule-associated protein MAP2, reduced the mobility of the motor 
protein KIF5 (Maas et al., 2009). From our time-lapse imaging experiment, where we 
overexpressed GFP-PURA in cultured hippocampal cells, we can however conclude that 
TRIM3 is not essential for mRNP integrity or trafficking. We observed equal amounts of 
total PURA-containing clusters per dendrite length and mobile PURA-containing clusters, 
confirming that TRIM3 is not essential for the existence for mRNP particles. When we 
separated all clusters in long distance (travel distance > 5 µm) and short distance (travel 
distance < 5 µm) clusters, we, however, detected two significantly different features of long 
distance particles. In TRIM3 deficient neurons, long distance clusters travelled further from 
their point of origin and they reached a higher maximal velocity. Taking into account that 
long distance clusters are only 26 – 30 % of all detected clusters, this certainly does not 
appear to be a substantial effect, but it may nonetheless give some insights into the role of 
TRIM3 in mRNP granules. Wilhelm and Vale (1993) brought forward four essential 
functions of mRNP granules: (i) assembly of mRNP particles, (ii) localization and transport 
via cytoskeletal motors, (iii) anchoring to local sites, and (iv) coordination of translation. 
Although Wilhelm and Vale had already speculated that recognition of local sites and 
anchoring would have to involve cytoskeletal (actin) elements, this matter has largely been 
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unaddressed over the last decades. This in mind, an interpretation of our trafficking 
phenotype could be that TRIM3 may serve as recognition or anchoring protein of certain 
cytoskeletal elements, allowing mRNP particles to recognize synapses or other local sites in 
need of local protein synthesis. Losing TRIM3 may reduce the ability of mRNP granules to 
recognize specific local sites, which may explain the longer distances travelled and the higher 
velocity. Further experiments are required to address this hypothesis. 
If TRIM3 is not essential for mRNP trafficking, we should consider the possibility 
that it travels as cargo on mRNP granules to exert its function at the synapse. This raises the 
question of what its local function might be. Given that a large fraction of proteins identified 
in PURA containing mRNP particles, such as eEF1a1, eIF2a or RPL3 among others (Kanai 
et al., 2004), are involved in protein synthesis, it seems likely that TRIM3 also has a function 
in local mRNA translation. It is possible that TRIM3 acts as translational quality control as 
recently described (Duttler et al., 2013) or similar to the E3 ligase Not4 (Panasenko, 2014). 
It could also exert a function on local translation via modulation of the miRNA pathway, as 
was shown for several other NHL (NCL-1, HT2A, Lin-41) domain containing TRIM proteins 
such as C. elegans Nhl-2 (Hammell et al., 2009) or TRIM32 (Schwamborn et al., 2009). The 
NHL domain of TRIM3 might however also be responsible for its incorporation into mRNP 
granules in the first place. TRIM71, a TRIM3 paralog, and BRAT, a TRIM3 ortholog in 
Drosophila, were both shown to bind RNAs through their NHL domain (Kwon et al., 2013; 
Loedige et al., 2013; Loedige et al., 2014). Loedige et al. (2014) used structural homology 
modeling to predict that all NHL domain containing TRIM proteins have the potential to bind 
RNA. Further experiments are required to determine what the precise role of TRIM3 in 
mRNP complexes is. An obvious requirement for this is that we know which substrate 
proteins are (poly)-ubiquitylated by TRIM3. 
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Abstract 
Post-translational modification of proteins with ubiquitin plays an important regulatory role 
in many cellular processes, but is most widely known for its ability to target proteins for 
proteasomal degradation. Ubiquitylation is a tightly controlled and protein-specific process 
facilitated by a cascade of enzymes. Specificity is achieved by the last enzyme in that cascade, 
an E3 ubiquitin ligase. Several hundred ubiquitin ligases and several thousand ubiquitylated 
proteins have been identified, but it remains largely elusive which protein is ubiquitylated by 
which ligase. Experimental approaches aimed at identifying specific ligase-substrate pairs 
face several challenges, including the transient nature of the ligase-substrate interactions and 
the low steady state of ubiquitylated proteins due to de-ubiquitylation and proteasomal 
degradation. In this chapter we describe a mass spectrometry-based approach to identify 
potential substrates of the E3 ligase TRIM3 in two different brain areas, the hippocampus 
and the cerebellum. By combining results obtained from co-immunoprecipitation interaction 
proteomics and affinity purification of poly-ubiquitylated proteins, and including Trim3 
knockout tissue as a negative control, we were able to overcome most of the aforementioned 
challenges and put forward a high-confidence set of potential substrates of TRIM3 for further 
validation. 
 
Introduction 
Ubiquitin is a conserved 8.5 kDa protein containing 76 amino acids, which is found in all 
eukaryotic cells (Goldstein et al., 1975). By attaching ubiquitin to another protein, the fate 
and function of the latter can be changed entirely. Many functional alterations of mono-
ubiquitylated proteins have been described, but when additional ubiquitins are added to the 
substrate-attached ubiquitin in a sequential manner (Hershko and Ciechanover, 1998), the 
substrate protein is poly-ubiquitylated and will be targeted to the 26S proteasome for 
degradation (Coux et al., 1996). The attachment of ubiquitin is catalyzed by a cascade of 
enzymes, including an E1 (ubiquitin activating enzyme), an E2 (ubiquitin conjugating 
enzyme) and an E3 ligase (ubiquitin ligating enzyme) (Hershko, 1983; Hershko and 
Ciechanover, 1998). Specificity of this enzymatic cascade is achieved by the E3 ligases that 
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recognize specific substrates and catalyze the ubiquitin transfer (Berndsen and Wolberger, 
2014). Ubiquitylation has been the subject of many studies and many proteins are known to 
be ubiquitylated (Komander and Rape, 2012; Popovic et al., 2014). Recently, new enrichment 
strategies were developed that extended the number of known ubiquitylated proteins by 
several thousands. In all these studies antibodies were used that recognize the di-glycil 
remnant, which is left on lysine residues of ubiquitylated proteins after trypsin digestion. 
Taken together these studies identified more than 20,000 ubiquitylation sites and more than 
5,000 ubiquitylated proteins (Kim et al., 2011; Udeshi et al., 2012; Wagner et al., 2011; Xu 
et al., 2010). 
Despite these fascinating findings demonstrating how ubiquitous ubiquitylation is, there is 
currently no good way to directly identify specific E3-ligase-subtrate partners. In this chapter 
we establish a method to detect and identify poly-ubiquitylated substrates of the E3 ubiquitin 
ligase TRIM3. We make use of a recently generated Trim3 knockout mouse (Labonte et al., 
2013) to identify specific protein interactors of TRIM3 and detect proteins that are 
differentially poly-ubiquitylated between Trim3-/- and wildtype mice. We employ Tandem 
Ubiquitin Binding Entities (TUBEs) (Hjerpe et al., 2009; Lopitz-Otsoa et al., 2012) to 
specifically identify proteins that are poly-ubiquitylated and would therefore be targeted for 
proteasomal degradation. By combining TRIM3 interaction data and data of enriched poly-
ubiquitylated proteins we aimed to identify a limited number of high-confidence substrates 
of TRIM3. 
 
Material and Methods 
Animals 
Trim3-/- mice were maintained on a C57BL/6J background. Wildtype littermates were used 
as controls in all experiments. Mice were individually housed on sawdust in standard 
Makrolon type II cages (26.5 cm long, 20.5 cm wide and 14.5 cm high) enriched with 
cardboard nesting material and a plastic tube under 12/12h dark/light cycle with access to 
water and food ad libitum. All animal experiments were approved by the animal ethics 
committee of the VU University Amsterdam, The Netherlands. 
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Synaptic protein isolation and quantification 
Brain tissue was obtained from C57BL/6J mice. Animals were sacrificed by cervical 
dislocation. Cerebellum and hippocampus were dissected and stored at -80° C. Synapse-
enriched protein fractions (P2 + M, pellet 2 + microsomes) were isolated as previously 
described (Klemmer et al., 2009). Protein concentrations were measured using Bradford 
Protein-Assay (Bio-Rad Laboratories, USA) and equal amounts of protein were loaded on a 
4 - 20 % gradient SDS-PAGE gel (Criterion TGX Stain-Free Gel, Bio-Rad Laboratories, 
USA). Total protein amounts were imaged after electrophoresis using Criterion Stain Free 
Imager (Bio-Rad Laboratories, USA). Gels were then transferred to PVDF membranes (Bio-
Rad Immuno-Blot PVDF membrane, Bio-Rad Laboratories, USA) and blots were blocked 
by either immersing the membrane in 5 % nonfat dry milk in TBS-T (TBS plus 0.025 % 
Tween, pH 7.4) or 0.5 % BSA in TBS-T (TBS plus 0.025 % Tween, pH 7.4) for 1 h. Blots 
were then incubated with the antibody of interest for 1h at room temperature or overnight at 
4° C, followed by a 1h incubation with a secondary antibody conjugated to HRP. Proteins 
were visualized by ECL treatment (SuperSignal West Femto Chemiluminescent Substrate, 
Thermo Scientific, USA) and scanned using the Odyssey Fc imager (Li-Cor, USA). 
Antibodies used: rabbit anti-TRIM3 (CLRPGDLPPSPDDVK, GenScript, 1:1,000), rabbit 
anti-TRIM3 (QAPEGAHDPEDPHPC, GenScript, 1:500), goat anti-RNF22 (ab4215, 
Abcam, 1:500), mouse anti-poly-ubiquitin (FK1, BML-PW8805, Enzo Life Sciences, 
1:1,000), mouse anti-SAPAP1 (75-236, Neuromab, 1:1,000), mouse anti-SHANK1 (75-064, 
Neuromab, 1:1,000), mouse anti-GLUR1 (75-327, Neuromab, 1:10,000), mouse anti-
GLUR2 (75-002, Neuromab, 1:1,000), mouse anti-NR2B (73-097, Neuromab, 1:10), rabbit 
anti-HOMER1 (AP7302c, Abgent, 1:200), rabbit anti-AP2A1 (11401-1-AP, Proteintech, 
1:1,500), rabbit anti-DNM3 14737-1-AP, Proteintech, 1:800), rabbit anti-ACTN4 (19096-1-
AP, Proteintech, 1:1,500), mouse anti-AP2M1 (611350, BD Biosciences, 1:10,000), rabbit 
anti-ANXA5 (NB100-1930, Novus Biologicals, 1:2,000), rabbit anti-NME1 (ABS95, 
Millipore, 1:2,000) 
Co-Immunoprecipitation of TRIM3 and interactors 
For each immunoprecipitation (IP) experiment 10 mg of P2 + M from wildtype or 
Trim3-/- mice (control for co-immunoprecipitation specificity) were extracted in an equal 
volume of Triton X-100 containing extraction buffer (2 % Triton X-100, 150 mM NaCl, 
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25 mM HEPES pH 7.4, protease inhibitors (Complete Protease Inhibitor Cocktail, Roche 
Diagnostics) for 1 h on a rotator at 4° C. Insoluble material was then pelleted 20,000 g for 
20 min at 4° C. The pellet was then re-extracted in 1 % Triton X-100 extraction buffer (1 % 
Triton X-100, 150 mM NaCl, 25 mM HEPES pH 7.4, protease inhibitors) for 1h. Insoluble 
material was again pelleted at 20,000 g for 20 min. Supernatants from the first and second 
extraction were then pooled, centrifuged at 20,000 g for 20 min and the final supernatant 
served as input for the immunoprecipitation. 
Three different antibodies raised against TRIM3 were used for immunoprecipitations 
(IPs): goat anti-RNF22 (ab4215, Abcam), rabbit anti-Trim3 (epitope: 
CLRPGDLPPSPDDVK-NH2, GenScript) and rabbit anti-Trim3 (epitope: 
QAPEGAHDPEDPHPC, GenScript). All IPs were performed with 10 µg of antibody, which 
were added to the final supernatant and incubated overnight on a rotator at 4° C. Next day 
30 µl of protein A/G beads (Protein A/G Plus-Agarose, Santa Cruz Biotechnology Inc.) were 
washed 3 times in washing buffer (0.1 % Triton X-100, 150 mM NaCl, 25 mM HEPES 
pH 7.4) and added to each IP. Beads were incubated for 120 min on a rotator at 4° C, then 
pelleted at 2,500 g and washed four times in ice-cold washing buffer. TRIM3 and interacting 
proteins were eluted off the beads by adding SDS containing loading buffer and boiling for 
5 min. Samples were separated on SDS page and immunoblotted or in-gel digested (Chen et 
al., 2011b) for mass spectrometry analysis. 
Extraction efficiency optimization for poly-ubiquitylated proteins 
In order to increase the extraction yield of poly-ubiquitylated proteins from brain material, 
13 combinations of four different detergents (n-Dodecyl-β-D-maltoside (DDM), sodium 
deoxycholate (DOC), Tween 20, IGEPAL CA-630) in different concentrations were tested. 
Equal amounts of input material were extracted twice for one hour at 4° C on a rotator and 
remaining insoluble material pelleted at 20,000 g. Pooled Supernatants and remaining pellets 
were separated on a 0.5 % 2,2,2-Trichloroethanol containing 10 % SDS-PAGE. Total protein 
amounts were imaged after electrophoresis using Criterion Stain Free Imager (Bio-Rad 
Laboratories). Gels were then transferred to PVDF membranes (Bio-Rad Immuno-Blot 
PVDF membrane, Bio-Rad Laboratories) and blots were blocked by immersing the 
membrane 0.5 % BSA in TBS-T (TBS plus 0.025 % Tween, pH 7.4) for 1 hour. Blots were 
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then incubated with mouse anti-poly-ubiquitin (FK1, BML-PW8805, Enzo Life Sciences, 
1:1,000) antibody for 1 h at room temperature, followed by a one hour incubation with a 
secondary antibody conjugated to HRP. Poly-ubiquitylated proteins were visualized by ECL 
treatment (SuperSignal West Femto Chemiluminescent Substrate, Thermo Scientific, USA) 
and scanned using the Odyssey Fc imager (Li-Cor, USA). Extraction efficiency was scored 
by measuring and ranking stain-free gel signal intensities of supernatants, pellets and by 
measuring western blot poly-ubiquitin signal intensities. Scored ranks were averaged and the 
most efficient poly-ubiquitin extraction selected for TUBEs pull-down. 
Enrichment of poly-ubiquitylated proteins 
Tandem ubiquitin binding entities (TUBEs) immobilized to agarose beads were purchased 
from LifeSensors (Malvern, PA). For each affinity purification experiment, 20 mg of 
hippocampal P2 + M protein fraction was added to 100 µl of TUBEs slurry. Purification of 
bound proteins was performed according to the manufacturer’s protocol with minor 
modifications. Not NP40, but a combination of 0.5 % Na-deoxycholate (DOC) and 1 % 
n-dodecyl-β-D-maltoside (DDM) in 25 mM HEPES, 150 mM NaCl (pH 7.2) was used as 
solubilizing detergent. Deubiquitylation and proteasomal degradation were minimized by 
adding 10 mM N-ethylmaleimide (NEM), 20 µM MG132 (Tocris Bioscience) and protease 
inhibitors (Roche) to all extraction buffers. Tris was replaced by HEPES as the buffering 
agent. Purified proteins were washed three times in extraction buffer, one time in high-salt 
buffer (500 mM NaCl) and one time in no-salt buffer. Proteins were then eluted in 0.15 % 
trifluoroacetic acid (TFA) and lyophilized for further analysis. 
 
Trypsin digestion 
Immunoprecipitated protein samples were separated on SDS-PAGE and in-gel trypsin-
digested as previously described (Chen et al., 2011a). TUBEs-purified proteins were re-
solubilized in 50 mM NH4HCO3 / 10 % acetonitrile, brought to 2 mM DTT and heated to 
60° C for 20 min. Proteins were then alkylated with 8 mM iodoacetamide for 1 h. Alkylation 
was stopped by bringing samples to 8 mM DTT. Samples were then brought to a final 
concentration of 25 mM NH4HCO3, 8 % acetonitrile and 2 mM DTT, and digested with 
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trypsin (mass spectrometry grade; Promega, Fitchburg, WI, USA) overnight at room 
temperature. Digestion was stopped by adding 1 % TFA. Peptides were purified over a C18 
column and lyophilized. 
 
Nano-LC MS/MS 
Peptides were re-dissolved in 20 μl 0.1 % TFA and subjected to nano-LC MS/MS. Peptides 
were delivered with a FAMOS autosampler at 30 μL/min to a Pepmap C18 trap column 
(5 mm x 300 μm i.d.; Dionex, Sunnyvale, CA, USA) and separated on an Alltima analytical 
capillary C18 column (150 mm x 100 μm i.d.) at 400 nl/min using the LCPacking Ultimate 
system. The peptides were separated using a linearly increasing concentration of acetonitrile 
from 5 – 35 % in 80 min, from 35 – 45 % in 7 min, from 45 – 90 % in 2 min and then held 
at 90 % for an additional 11 min. The eluent was mixed with matrix (7 mg α-cyano-
hydroxycinnaminic acid in 1 mL 70 % acetonitrile, 0.1 % trifluoroacetic acid, 10 mM 
ammonium monobasic phosphate) delivered at a flow rate of 1.5 μL / min, and deposited off-
line to the Applied Biosystems metal target every 15 s for a total of 384 spots, using an 
automatic robot (Probot from Dionex, Thermo Fisher Scientific, USA). A 5800 proteomics 
analyzer (Applied Biosystems, SCIEX, USA) was used for peptide analysis. Collision-
induced dissociation (CID) was performed at 2 kV, the collision gas was nitrogen. MS / MS 
spectra were collected from 2500 laser shots. The peptides with signal to noise ratio above 
50 at the MS mode were selected for MS/MS experiment; a maximum of 25 MS/MS were 
allowed per spot. The precursor mass window was 200 relative resolution (FWHM, full width 
at half maximum).  
 
Peptide data analysis and Protein inference 
MS / MS spectra were annotated against a concatenated target-decoy database of Uniprot 
mouse reference proteome sequences (version 02 / 2012) using ProteinPilot software (v3.0; 
Applied Biosystems, Foster City, CA, USA) using the Paragon algorithm (v3.0.0.0) (Shilov 
et al., 2007). Database searches were performed with trypsin-specificity and alkylation of 
cysteine residues by iodoacetamide. For each spectrum the best scoring peptide sequence was 
selected as spectrum annotation. Protein inference was performed using IsoformResolver 
software (Meyer-Arendt et al., 2011) aiming for consistent protein assignment of peptides 
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across experiments. False discovery rate (FDR) for peptide and protein identification were 
established using Mayu (Reiter et al., 2009). Peptide-spectrum matches were truncated at 5 % 
FDR and protein identifications were truncated at 1 % FDR. Proteins were quantified 
according to their normalized spectral intensity value (Griffin et al., 2010), their peptide ratio 
(wildtype / Trim3-/-) and their spectral count ratio (wildtype / Trim3-/-). Values contributed by 
peptides shared by different proteins were apportioned according to the spectral intensity 
values obtained from unique peptides of the respective proteins. Apportioned values were 
then transformed as follows: all values were divided by the lowest value in the sample, the 
value of 1 was added to each value to allow log transformation, and all resulting values were 
log2 transformed. Candidate TRIM3 interactors were defined as all proteins that were 
immunoprecipitated with at least two out of three antibodies from wildtype tissue and that 
showed at least a 2-fold (log2) enrichment compared with samples obtained from Trim3-/- 
tissue. For candidate TRIM3 substrates we selected all proteins that were identified in at least 
two out three TUBEs affinity purification replicates from wildtype tissue, and had an average 
enrichment of at least 2-fold (log2) compared with samples obtained from Trim3-/- tissue. An 
arbitrary cut-off for the highest ranking 100 potential TRIM3 interactors and the highest 
ranking 300 poly-ubiquitylated was applied. Highest ranked interactors and poly-
ubiquitylated proteins were then cross-referenced to identify potential TRIM3 substrates.  
 
Fear conditioning 
Fear conditioning experiments were carried out as described (Misane et al., 2005; Stiedl et 
al., 2000) using a computerized fear conditioning system (TSE, 303410, Bad Homburg, 
Germany). In brief, mice were placed in an acrylic cage mounted into a constant illuminated 
(450 lx) fear conditioning box. After a 180 s exploration period, mice received a 2 s foot 
shock (0.7 mA) delivered through a metal floor grid. Mice were returned to their home cages 
30 s after termination of the shock. Animals were sacrificed 24 h after the shock and brains 
dissected and processed for biochemical analysis of synaptosomes. 
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Results 
Several candidate synaptic proteins are not regulated by TRIM3 in vivo 
In search for a synaptic role of TRIM3 we asked which synaptic proteins are likely candidate 
substrates for poly-ubiquitylation by TRIM3. It was recently reported that TRIM3 can poly-
ubiquitylate the postsynaptic scaffold protein GKAP in vitro, leading to a significant 
reduction in the levels of both GKAP and its associated scaffold SHANK1 (Hung et al., 
2010). These findings were, however, challenged by the same authors who subsequently 
showed that the activity-dependent removal of GKAP from synapses in vivo does not likely 
require TRIM3 (Shin et al., 2012). To test GKAP and SHANK1 as potential TRIM3 
substrates in vivo we quantified their levels in hippocampal synapse-enriched fractions from 
Trim3-/- mice and wildtype controls, both under basal conditions (Figures 1A and 1B) and 
2 h after fear conditioning (Figures 1C and 1D). We did not observe an increase in GKAP or 
SHANK1 protein levels in Trim3-/- mice as would be expected if these proteins underwent 
TRIM3-dependent poly-ubiquitylation and proteasomal degradation (Figure 1). In addition 
to GKAP and SHANK, iTRAQ proteomics analysis performed in our lab identified 12 
synaptic proteins of which the levels were increased in synapse-enriched preparations from 
Trim3-/- mice compared to wildtype controls (unpublished data), including the known TRIM3 
interactor alpha-actinin-4 (El-Husseini et al., 2000). Using quantitative immunoblotting on 
the same synapse-enriched fractions we could also rule these proteins out as ubiquitylation 
substrates of TRIM3 (Figure S1). 
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Figure 1 GKAP and SHANK1 levels are not affected in Trim3-/- mice. (A - B) Hippocampal 
synapse-enriched fractions (P2 + M) were prepared from wildtype and Trim3-/- mice. Samples were 
immunoblotted for GKAP (A) and SHANK1 (B). Protein levels of GKAP and SHANK1 are not 
affected by loss of TRIM3 in the synapse enriched fraction P2 + M (means ± SEM, two-tailed t test, 
p ˃ 0.05, n = 8 per genotype). (C - D) Synaptosomes were prepared from wildtype and Trim3-/- mice 
under control conditions (home cage) and 2 hours after contextual fear conditioning (shock). Samples 
were immunoblotted and stained for GKAP (C) and SHANK1 (D). Normalized protein levels were 
calculated by dividing Western blot (WB) signal intensities by the total protein intensities (stain-free 
gel) and expressed relative to wildtype levels. GKAP and SHANK1 levels did not differ between 
conditions (means ± SEM, two-tailed t test, p ˃ 0.05, n = 4 per genotype). 
 
Identification of TRIM3 ubiquitylation substrates 
To identify potential TRIM3 substrate proteins we reasoned that a bona fide substrate should 
(i) physically interact with TRIM3, even if only transiently or weak, and (ii) be less poly-
ubiquitylated in Trim3-/- mice. To detect differentially ubiquitylated proteins between 
wildtype and Trim3-/- mice we used TUBEs (Tandem Ubiquitin Binding Entities). TUBEs 
are recombinant proteins based on the E1 ubiquitin activating enzyme UBE1 and RAD23A, 
a protein that is essential for the delivery of poly-ubiquitylated proteins to the proteasome. 
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TUBEs have a very high affinity to poly-ubiquitin (Hjerpe et al., 2009; Lopitz-Otsoa et al., 
2012) and thus would strongly enrich for proteins that are poly-ubiquitylated and targeted for 
proteasomal degradation. TUBEs furthermore have a protective function. Ubiquitylation is a 
reversible process, and a large number of de-ubiquiylation enzymes cleave ubiquitin from 
substrate proteins. Moreover, de-ubiquitylation is enhanced in cell lysates (Komander et al., 
2009). TUBEs, by binding to poly-ubiquitylated proteins, protect proteins from de-
ubiquitylation and proteasomal degradation, thereby allowing identification of transient poly-
ubiquitylation events at any moment in time, even when poly-ubiquitylated proteins are of 
low abundances. 
We first optimized TUBEs methodology to (i) increase the yield of the TUBEs pull-down 
and (ii) demonstrate the efficacy and reproducibility of the TUBEs approach. To increase the 
yield, we first aimed to optimize extraction efficiency and solubility of poly-ubiquitylated 
proteins from synapse-enriched fractions. We tested four different detergents (Tween-20, 
n-Dodecyl β-D-maltoside (DDM), deoxycholate (DOC) and IGEPAL CA-630) in 11 
different combinations and concentrations (Table 1 and Figure 2). Extraction efficiency was 
scored by analyzing (i) protein amounts of the soluble and insoluble fractions after extraction 
on SDS-PAGE and (ii) by poly-ubiquitin staining intensity after immunoblotting (Figure 2). 
Detergent combinations of DDM + DOC and CA-630 + DOC scored highest on SDS-PAGE 
and immunoblot (Figure 2, conditions 5 and 8), and we chose to perform all following 
experiments with a combination of 1 % DDM and 0.5 % DOC. 
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Table 1 Extraction optimization for poly-ubiquitylated proteins from synapse-enriched cellular 
fractions. Synapse-enriched fractions were extracted twice for 1 h in HEPES buffer (25 mM HEPES, 
150 mM NaCl, pH 7.2) containing different detergents as indicated in the table. Soluble and insoluble 
fractions were resolved on SDS-PAGE, then imaged and immunoblotted for poly-ubiquitin. Signal 
intensities of all samples from SDS-PAGE and western blot were scored and a combined rank was 
assigned to each extraction procedure. 
Extraction Buffers   Rank  
First Extraction 
Second 
Extraction             Soluble Insoluble 
Poly-Ub 
Blot Combined  
DDM 1 % 0.5 % DOC 1 2 4 1 
CA-630 1 % 0.5 % DOC 6 4 2 2 
0.5 % Tween, 0.5 % CA-
630 0.5 % DOC 4 1 10 3 
CA-630 1 %, 0.1 % DOC CA-630 1 %, 0.1 % DOC 7 3 6 4 
DOC 0.5 %, 0.1 % CA-
630 DOC 0.5 %, 0.1 % CA-630 3 5 9 5 
0.5 % Tween, 0. 5% CA-
630, 0.1 % DOC 
0.5 % Tween, 0.5 % CA-
630, 0.1 % DOC 8 10 1 6 
0.5 % Tween, 0.5 % CA-
630 
0.5 % Tween, 0.5 % CA-
630 5 7 7 7 
CA-630 1 % CA-630 1 % 2 6 11 8 
DOC 0.5 % DOC 0.5 % 9 8 3 9 
DDM 1 % DDM 1 % 11 9 5 10 
DDM 1 %, 0.1 % DOC DDM 1 %, 0.1 % DOC 10 11 8 11 
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Figure 2 Exemplary immunoblot and stain-free gel images of different extraction conditions on 
synapse-enriched cellular fractions. Synapse-enriched fractions were extracted twice in buffers 
containing different detergents. Soluble (middle panel) and insoluble fractions (bottom panel) were 
resolved on SDS-PAGE, then imaged and immunoblotted for poly-ubiquitin (top panel – only soluble 
fractions). Signal intensities of all samples from SDS-PAGE and western blot were scored and a 
combined rank was assigned to each extraction procedure. (Extraction conditions (left to right): 1. DOC 
0.5 %/0.1 % CA-630, 2. DDM 1 %, 3. 0.5 % Tween-20/0.5 % CA-630, 4. DOC 0.5 %, 5. DDM 
1 %/0.5% DOC, 6. 0.5 % Tween-20/0.5 % CA-630/0.1 % DOC, 7. DDM 1 %/0.1 % DOC, 8. CA-630 
1 %/0.5 % DOC, 9. CA-630 1 %/0.1 % DOC, 10. 0.5 % Tween-20/0.5 % CA-630/0.5 % DOC, 11. CA-
630. 
 
TUBEs efficacy was demonstrated by showing that TUBEs pull-down, but not a pull-down 
with empty agarose beads, resulted in a strong enrichment of poly-ubiquitylated proteins 
detected by immunoblotting (Figure 3A). Moreover, the coomassie-stained gel revealed that 
the TUBEs-enriched protein fraction contained many individual proteins that were not 
detected in the control pull-down samples (Figure 3B). We then performed three TUBEs pull-
down replicates on independent synapse enriched samples and identified proteins using mass 
spectrometry. On average we were able to detect 3150 peptides mapping to 577 proteins with 
at least one unique peptide. Reproducibility at the protein level was 79.4 % between replicates 
(Figure 3C). 
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Figure 3 Validation of the TUBEs pull-down approach. (A) TUBEs immobilized to agarose beads 
were added to 2 mg of hippocampal protein extract and incubated for 2 h in the presence of MG132 
and protease inhibitors. Input, unbound fraction, TUBEs pull-down (50 %) and control pull-down 
(agarose beads only) were resolved on SDS-PAGE and immunoblotted for poly-ubiquitin. A strong 
enrichment for poly-ubiquitylated proteins (50 - 250 kDa) was observed in the TUBEs pull-down 
fraction (left), but not in the control pull-down fraction (right). (B) When resolved on SDS-PAGE and 
coomassie-stained for total protein content, the TUBEs pull-down appeared to be highly enriched in 
proteins compared with the control pull-down sample. (C) Venn diagram indicating reproducibility of 
TUBEs pull-down between three independent replicate experiments. 
 
We then designed a substrate identification strategy (Figure 4) in which we 
immunoprecipitated TRIM3 from hippocampal and cerebellar synapse-enriched fractions 
using three different antibodies, and in parallel performed affinity purification of poly-
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ubiquitylated proteins from synapse-enriched fractions using TUBEs in triplicate. In both 
experiments, Trim3-/- tissue fractions were used as negative controls. Proteins from co-
immunoprecipitates and TUBEs pull-downs were then identified and quantified using mass 
spectrometry, and results from both experiments compared to find proteins that specifically 
co-imunoprecipitated with TRIM3 from wildtype tissue and not Trim3-/- tissue, and which 
were more ubiquitylated in wildtype tissue compared with Trim3-/- tissue. 
 
 
Figure 4 Strategy to identify TRIM3 ubiquitylation substrates. Hippocampal synapse-enriched 
protein fractions were used as input for both immunoprecipitation (left) and poly-ubiquitin affinity pull-
down (right). Immunoprecipitation was performed with three independent antibodies raised against 
different epitopes of TRIM3 (AB1 epitope: QAPEGAHDPEDPHPC, AB2 epitope: 
CLRPGDLPPSPDDVK, AB3 epitope: AKREDSPGPEVQP). Samples from Trim3-/- mice served as a 
control for co-immunoprecipitation specificity. Poly-ubiquitin affinity pull-down was performed using 
TUBEs. Three independent replicates were performed. The parallel use of Trim3-/- and wildtype tissue 
allowed for identification of differentially poly-ubiquitylated proteins. All samples were analyzed by 
quantitative mass spectrometry and potential TRIM3 substrates were identified by ranking and 
comparing results from all six samples (see Material and Methods for details). 
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Using immunoprecipitation we identified 110 potential TRIM3 interactors in hippocampus 
and 186 in cerebellum (Tables S1 - S2) that consistently co-immunoprecipitated with TRIM3 
using two or three antibodies, specifically from wildtype tissue. Several proteins were 
identified that were previously reported to interact with TRIM3. Myosin Vb, for instance, is 
a known interactor of TRIM3 (El-Husseini, 1999), and we found myosin Vb and TRIM3 to 
interact in the hippocampus (Table S1). In contrast, in the cerebellum we found myosin 18b 
(Table S2) to interact with TRIM3. We also detected numerous proteins reported to be 
present in mRNP particles alongside TRIM3 (Kanai et al., 2004). While Kanai et al. (2004) 
used whole brain homogenate for mRNP isolation, our data show a more differentiated 
picture. Whereas TRIM2 co-precipitated with TRIM3 from both hippocampus and 
cerebellum, Eef1a2 only co-precipitated from hippocampus and HSPA2 co-precipitated with 
TRIM3 only from cerebellum. 
Using the TUBE approach, we identified a total of 1015 poly-ubiquitylated proteins in the 
hippocampus and 1018 in cerebellum. To limit the number of potential substrates we 
introduced a cut-off at the 100 highest-ranked potential TRIM3 interactors and the 300 
most-enriched poly-ubiquitylated proteins in hippocampus and cerebellum of wildtype 
animals. In order to identify potential TRIM3 ubiquitylation substrates we compared 
potential interactors with enriched poly-ubiquitylated proteins and created an overlap of 
proteins present in both. Overlapping proteins were considered likely ubiquitylation 
substrates (Figure 5). 
The overlap between TRIM3 interactors and potential TRIM3 substrates was very little and 
yielded a limited list of potential substrates. In the hippocampus we identified five proteins 
that met both criteria: gamma-actin (ACTG1), immunoglobulin-like and fibronectin type III 
domain-containing protein 1 (IGFN1), kalirin (KALRN), ADP/ATP translocase 1 
(SLC25A4) and macoilin (TMEM57) (Figure 5A). ACTG1 ranked the highest in both 
criteria. In the cerebellum we identified seven proteins: vimentin (VIM), GRB10 interacting 
GYF protein 2 (GIGYF2), GM8765, heat shock protein 90kDa alpha – class B member 1 
(HSP90AB1), adenylate cyclase 1 (ADCY1), synaptosomal-associated protein – 25kDa 
(SNAP25) and neuroplastin (NPTN). 
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Figure 5 Combination of co-immunopricipation and TUBEs pull-down reveals potential TRIM3 
ubiquitylation substrates. (A) Venn diagram indicating the five proteins that were identified in the 
hippocampus as potential TRIM3 substrates with the highest confidence based on combined co-
immunopreciptation and differential TUBEs pull-down. (B) Venn diagram indicating the seven proteins 
that were identified in the cerebellum as potential TRIM3 substrates. For both brain regions a cut-off 
was set for the highest ranking 100 TRIM3 interactors and the highest ranking 300 TUBEs pull-down 
proteins that were more poly-ubiquitylated in wildtype mice compared to Trim3-/- mice (see Materials 
and Methods for inclusion criteria).  
 
Discussion 
In this chapter we excluded several synaptic proteins as TRIM3 ubiquitylation substrates and 
developed an experimental approach to identify true TRIM3 substrates. We were able to 
identify candidate TRIM3 ubiquitylation substrates by using a dual mass spectrometry 
approach combining co-immunoprecipitation and enrichment of poly-ubiquitylated proteins. 
Many synaptic proteins, including CaMKIIα, PSD-95, GKAP and receptors for AMPA, 
NMDA and GABA are known to be ubiquitylated (Lin and Man, 2013; Na et al., 2012). 
TRIM3 was shown to poly-ubiquitylate GKAP in an in vitro overexpression assay, leading 
to a significant reduction in the levels of both GKAP and its associated scaffold SHANK1 
(Hung et al., 2010). If TRIM3 indeed targeted GKAP and/or SHANK1 in vivo for 
proteasomal degradation, Trim3-/- mice should have higher levels of both proteins. We found 
no such increase in hippocampal synapse-enriched fractions from TRIM3-/- mice, independent 
of whether these mice underwent hippocampal stimulation (i.e., fear conditioning) or not. 
Moreover, Shin et al. (2012) showed that the activity-dependent removal of GKAP form 
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synapses in vivo does not necessarily require TRIM3. Together, these findings led us to 
conclude that TRIM3 does not target GKAP or SHANK1 for proteasomal degradation. 
We therefore set out to identify true TRIM3 substrates. Due to the nature of the 
ubiquitylation process, its reversibility by DUBs (Wilkinson, 2000) and the low steady-state 
levels of ubiquitylated substrate proteins (Pickart, 2004; Pickart and Eddins, 2004), no direct 
way to identify substrate proteins of E3 ligases in vivo has been developed to date. Indirect 
methods used to identify substrate proteins often involve overexpression of tagged proteins 
of the ubiquitin proteasome pathway, such as ubiquitin itself in cell lines (Beers and Callis, 
1993; Lee et al., 2011; Peng et al., 2003). Other used methods include yeast two-hybrid 
(Drury et al., 1997; Thomas et al., 1995), protein microarrays (Loch et al., 2011) and co-
precipitation (Yaron et al., 1998). A major drawback of all of these methods is that they do 
not extend beyond establishing physical interaction between two proteins, and normally 
result in long lists of candidate proteins that still need to be validated as substrates. With our 
approach, combining enrichment of poly-ubiquitylated proteins from brain tissue using 
TUBEs and the identification of TRIM3 interactors using co-immunoprecipitation, and using 
Trim3-/- mice as specificity controls, we were able identify a small number of potential 
substrate proteins that interact with TRIM3 and are significantly less ploy-ubiquitylated in 
Trim3-/- mice. Our approach is also superior to using di-glycil antibodies (Wagner et al., 
2011) for quantitative detection of ubiquitylation for three reasons: (i) di-glycil antibodies 
are not able to differentiate between the type of ubiquitylation (mono-, multiple-mono-, poly-
ubiquitylation), (ii) they only detect peptides with di-glycil modified lysines, making it 
impossible to detect isoforms of proteins sharing the majority of peptides, and (iii) other 
modifications such as neddylation, leaving the same glycin-gylcin remnant after trypsin 
digestion, will be falsely identified as ubiquitylation. 
The fact that we find non-overlapping protein sets as candidate TRIM3 substrates in 
hippocampus and cerebellum suggests that TRIM3 has different functions according to its 
localization. This is further supported by our finding that TRIM3 is localized post-
synaptically in hippocampus and axonally / pre-synaptically in cerebellum (Chapter 2). Of 
the 12 proteins that we identified (five in hippocampus and seven in cerebellum) three are of 
particular interest because they are components or regulators of the neuronal cytoskeleton. In 
the hippocampus we identified kalirin as a potential substrate. Kalirin is a guanine exchange 
factor for several key actin-modulatory GTPases including RhoG, RhoA and Rac (May et 
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al., 2002; Penzes et al., 2001). Kalirin was shown to be involved in the maintenance of 
hippocampal pyramidal cell dendrites and dendritic spines (Ma et al., 2003). A kalirin 
isoform, kalirin-7, was reported to be localized in dendritic spines and a knock-down using 
RNAi resulted in a loss of spines (Zhong et al., 2006). Cahill et al. (2009) created a Kalirin 
knockout mouse, and observed a robust reduction in spine density in cortex, deficits in 
working memory and sociability and increased locomotor activity. An even higher-ranking 
candidate TRIM3 substrate in the hippocampus was gamma-actin. Interestingly, TRIM3 
contains a long actin-binding protein-like repeat (El-Husseini, 1999) and its close paralog 
TRIM32 was reported to ubiquitylate actin in muscle (Kudryashova et al., 2005). Although 
a role for gamma-actin in regulating actin stability has been suggested (Belyantseva et al., 
2009; Bergeron et al., 2010), no specific contribution of actin-gamma to synaptic stability or 
plasticity has been reported, yet. We will further discuss the role of actin-gamma as a 
potential TRIM3 substrate in Chapter 5. 
In the cerebellum we identified the intermediate filament protein vimentin as a 
potential TRIM3 substrate. It is interesting to note that TRIM2, the closest relative of TRIM3, 
was shown to also target intermediate filaments, in particular neurofilament light chain, for 
proteasomal degradation in cerebellar Purkinje cells (Balastik et al., 2008). Consequently, 
Trim2-/- mice show a strong neurodegenerative phenotype (Balastik et al., 2008). While 
TRIM2 and TRIM3 may thus both target intermediate filament proteins in the cerebellum, 
they most likely do so in different neurons as TRIM3 expression was detected primarily in 
cerebellar granule neurons, and not in Purkinje cells (Chapter 2). Despite these intriguing 
observations, one should keep in mind that vimentin expression is normally associated with 
developing neurons, and vimentin appears to be depleted as an important intermediate 
filament constituent in adult neurons (Yabe et al., 2003). This could disqualify vimentin as a 
likely TRIM3 substrate, but could also imply that TRIM3 is somehow involved in the 
developmental decrease of vimentin levels. 
To summarize, we showed that neither GKAP nor SHANK1 protein levels are 
affected by TRIM3, and we also excluded several other synaptic proteins as candidate TRIM3 
substrates. We further developed a novel method that is sensitive enough to detect a small, 
but distinct set of potential substrate proteins of TRIM3, demonstrating the feasibility of this 
approach. We conclude that this approach could be applied to any ubiquitin ligase for which 
appropriate controls, e.g., knockout animal, are available. 
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Supplementary 
 
Figure S1 (A - B) Quantitated protein expression (A) and quantitative western blot images (B) for 
GLUR1, GLUR2, NR2B, HOMER1, EF1A2, AP2A1, DNM3, ACTN4. AP2M1, ANXA5, NME1 and 
CKB on hippocampal synaptosomal samples (n = 5 per genotype, WT = +/+, TRIM3 KO = -/-) from 
mice under home cage conditions. All data points show mean ± SEM, two-tailed t test, all non-
significant, n = 5. Quantities are presented relative to WT samples set to a value of 1. [GLUR1: WT 
1 ± 0.13, KO 0.99 ± 0.10; GLUR2: WT 1 ± 0.13, KO 1 ± 0.11; NR2B: WT 1 ± 0.09, KO 1.10 ± 0.20; 
HOMER1: WT 1.00 ± 0.11, KO 0.84 ± 0.07; EF1A2: WT 1 ± 0.12, KO 1.07 ± 0.11; 
AP2A1: WT 1 ± 0.18, KO 0.85 ± 0.14; DNM3: WT 1 ± 0.13, KO 0.92 ± 0.08; ACTN4: WT 1 ± 0.10, 
KO 0.85 ± 0.05; AP2M1: WT 1 ± 0.15, KO 0.99 ± 0.11; ANXA5: WT 1 ± 0.05, KO 0.88 ± 0.08; 
NME1: WT 1 ± 0.08, KO 1 ± 0.10; CKB: WT 1 ± 0.09, KO 1.15 ± 0.1]  
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Table S1 TRIM3 interactors in hippocampus detected with at least 2 out of 3 antibodies and at 
least one unique peptide. 
Gene 
symbol Protein name 
Antibody 
Count 
Average 
# peptides 
1700013D24Rik MCG1037134 2 1.5 
Aard Alanine and arginine-rich domain-containing protein 2 1 
Actg1 Uncharacterized protein 2 1 
Acy3 Aspartoacylase-2 2 1 
Agrn Isoform 2 of Agrin 2 2 
Akap8l A-kinase anchor protein 8-like 2 1 
Als2 Alsin 2 1 
Amigo2 Amphoterin-induced protein 2 2 1 
Ankzf1 Ankyrin repeat and zinc finger domain-containing protein 1 2 2 
Antxr1 Isoform 2 of Anthrax toxin receptor 1 2 1.33 
Atp4a Potassium-transporting ATPase alpha chain 1 2 1.33 
Blzf1 Isoform 2 of Golgin-45 2 1.33 
Bnc1 Uncharacterized protein 2 1.67 
Brca2 Breast cancer type 2 susceptibility protein homolog 2 3 
Bsn Isoform 2 of Protein bassoon 2 1 
Cand1 Cullin-associated NEDD8-dissociated protein 1 2 1.33 
Cbs Isoform 2 of Cystathionine beta-synthase 2 1 
Cdca7l Cell division cycle-associated 7-like protein 2 1 
Cdh23 Isoform 2 of Cadherin-23 2 1 
Celsr2 Isoform 2 of Cadherin EGF LAG seven-pass G-type receptor 2 2 2.5 
Copa Coatomer subunit alpha 2 1 
Ctnnal1 Alpha-catulin 2 1.33 
D1Pas1 Putative ATP-dependent RNA helicase Pl10 2 2 
Daam2 Disheveled-associated activator of morphogenesis 2 2 1 
Dcaf13 DDB1- and CUL4-associated factor 13 2 1.5 
Def6 Isoform 2 of Differentially expressed in FDCP 6 2 1 
Eef1a2 Elongation factor 1-alpha 2 2 1 
Elmo3 Isoform 2 of Engulfment and cell motility protein 3 3 1.33 
Epg5 Ectopic P granules protein 5 homolog 2 1 
Eppk1 Epiplakin 2 1 
Erbb2ip Isoform 1 of Protein LAP2 2 1.67 
Exog Nuclease EXOG_ mitochondrial 2 1.33 
Fhdc1 FH2 domain-containing protein 1 2 2 
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Gene 
symbol Protein name 
Antibody 
Count 
Average 
# peptides 
Gadl1 Glutamate decarboxylase-like protein 1 2 1 
Galntl4 
Putative polypeptide N-acetylgalactosaminyltransferase-like 
protein 4 2 1 
Gatad2a Transcriptional repressor p66 alpha 2 1 
Gm5771 MCG140783 2 1.5 
Golga1 Isoform 2 of Golgin subfamily A member 1 2 1 
Grn Granulins 2 1 
Hkdc1 Putative hexokinase HKDC1 2 1 
Hmcn1 Uncharacterized protein 2 2 
Igfn1 
Immunoglobulin-like and fibronectin type III domain-
containing protein 1 2 2.5 
Ino80 Isoform 2 of DNA helicase INO80 2 1.33 
Kalrn Isoform 2 of Kalirin 2 3 
Kiaa1009 Protein QN1 homolog 2 1.33 
Kif6 Uncharacterized protein 2 1 
Lilra6 Uncharacterized protein 2 1 
Magi1 
Membrane-associated guanylate kinase_ WW and PDZ domain-
containing protein 1 2 2 
Map2 Microtubule-associated protein 2 2 1 
Map3k3 Mitogen-activated protein kinase kinase kinase 3 2 1 
Mast1 Microtubule-associated serine/threonine-protein kinase 1 2 1.5 
Mbd3 Uncharacterized protein 2 1 
Mpdz Isoform 2 of Multiple PDZ domain protein 2 1 
Mup20 Major urinary protein 20 2 1 
Myo5b Isoform 3 of Unconventional myosin-Vb 2 1 
Naalad2 N-acetylated-alpha-linked acidic dipeptidase 2 2 1.5 
Nadsyn1 Glutamine-dependent NAD(+) synthetase 2 1.5 
Narg2 NMDA receptor-regulated protein 2 2 1 
Nfatc1 
Isoform Beta of Nuclear factor of activated T-cells_ 
cytoplasmic 1 2 1.5 
Nsun4 Isoform 4 of Sperm head and tail associated protein 2 1 
Odz2 Teneurin-2 2 1.5 
Pde4a cAMP-specific 3'_5'-cyclic phosphodiesterase 4A 2 1 
Polr3c DNA-directed RNA polymerase III subunit RPC3 2 1 
Pop1 Processing of 1_ ribonuclease P/MRP family_ (S. cerevisiae) 2 1 
Ppp1r12b Protein phosphatase 1 regulatory subunit 12B 2 1 
Prkaa1 5'-AMP-activated protein kinase catalytic subunit alpha-1 2 1 
Prkaa2 5'-AMP-activated protein kinase catalytic subunit alpha-2 2 
 
1 
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Gene 
symbol Protein name 
Antibody 
Count 
Average 
# peptides 
Ptprd Protein tyrosine phosphatase_ receptor type_ D 2 2.5 
Rab10 Ras-related protein Rab-10 2 1 
Rab33b Ras-related protein Rab-33B 3 1.33 
Rab39a Ras-related protein Rab-39A 2 1 
Rab39b Ras-related protein Rab-39B 3 1.67 
Rec8 Meiotic recombination protein REC8 homolog 2 1 
Rictor Rapamycin-insensitive companion of mTOR 2 1.5 
Rif1 Isoform 2 of Telomere-associated protein RIF1 2 2.5 
Rock2 Uncharacterized protein 2 2 
Rplp0 60S acidic ribosomal protein P0 2 1 
Safb Scaffold attachment factor B1 2 1 
Safb2 Scaffold attachment factor B2 2 1.67 
Scube2 
Signal peptide_ CUB and EGF-like domain-containing protein 
2 2 1 
Serbp1 
Isoform 2 of Plasminogen activator inhibitor 1 RNA-binding 
protein 2 2 
Sh2d3c Isoform 2 of SH2 domain-containing protein 3C 2 1 
Sh3d21 Isoform 2 of SH3 domain-containing protein 21 2 1 
Skint6 Selection and upkeep of intraepithelial T-cells protein 6 2 2 
Slc1a3 Excitatory amino acid transporter 1 2 1 
Slc27a4 Long-chain fatty acid transport protein 4 2 1 
Smtn Isoform L2 of Smoothelin 3 1.33 
Smurf1 E3 ubiquitin-protein ligase SMURF1 2 1 
Snx2 Sorting nexin-2 2 1.5 
Spnb4 Uncharacterized protein 2 2 
Spta1 Spectrin alpha chain_ erythrocyte 2 2.5 
St6galnac1 Alpha-N-acetylgalactosaminide alpha-2_6-sialyltransferase 1 2 1.5 
St6galnac6 
Isoform 2 of Alpha-N-acetylgalactosaminide alpha-2_6-
sialyltransferase 6 3 1.33 
Stard9 StAR-related lipid transfer protein 9 2 2 
Sult1e1 Estrogen sulfotransferase_ testis isoform 2 1 
Syne3 Isoform 2 of Nesprin-3 2 1 
Synj2 Isoform 2 of Synaptojanin-2 2 1.5 
Sytl2 Isoform 2 of Synaptotagmin-like protein 2 2 1 
Tmem57 Macoilin 2 1 
Tnrc18 Trinucleotide repeat-containing gene 18 protein 2 2.5 
Trim2 Tripartite motif-containing protein 2 2 12 
Ube1ay Ubiquitin-like modifier-activating enzyme 1 Y 2 1 
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Gene 
symbol Protein name 
Antibody 
Count 
Average 
# peptides 
Ythdc2 Probable ATP-dependent RNA helicase YTHDC2 2 1.5 
Zc3h13 Uncharacterized protein 2 2 
Zfp937 Novel zinc fingerprotein 2 1 
Znf879 Zinc finger protein 879 2 1 
Znfx1 NFX1-type zinc finger-containing protein 1 2 1 
 
Table S2 TRIM3 interactors in cerebellum detected with at least 2 out of 3 antibodies and at 
least one unique peptide. 
Gene 
symbol Protein name 
Antibody 
Count 
Average 
# peptides 
1110002E22Rik Uncharacterized protein 2 3 
5430421N21Rik Uncharacterized protein 2 4.33 
A430107O13Rik RIKEN cDNA A430107O13 gene 2 1 
Abca9 ATP-binding cassette sub-family A member 9 2 1.5 
Abcb4 Multidrug resistance protein 3 2 3 
Adcy1 Adenylate cyclase type 1 2 1 
Ahnak Uncharacterized protein 2 4 
Ahr Aryl hydrocarbon receptor 2 1 
AI481877 
Likely orthologue of H. sapiens chromosome 9 open 
reading frame 84 2 2 
Akap13 Uncharacterized protein 2 4.5 
Akap9 Uncharacterized protein 2 2.5 
Ank1 Isoform Br2 of Ankyrin-1 2 3.5 
Ankrd12 Ankyrin repeat domain 12_ isoform CRA_a 2 2 
Ankrd50 Ankyrin repeat domain 50 (Fragment) 3 3 
Ano6 Anoctamin-6 2 2 
Anxa1 Annexin A1 2 1 
Ap2m1 AP-2 complex subunit mu 3 3 
Arhgef10l 
Isoform 4 of Rho guanine nucleotide exchange factor 
10-like protein 2 1.5 
Atp2b1 MCG13663_ isoform CRA_a 2 1.33 
Atp4a Potassium-transporting ATPase alpha chain 1 2 3.33 
Atp5j2 ATP synthase subunit f_ mitochondrial 2 1.5 
Atp7a Copper-transporting ATPase 1 2 2.5 
Baz2a 
Isoform 2 of Bromodomain adjacent to zinc finger 
domain protein 2A 2 1 
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Gene 
symbol Protein name 
Antibody 
Count 
Average 
# peptides 
Brwd1 
Isoform B of Bromodomain and WD repeat-containing 
protein 1 2 2 
C030017K20Rik RIKEN cDNA C030017K20 gene (Fragment) 2 1.5 
C87977 Expressed sequence C87977 (Fragment) 2 1 
Ccdc109b Uncharacterized protein 2 1 
Ccdc165 
Isoform 3 of Coiled-coil domain-containing protein 
165 2 3 
Ccdc79 Isoform 2 of Coiled-coil domain-containing protein 79 2 1.5 
Cd163l1 RIKEN cDNA E430002D04_ isoform CRA_a 2 2 
Cdh23 Isoform 2 of Cadherin-23 3 2 
Cenpe Centromere-associated protein E 3 2.67 
Cep112 Centrosomal protein of 112 kDa 2 3 
Cep55 Isoform 2 of Centrosomal protein of 55 kDa 2 1 
Cep95 Centrosomal protein of 95 kDa 2 1 
Chchd7 
Coiled-coil-helix-coiled-coil-helix domain-containing 
protein 7 2 2 
Col22a1 Uncharacterized protein 2 3.5 
Col4a3 Collagen alpha-3(IV) chain 2 2.5 
Col6a3 Uncharacterized protein 2 3.5 
Creb5 Cyclic AMP-responsive element-binding protein 5 2 1 
Cul5 Uncharacterized protein 3 2.33 
Cyth3 Cytohesin 3 (Fragment) 2 1 
Ddah2 N(G)_N(G)-dimethylarginine dimethylaminohydrolase 2 1 
Ddx50 ATP-dependent RNA helicase DDX50 2 1.5 
Dgcr6 Isoform 2 of Protein DGCR6 2 1.33 
Dido1 Death-inducer obliterator 1 2 2 
Dnah5 Dynein heavy chain 5_ axonemal 2 2.5 
Dnahc9 Dynein_ axonemal_ heavy chain 9 2 3.5 
Dnmt1 DNA (cytosine-5)-methyltransferase 1 2 4 
Dusp13 Uncharacterized protein 2 1.5 
Dync1h1 Cytoplasmic dynein 1 heavy chain 1 2 6 
Dync2h1 Isoform 2 of Cytoplasmic dynein 2 heavy chain 1 2 2.5 
Eea1 Early endosome antigen 1 2 3 
Eftud1 
Elongation factor Tu GTP-binding domain-containing 
protein 1 2 3 
Egln2 Egl nine homolog 2 2 1.33 
Eif4g1 
Isoform 2 of Eukaryotic translation initiation factor 4 
gamma 1 2 1.5 
Erlin2 Erlin-2 2 1.5 
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Gene 
symbol Protein name 
Antibody 
Count 
Average 
# peptides 
Fam184b Protein FAM184B 2 2.5 
Fastk Uncharacterized protein 3 1.33 
Gas8 Growth arrest-specific protein 8 2 1 
Gigyf2 
PERQ amino acid-rich with GYF domain-containing 
protein 2 2 2 
Gm14548 Uncharacterized protein 2 2 
Gm597 Uncharacterized protein 2 1 
Gm8765 Predicted 2 2 
Golga3 Isoform 1 of Golgin subfamily A member 3 2 1.5 
Gpsm1 Isoform 2 of G-protein-signaling modulator 1 2 2.5 
Gripap1 GRIP1-associated protein 1 2 1 
Heatr1 HEAT repeat containing 1 2 2 
Helb Helicase (DNA) B 2 1.5 
Hinfp Histone H4 transcription factor 2 1 
Hivep3 Uncharacterized protein 2 2.67 
Hsf1 Isoform 1 of Heat shock factor protein 1 2 2 
Hsp90ab1 Heat shock protein HSP 90-beta 2 1.5 
Hspa2 Heat shock-related 70 kDa protein 2 3 1.67 
Iars Isoleucine--tRNA ligase_ cytoplasmic 2 1.5 
Inpp5j Phosphatidylinositol 4_5-bisphosphate 5-phosphatase 2 3 
Kdm2b Lysine-specific demethylase 2B 2 4.5 
Kif18a Kinesin-like protein KIF18A 2 1 
Kif23 Uncharacterized protein 2 1 
Kif26a Kinesin-like protein KIF26A 3 2 
Klhl28 Kelch-like protein 28 2 1.5 
Lipe Uncharacterized protein 2 2 
Lman1 Protein ERGIC-53 2 1.5 
Mag Isoform S-MAG of Myelin-associated glycoprotein 2 2.67 
Map7d3 Isoform 2 of MAP7 domain-containing protein 3 2 1 
Mcf2l Guanine nucleotide exchange factor DBS 2 3.5 
Mmrn2 Multimerin-2 2 1 
Mon2 Isoform 2 of Protein MON2 homolog 2 1.33 
Mpnd MPN domain-containing protein 2 2 
Msh3 Uncharacterized protein 2 1.5 
Msn Moesin 2 2 
Mtap4 Microtubule-associated protein (Fragment) 2 1 
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Gene 
symbol Protein name 
Antibody 
Count 
Average 
# peptides 
Myo18b Uncharacterized protein 2 4 
Narg2 NMDA receptor-regulated protein 2 2 1 
Ncoa4 Nuclear receptor coactivator 4 2 1.5 
Ndst1 
Bifunctional heparan sulfate N-deacetylase/N-
sulfotransferase 1 2 1.5 
Nfasc Neurofascin 2 2.5 
Nfatc1 Nuclear factor of activated T-cells_ cytoplasmic 1 3 1.67 
Nktr NK-tumor recognition protein 2 1.5 
Nlgn1 Isoform 2 of Neuroligin-1 2 1 
Nox1 Isoform 2 of NADPH oxidase 1 2 2 
Noxin Nitric oxide-inducible gene protein 2 2.5 
Npas1 Neuronal PAS domain-containing protein 1 2 1 
Npcd Neuronal pentraxin chromo domain 2 2.5 
Nptn Neuroplastin 2 2.67 
Nudt6 
Nudix (Nucleoside diphosphate linked moiety X)-type 
motif 6 2 1 
Numa1 Uncharacterized protein 2 3.67 
Obscn Obscurin 2 1.5 
Odf2 Outer dense fiber of sperm tails 2 2 1.5 
Odz3 Isoform 2 of Teneurin-3 2 5.5 
Olfr1213 Olfactory receptor 1213 2 1 
Osbpl3 Oxysterol-binding protein-related protein 3 2 1 
Pdap1 28 kDa heat- and acid-stable phosphoprotein 2 1 
Pdss2 Decaprenyl-diphosphate synthase subunit 2 2 1.5 
Pik3cg 
Phosphatidylinositol-4_5-bisphosphate 3-kinase 
catalytic subunit gamma isoform 2 2 
Plcb2 
1-phosphatidylinositol-4_5-bisphosphate 
phosphodiesterase beta-2 2 1.5 
Plcb4 Phospholipase C beta 4 2 1.5 
Plch2 
1-phosphatidylinositol-4_5-bisphosphate 
phosphodiesterase eta-2 2 3.5 
Plekha7 
Isoform 2 of Pleckstrin homology domain-containing 
family A member 7 2 3.5 
Plekhg4 Uncharacterized protein 2 1 
Polm Polymerase (DNA directed)_ mu 3 1.67 
Polr3b DNA-directed RNA polymerase III subunit RPC2 2 1.5 
Ppp1r13b Apoptosis-stimulating of p53 protein 1 2 2.5 
Prmt10 Putative protein arginine N-methyltransferase 10 2 1.5 
Rab33b Ras-related protein Rab-33B 2 2.33 
Rab39a Ras-related protein Rab-39A 2 1.5 
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Gene 
symbol Protein name 
Antibody 
Count 
Average 
# peptides 
Rad54l DNA repair and recombination protein RAD54-like 2 1.5 
Ranbp9 Isoform 2 of Ran-binding protein 9 2 1 
Rasgrf1 Ras-specific guanine nucleotide-releasing factor 1 2 1.5 
Rgs16 Regulator of G-protein signaling 16 2 1 
Ric8a Synembryn-A 2 1 
Rif1 Isoform 2 of Telomere-associated protein RIF1 2 4 
Ros1 Proto-oncogene tyrosine-protein kinase ROS 2 2.5 
Rsbn1 Round spermatid basic protein 1 2 1 
Rsph9 Radial spoke head protein 9 homolog 2 1.5 
Safb2 Scaffold attachment factor B2 2 1 
Scaper Uncharacterized protein 2 2 
Scin Adseverin 2 3.5 
Sdk2 Protein sidekick-2 2 3.5 
Sec1 Galactoside 2-alpha-L-fucosyltransferase 3 2 1.5 
Sec14l2 SEC14-like protein 2 2 1 
Sema6a Isoform 2 of Semaphorin-6A 2 1.5 
Serpinf2 Alpha-2-antiplasmin 2 2 
Shisa6 Protein shisa-6 homolog 2 1 
Slc38a10 
Isoform 2 of Putative sodium-coupled neutral amino 
acid transporter 10 2 3 
Smu1 WD40 repeat-containing protein SMU1 2 2.33 
Snap25 Synaptosomal-associated protein 25 2 1.33 
Snrnp200 Activating signal cointegrator 1 complex subunit 3-like 2 3.67 
Snx25 Uncharacterized protein 2 1 
Sorbs1 Sorbin and SH3 domain-containing protein 1 2 3.5 
Sp140 Sp140 nuclear body protein 2 3.5 
Srgap1 SLIT-ROBO Rho GTPase-activating protein 1 2 1 
St6galnac1 
Alpha-N-acetylgalactosaminide alpha-2_6-
sialyltransferase 1 2 2 
Synj1 Synaptojanin-1 3 2.33 
Taok2 Serine/threonine-protein kinase TAO2 2 2.5 
Tarsl2 Probable threonine--tRNA ligase 2_ cytoplasmic 2 1 
Tbc1d8b TBC1 domain family member 8B 2 1.5 
Tbc1d9 TBC1 domain family member 9 2 2 
Tbx10 Isoform 2 of T-box transcription factor TBX10 2 1 
Tfap2b Transcription factor AP-2-beta 2 1.5 
Tm6sf1 Transmembrane 6 superfamily member 1 2 1 
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Trim21 E3 ubiquitin-protein ligase TRIM21 3 2.33 
Trpm1 Uncharacterized protein 2 1.5 
U2af1l4 Splicing factor U2AF 26 kDa subunit 2 1 
Ush2A Isoform 3 of Usherin 3 1.67 
Utp15 
U3 small nucleolar RNA-associated protein 15 
homolog 2 2.5 
Vdac1 
Isoform Mt-VDAC1 of Voltage-dependent anion-
selective channel protein 1 2 1 
Vim Vimentin 2 1.5 
Vti1b Uncharacterized protein 2 1 
Vwf von Willebrand factor 2 1.5 
Wdr35 Isoform 2 of WD repeat-containing protein 35 2 1 
Wfs1 Wolframin 2 1.5 
Wipi2 
WD repeat domain phosphoinositide-interacting 
protein 2 2 1.5 
Wwc2 Protein WWC2 2 2.33 
Zfp292 Isoform 2 of Zinc finger protein 292 2 2 
Zfp420 MCG144734_ isoform CRA_a 2 1.5 
Zfp804b Uncharacterized protein (Fragment) 2 2 
Zfyve26 Zinc finger FYVE domain-containing protein 26 2 2 
Znf354a Zinc finger protein 354A 2 1 
Znf827 Zinc finger protein 827 2 3 
Zscan10 
Isoform 2 of Zinc finger and SCAN domain-containing 
protein 10 2 2.5 
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Abstract 
Stimulus-dependent structural and physiological synaptic plasticity require remodeling of the 
actin cytoskeleton. Two actin isoforms, β-actin and γ-actin, are expressed in neurons, yet 
their specific contribution to plasticity is unknown. We demonstrate that the E3 ubiquitin 
ligase TRIM3 co-localizes with, interacts with, and regulates γ-actin in hippocampal neurons. 
Actg1 mRNA transcripts and TRIM3 protein are both present in messenger ribonucleoprotein 
granules responsible for the dendritic targeting of mRNAs. TRIM3 regulates γ-actin through 
poly-ubiquitylation, most likely co-translationally in dendritic spines. We furthermore 
demonstrate the importance of γ-actin in learning and memory by showing that hippocampus-
specific Actg1 knockout mice have enhanced fear memory. These findings show for the first 
time that γ-actin is involved in regulating neuronal plasticity mechanisms underlying memory 
formation, and identify TRIM3 as an important upstream regulator of γ-actin-dependent 
plasticity. 
 
Introduction 
Synaptic plasticity has been widely established as the underlying mechanism of learning and 
memory formation. Many studies have shown that protein synthesis is an essential 
mechanism regulating protein content of synapses and thereby affecting synaptic strength 
and learning (Fonseca et al., 2006a; Frey et al., 1988; Huang et al., 1996). Synaptic protein 
degradation mediated by the ubiquitin proteasome system, was already proposed as a 
plasticity mechanism in the 1980s (Lynch and Baudry, 1984), but has only recently come 
into focus. In 2006 Fonseca et al. (Fonseca et al., 2006b) demonstrated that long-term 
potentiation (LTP) is not solely dependent on protein synthesis, but also on protein 
degradation. They showed that blocking the proteasome leads to a similar decrease in LTP 
as blocking translation. Only when inhibiting protein synthesis and degradation at the same 
time, LTP was restored. This led the authors to conclude that a delicate balance in synaptic 
protein synthesis and degradation is essential for synaptic plasticity. Since then numerous 
studies have been published highlighting the importance of synaptic E3 ubiquitin ligases 
targeting specific synaptic proteins for degradation. One of the first to be identified was 
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ubiquitin ligase E3A (UBE3A), which was recently demonstrated to ubiquitylate Arc 
(activity-regulated cytoskeleton-associated protein) and thereby affect AMPA receptor 
internalization (Greer et al., 2010). AMPA receptor subunits themselves (Lin et al., 2011; 
Schwarz et al., 2010), as well as many other key components of synapses such as PSD-95, 
SHANK and NMDA receptors are also subject to ubiquitin-mediated degradation (Colledge 
et al., 2003; Ehlers, 2003; Kato et al., 2005).  
In the previous chapters we demonstrated that TRIM3 is a synaptic E3 ubiquitin 
ligase, that when knocked out, causes enhanced LTP in the hippocampus, enhanced 
contextual fear memory consolidation and higher spine density in hippocampal pyramidal 
neurons. After demonstrating that GKAP and SHANK are not TRIM3 ubiquitylation 
substrates, as was recently proposed by Hung et al. (2010), we hypothesized that the 
electrophysiological, structural and behavioral phenotype in TRIM3 deficient mice is most 
likely caused by an as yet unidentified synaptic ubiquitylation substrate of TRIM3. Using a 
mass-spectrometry-based substrate identification assay we then identified gamma-actin 
(ACTG1), one of six known actin isoforms in mammals (Vandekerckhove and Weber, 1978), 
as the most likely ubiquitylation substrate of TRIM3. Two closely related TRIM3 paralogs, 
TRIM2 and TRIM32, also ubiquitylate cytoskeletal proteins (Balastik et al., 2008; 
Kudryashova et al., 2005) and TRIM3 itself contains an actin binding protein-like repeat (El-
Husseini, 1999).  
Cytoskeletal proteins such as actins are often viewed as stable and rigid cellular structures, 
yet in neurons, and especially in synapses and dendritic spines, the actin skeleton is highly 
dynamic (Hotulainen and Hoogenraad, 2010). Actin remodeling contributes to the structural 
changes observed during synaptic plasticity, i.e., spine growth and new synapse formation 
(Matsuzaki et al., 2004; Okamoto et al., 2004), and plays a key role in membrane insertion, 
clustering and internalization of postsynaptic receptors (Allison et al., 1998; Charrier et al., 
2006), all of which are essential to the expression of physiological plasticity, i.e. long-term 
potentiation (LTP) or long-term depression (LTD) (Choquet and Triller, 2003; Malinow and 
Malenka, 2002; Shepherd and Huganir, 2007). Moreover, beta-actin is known to be locally 
translated, indicating that also tight control of local actin levels plays an important role in the 
expression of synaptic plasticity (Buxbaum et al., 2014; Leung et al., 2006). 
In this chapter we aim to validate ACTG1 as an ubiquitylation substrate of TRIM3, 
and to establish regulation of ACTG1 by TRIM3 as a potential mechanisms underlying 
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synaptic plasticity. We first use a biochemical approach to demonstrate that TRIM3 and 
ACTG1 co-localize and interact in hippocampal synapses. We then show that TRIM3 poly-
ubiquitylates ACTG1 in an activity dependent manner. Using an mRNP-precipitation-qPCR 
approach we furthermore demonstrate that Actg1 mRNA is present in TRIM3-containing 
mRNP granules. We finally highlight the importance of ACTG1 in learning by showing that 
forebrain-specific Actg1 knockout mice show enhanced memory in a contextual fear memory 
paradigm. 
Material and Methods 
Animals 
The generation of Trim3-/- mice was described previously (Labonte et al., 2013). Actg1lox/lox 
mice (Perrin et al., 2010) (kind gift of Dr. James Ervasti) were crossed with CamkIIa-Cre 
mice (Mantamadiotis et al., 2002) in order to generate Actg1-cKO mice. All mice were 
maintained on a C57BL/6J background. In all experiments wildtype littermates were used as 
controls. Mice were individually housed on sawdust in standard Makrolon type II cages 
(26.5 cm long, 20.5 cm wide and 14.5 cm high) enriched with cardboard nesting material 
under 12/12 h dark/light cycle with access to water and food ad libitum. All animal 
experiments were approved by the animal ethics committee of the VU University 
Amsterdam, The Netherlands. 
Cellular fractionation and synaptic protein isolation 
Brain tissue was obtained from wildtype and Trim3-/- mice. Animals were sacrificed by 
cervical dislocation. Hippocampi were dissected and synaptic fractions isolated as previously 
described (Klemmer et al., 2009). Protein concentrations were measured using Bradford 
Protein-Assay (Bio-Rad Laboratories, USA) and equal amounts of protein were loaded on a 
4 – 20 % gradient SDS-PAGE gel (Criterion TGX Stain-Free Gel, Bio-Rad Laboratories, 
USA). Total protein amounts were imaged after electrophoresis using Criterion Stain Free 
Imager (Bio-Rad Laboratories, USA). Gels were then transferred to PVDF membranes (Bio-
Rad Immuno-Blot PVDF membrane, Bio-Rad Laboratories, USA) and blots were blocked 
by immersion in 5 % nonfat dry milk in TBS-T (TBS plus 0.025 % Tween, pH 7.4) for 1 h. 
Blots were then incubated with the antibody of interest for 1 h at room temperature, followed 
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by 1 h incubation with a secondary antibody conjugated to HRP. Proteins were visualized by 
enhanced chemiluminescence (ECL) (SuperSignal West Femto Chemiluminescent Substrate, 
Thermo Scientific, USA) and scanned using the Odyssey Fc imager (Li-Cor, USA). 
Antibodies used: ACTG1 (clone 2A3, ab123034, Abcam, 1:10,000), TRIM3 
(CLRPGDLPPSPDDVK, GenScript, 1:1,000), SYP (sc-9116, Santa Cruz, 1:2,000), PSD-95 
(73-028, Neuromab, 1:10).  
Cell culture and Immunoprecipitation 
Human embryonic kidney cells (HEK293) were maintained in Dulbecco’s modified Eagle 
medium supplemented with 10 % fetal bovine serum and 1 % Penicillin-Streptomycin (all 
from Life Technologies Thermo Fisher Scientific Inc., USA) at 37° C and 5 % CO2. Cells 
were co-transfected with GFP-TRIM3, GFP-ΔRBCC-TRIM3 or mock transfected at 
60 – 80 % confluence using polyethylenimine (PEI). For initial screening cells were sampled 
starting 12h after transfection at three hour intervals for 12 h. Cells were washed with ice 
cold PBS and subsequently lysed in SDS containing loading buffer. For quantitative analysis 
cells were lysed 48 h after transfection. Samples were then separated on a 4 - 20% gradient 
SDS-PAGE gel (Criterion TGX Stain-Free Gel, Bio-Rad Laboratories, USA), total protein 
amounts imaged using Criterion Stain Free Imager (Bio-Rad Laboratories, USA) and then 
transferred to PVDF membranes (Bio-Rad Immuno-Blot PVDF membrane, Bio-Rad 
Laboratories, USA). Blots were blocked by immersing the membrane in 5 % nonfat dry milk 
in TBS-T (TBS plus 0.025 % Tween, pH 7.4) for 1 h, washed and incubated with antibodies 
for ACTG1 (clone 2A3, ab123034, Abcam, 1:10,000) and ACTB (A5441, Sigma-Aldrich, 
1:10,000) for 1 h at room temperature, followed by a 1 h incubation with a secondary 
antibody conjugated to HRP. Proteins were visualized by ECL (SuperSignal West Femto 
Chemiluminescent Substrate, Thermo Scientific, USA) and scanned using the Odyssey Fc 
imager (Li-Cor, USA) for Western blot analysis. Protein quantities were calculated by 
dividing the background corrected signal intensity of each Western blot protein band 
(ImageStudio Software v. 2.0.38, Li-Cor, USA) by the background corrected signal intensity 
of the corresponding stain-free gel protein lane (Image Lab 3.0, Bio-Rad, USA). Significance 
was testes using a two-tailed t test. Values are presented as mean ± SEM expressed relative 
to wildtype samples. 
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For immunoprecipitation HEK293 cells were co-transfected with GFP-TRIM3 or mock 
transfected at 60 - 80% confluence. 48 h after transfection cells were washed with ice cold 
PBS (see above) and subsequently lysed in extraction buffer (1 % Triton X-100, 150 mM 
NaCl, 25 mM HEPES pH 7.4) supplemented with protease inhibitors (Complete Protease 
Inhibitor Cocktail, Roche Diagnostics) for 1 h at 4° C on a rotator. Insoluble material was 
pelleted at 20,000 g for 20 min and the supernatant used for immunoprecipitations (IPs). 
Antibodies used for IPs were: ACTG1 (clone 2-4, sc65634, Santa Cruz) and TRIM3 
(CLRPGDLPPSPDDVK, GenScript). IPs and input were separated on a 4 – 20 % gradient 
SDS-PAGE gel (Criterion TGX Stain-Free Gel, Bio-Rad Laboratories) and immunoblotted 
as described earlier using antibodies for ACTG1 (clone 2-4, sc65634, Santa Cruz) and 
TRIM3 (CLRPGDLPPSPDDVK, GenScript). 
 
Ubiquitylation assay in HEK293 cells 
HEK293 cells were transfected with myc-TRIM3, myc-ΔRBCC-TRIM3 or mock transfected 
at 60 - 80% confluence using polyethylenimine (PEI). 48 h after transfection cells were either 
washed with ice cold PBS and subsequently lysed in extraction buffer (2 % SDS, 150 mM 
NaCl, 2 mM DTT, 25 mM HEPES pH 7.4) supplemented with protease inhibitors (Complete 
Protease Inhibitor Cocktail, Roche Diagnostics) or first treated with 20 µM MG132 (Tocris 
Bioscience, 1748) and 500 nM TPA (12-O-Tetradecanoylphorbol-13-acetate, Sigma-
Aldrich, P1585) for four hours and then lysed. Samples were then sonicated, boiled for 
10 min and again sonicated. Extracts were diluted to a SDS concentration of 0.1 % with 
Triton X-100 containing extraction buffer (1 % Triton X-100, 150 mM NaCl, 25 mM HEPES 
pH 7.4). Insoluble material was pelleted at 20,000 g for 20 min and the supernatant used for 
immunoprecipitations (IPs). 25 µg of ACTG1 antibody (clone 2A3, ab123034, Abcam) were 
added to each sample and incubated overnight on a rotator at 4° C. Next day 50 µl of protein 
A / G beads (Protein A/G Plus-Agarose, Santa Cruz Biotechnology Inc.) were washed three 
times in washing buffer (0.1% Triton X-100, 150 mM NaCl, 25 mM HEPES pH 7.4) and 
added to each IP sample. Beads were incubated for 120 min on a rotator at 4° C, then pelleted 
at 2,500 g and washed four times in ice-cold extraction buffer (1 % Triton X-100, 150 mM 
NaCl, 25 mM HEPES pH 7.4). ACTG1 was eluted off the beads by adding SDS containing 
loading buffer and heating to 55° C for 10 min. IPs and input were separated on a 4 – 20 % 
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gradient SDS-PAGE and immunoblotted. Blots were blocked in 0.5 % BSA in TBS-T (TBS 
plus 0.025 % Tween) for 1h. Blots were then incubated with antibodies for Ubiquitin (FK2, 
BML-PW8810, Enzo Life Sciences, 1:100) and ACTG1 (clone 2-4, sc65634, Santa Cruz, 
1:200) for 1 h at room temperature, followed by a 1 h incubation with a secondary antibody 
conjugated to HRP. Proteins were visualized by ECL (SuperSignal West Femto 
Chemiluminescent Substrate, Thermo Scientific, USA) and scanned using the Odyssey Fc 
imager (Li-Cor, USA). ACTG1 protein bands at 42 kDa blots were scanned for two minutes, 
ACTG1 bands of higher molecular weight for 10 - 20 min. Ubiquitylation was quantified by 
dividing the background corrected ubiquitin signal intensity (50 - 150 kDa) by the 
background corrected ACTG1 signal intensity (42 kDa) of the corresponding lane 
(ImageStudio Software v. 2.0.38, Li-Cor, USA). Experiments were performed in three 
independent replicates. Significance was tested using a two-tailed t-test. 
Hippocampal primary neuron culture 
Hippocampi were dissected from E18 wildtype and Trim3-/- mice and collected in Hanks 
balanced salts solution (HBSS; Sigma-Aldrich, USA), buffered with 7 mM HEPES 
(Invitrogen). Hippocampi were incubated for 30 min in trypsinated HBBS at 37° C. After 
washing, neurons were triturated with fire-polished Pasteur pipettes, counted and plated in 
Neurobasal medium (Invitrogen, USA) supplemented with 2 % B-27 (Invitrogen), 1.8 % 
HEPES, 1 % glutamax (Invitrogen, USA), 1 % Pen Strep (Invitrogen) and 0.2 % 14.3 mM 
β-mercapto-ethanol. Cultures were plated on poly-D-lysine (Sigma-Aldrich)-coated and 5 % 
heat-inactivated horse serum (Invitrogen)-treated glass coverslips. Neurons were plated at a 
seeding density of 250 cells/mm2. Half of the medium was replaced with fresh medium every 
week. After 14 days in culture, neurons were either lysed in SDS-containing loading buffer 
directly or first treated with 20 µM MG132 and 500 nM TPA for 4 h and then lysed. Samples 
were separated on SDS-PAGE and immunoblotted for ACTG1 (clone 2-4, sc65634, Santa 
Cruz, 1:1,000), TRIM3 (CLRPGDLPPSPDDVK, GenScript, 1:1,000), ACTB (A5441, 
Sigma-Aldrich, 1:10,000) and TUBB3 (T8660, Sigma-Aldrich, 1:2,000). Protein quantities 
were calculated by dividing the background corrected signal intensity of each Western blot 
protein band (ImageStudio Software v. 2.0.38, Li-Cor, USA) by the background corrected 
signal intensity of the corresponding stain-free gel protein lane (Image Lab 3.0, Bio-Rad, 
USA). Significance was tested using a two-tailed t-test. 
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Co-Immunoprecipitation of TRIM3 from Hippocampus 
For immunoprecipitation (IP) experiments 10 mg of hippocampal P2 + M from wildtype and 
Trim3-/- mice were extracted in equal volumes of Triton X-100-containing extraction buffer 
(2 % Triton X-100, 150 mM NaCl, 25 mM HEPES pH 7.4, protease inhibitors (Complete 
Protease Inhibitor Cocktail, Roche Diagnostics) for 1 h on a rotator at 4° C. Insoluble material 
was then pelleted at 20,000 g for 20 min at 4° C. The pellet was then re-extracted in 1 % 
Triton X-100 extraction buffer (1% Triton X-100, 150 mM NaCl, 25 mM HEPES pH 7.4, 
protease inhibitors) for one hour. Insoluble material was again pelleted at 20,000 g for 
20 min. Supernatants from the first and second extraction were then pooled, centrifuged at 
20,000 g for 20 min and the final supernatant served as input for the immunoprecipitation. 
Input was treated with RNase A (R4642, Sigma-Aldrich). After 24 h 10 µg of Trim3 antibody 
(epitope: QAPEGAHDPEDPHPC, GenScript) or ACTG1 antibody (clone 2-4, sc65634, 
Santa Cruz) were added to each sample and incubated overnight on a rotator at 4° C. Next 
day 30 µl of protein A/G beads (Protein A/G Plus-Agarose, Santa Cruz Biotechnology Inc.) 
were washed three times in washing buffer (0.1 % Triton X-100, 150 mM NaCl, 25 mM 
HEPES pH 7.4) and added to each IP sample. Beads were incubated for 120 min on a rotator 
at 4° C, then pelleted at 2,500 g and washed four times in ice-cold washing buffer. TRIM3 
and interacting proteins were eluted off the beads by adding SDS-containing loading buffer 
and boiling for 5 min. Samples were run on SDS-PAGE and immunoblotted for TRIM3 
(epitope: QAPEGAHDPEDPHPC, GenScript, 1:1,000) and ACTG1 (clone 2-4, sc65634, 
Santa Cruz, 1:10,000). 
RNA Immunoprecipitation 
Immunoprecipitations were performed in triplicate from wildtype and Trim3-/- mice 
hippocampi as described above.  All IP buffers contained 40 units RiboLock RNase inhibitor 
(R4642, Sigma-Aldrich) per milliliter. Antibodies used for IPs were TRIM3 (epitope: 
QAPEGAHDPEDPHPC, GenScript) and PURA (05-1361, Millipore). After 
immunoprecipitation RNA was isolated using Trizol (Thermo Fisher Scientific) following 
manufacturer’s instructions, DNase-treated and reverse transcribed to cDNA using random 
hexanucleotide primers. Gene expression levels of Actg1, Actb and Slc1a3 were analyzed 
using an ABI Prism® SDS 7900 (Applied Biosystems) system with SYBR Green as the 
reporter dye. Per 10 µl reaction a cDNA equivalent of 20 ng RNA was used with 300 nM 
 TRIM3 ubiquitylates gamma-actin in an activity-dependent manner 
 111 
gene specific primers (Actg1 Fw 5’ A C C A A C A G C A G A C T T C C A G G A T  3’, 
Actg1 Rev 5’ A G A C T G G C A A G A A G G A G T G G T A A  3’; 
Actb Fw 5’ A A G A T C A A G A T C A T T G C T C C T C C T G  3’, Actb Rev 5’ A G C 
T C A G T A A C A G T C C G C C T  3’; Slc1a3 Fw 5’ G T G G A C T G G T T T C T G 
G A C C G  3’, Slc1a3 Rev 5’ T C A T G T C G G G A C A A G T G C T C 3’). Levels of 
mRNA were compared using the ΔΔ-Ct method (Winer et al., 1999). Expression levels were 
normalized to the mean of Actb. 
 
Fear conditioning 
Fear conditioning experiments were carried out as described (Misane et al., 2005; Stiedl et 
al., 2000) using a computerized fear conditioning system (TSE, 303410, Bad Homburg, 
Germany). In brief, mice were placed in an acrylic cage mounted into a constant illuminated 
(450 lx) fear conditioning box. After a 180 s exploration period, mice received a 2 s foot 
shock (0.7 mA) delivered through a metal floor grid. Mice were returned to their home cages 
30 s after termination of the shock. Base-line behavior, activity, exploration and freezing 
were automatically measured by infrared laser beams before, during and after foot shock. 
Contextual fear memory was tested by measuring freezing (lack of movement aside from 
respiration and heart beat) at re-exposure of the animals to the conditioning box at and 24 h 
and 72 h after the foot shock. 
 
Results 
TRIM3 interacts and co-localizes with ACTG1  
In our assay to identify potential substrates of TRIM3 we found gamma-actin to be a strong 
interactor that is also specifically ubiquitylated in wildtype mice, but not in Trim3-/- mice. To 
establish whether ACTG1 levels are regulated by TRIM3 we first validated whether the two 
proteins physically interact. Expression of TRIM3 in HEK293 cells and immunoprecipitation 
of either TRIM3 or endogenously expressed ACTG1, resulted in co-immunoprecipitation of 
ACTG1 and TRIM3, respectively, only from TRIM3-expressing cells, but not from mock-
transfected cells (Figure 1A). Similarly, immunoprecipitation of TRIM3 from wildtype 
hippocampal synapse-enriched fractions, but not from Trim3-/- fractions, yielded ACTG1 and 
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vice versa (Figure 1B). Cellular fractionation of hippocampal tissue followed by 
immunoblotting for TRIM3, ACTG1 and markers for pre- and postsynaptic structures 
subsequently showed that TRIM3 and ACTG1 co-localize in all fractions, including 
postsynaptic fractions (Figure 1C). Thus, TRIM3 and ACTG1 physically interact in 
heterologous cells and in hippocampal synaptic protein fractions, and co-localize at synaptic 
sites. 
  
 TRIM3 ubiquitylates gamma-actin in an activity-dependent manner 
 113 
TRIM3 regulates ACTG1 levels 
We then asked whether TRIM3 also regulates ACTG1 protein levels. We first transfected 
HEK293 cells with TRIM3, ΔRBCC-TRIM3 or mock transfected them. When we sampled 
cells, we observed that ACTG1 protein amounts decreased with time in cells expressing 
TRIM3, whereas they increased in mock transfected or ΔRBCC-TRIM3 expressing cells 
(Figure 1D), indicating that TRIM3 may negatively regulate ACTG1 levels in HEK293 cells. 
 
 
Figure 1 TRIM3 interacts and co-localizes with ACTG1 and decreases ACTG1 levels in HEK293 
cells. (A) HEK293 cells were transfected with TRIM3 or mock transfected. Cells were lysed 48h after 
transfection. TRIM3 and ACTG1 were immunoprecipitated (IP) from the lysates, immunoblotted and 
stained for TRIM3 and ACTG1. TRIM3 can be observed in the ACTG1 IP, and ACTG1 in the TRIM3 
IP. No or significantly less TRIM3 or ACTG1 protein was detected in TRIM3 IPs from mock-
transfected cell lysate. (B) Hippocampal synapse-enriched fractions were prepared from wildtype and 
Trim3-/- mice. TRIM3 and ACTG1 were immunoprecipitated from the lysates, immunoblotted and 
stained for TRIM3 and ACTG1. TRIM3 can be observed in the ACTG1 IP, and ACTG1 in the TRIM3 
IP. No or significantly less TRIM3 or ACTG1 protein was detected in the TRIM3 IP on the 
Trim3-/- tissue sample. (C) Biochemical fractionation of hippocampal tissue followed by Western blot 
analysis showed that ACTG1 and TRIM3 are both detected in synaptic fractions. Enrichment of 
synapses is evidenced by PSD95 and SYP staining. (D) TRIM3 regulates ACTG1 levels in HEK293 
cells. HEK293 cells were transfected with TRIM3, ∆RBCC-TRIM3 or mock-transfected (NO TRIM3). 
After 12 h cells were lysed at three hour intervals for a time period of 12 h. Lysates were immunoblotted 
and stained for ACTG1. A decrease with time of ACTG1 could be observed in TRIM3 expressing cells, 
but not in cells expressing ΔRBCC-TRIM3 or mock-transfected cells.  
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In order to quantify the effect of TRIM3 on ACTG1 levels in HEK293 cells, we 
overexpressed TRIM3 and ΔRBCC-TRIM3 for 48 h and analyzed ACTG1 amounts in the 
lysates. Cells expressing TRIM3 showed a significant decrease of ACTG1 protein levels 
compared with ΔRBCC-TRIM3-expressing cells (∆RBCC-TRIM3 1 ± 0.12, TRIM3 
0.58 ± 0.05, n = 8, **p < 0.01) (Figure 2A). We did however also observe a significant 
reduction in beta-actin (ACTB) levels (∆RBCC-TRIM3 1 ± 0.08, TRIM3 0.67 ± 0.05, n = 8, 
**p  < 0.01) (Figure 2B), indicating that at least in HEK293 cells TRIM3 does not exclusively 
target ACTG1. In cultured hippocampal primary neurons a specific increase of ACTG1 levels 
was only observed in cells obtained from Trim3-/- mice compared with cells obtained from 
wildtype mice (TRIM3 1 ± 0.07, Trim3-/- 1.26 ± 0.10, n = 8, *p < 0.05) (Figure 2C). ACTB 
levels (TRIM3 1 ± 0.16, Trim3-/- 1.06 ± 0.10), and tubulin beta-3 (TUBB3) (TRIM3 1 ± 0.21, 
Trim3-/- 0.85 ± 0.06) levels were not affected (Figure 2D - E). Taken together, these data 
show that ACTG1 protein levels are downregulated in the presence of TRIM3. 
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Figure 2 TRIM3 regulates gamma-actin. (A - B) HEK293 cells were transfected with TRIM3 or 
ΔRBCC-TRIM3. Cells were lysed 48 h after transfection, lysates immunoblotted and stained for 
TRIM3 and ACTG1 (A), or TRIM3 and ACTB (B). Both ACTG1 and ACTB protein levels were 
significantly reduced in TRIM3 expressing cells compared to cells expressing ΔRBCC-TRIM3 (means 
± SEM, two-tailed t test, **p < 0.01, n = 8 per condition). (C - E) Hippocampal neurons from wildtype 
and Trim3-/- mice were cultured in vitro. Cells were lysed after 14 days, lysates immunoblotted and 
stained for TRIM3 and ACTG1 (C), TRIM3 and ACTB (D), or TRIM3 and TUBB3 (E). Normalized 
protein levels were calculated by dividing Western blot (WB) signal intensities by the total protein 
intensities (stain-free gel). ACTG1, but not ACTB or TUBB3, protein levels were significantly higher 
in neurons from Trim3-/- mice (means ± SEM, two-tailed t test, *p < 0.05, n = 8 per genotype). 
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TRIM3 poly-ubiquitylates ACTG1 
We then asked whether TRIM3 is indeed able to poly-ubiquitylate ACTG1. We expressed 
full length TRIM3 or ΔRBCC-TRIM3 in HEK293 cells for two days. Then proteasomal 
degradation was blocked by adding the proteasome inhibitor MG132 for four hours, cell 
lysates were harvested and ACTG1 was immunoprecipitated. The immunoprecipitates were 
subsequently immunoblotted for ubiquitin and for ACTG1. Unmodified ACTG1 was 
detected at the expected molecular weight of 42 kDa, but surprisingly we did not detect any 
increase in high-molecular weight ubiquitin staining (Figure 3A) or high-molecular weight 
ACTG1 species (Figure 3B) due to TRIM3 expression. Given that TRIM3 is part of mRNP 
particles and that many proteins in mRNP particles are involved in local translation (Kanai 
et al., 2004; Torvund-Jensen et al., 2014) we hypothesized that TRIM3 may exert its function 
during or shortly after translation. To test this hypothesis we repeated the overexpression 
experiments, but instead of only blocking the proteasome, we also stimulated the cells with 
tetradecanoylphorbol acetate (TPA) for a period of four hours prior to harvesting. 
Tetradecanoylphorbol acetate is a phorbol ester known to promote cell growth and protein 
synthesis that can be tolerated by cells for prolonged period of time (Herbert et al., 2000; 
Kazanietz et al., 2000). It acts by activating protein kinase C, the mTOR pathway and others 
(Carriere et al., 2011; Herbert et al., 2000; Kazanietz, 2000; Kazanietz et al., 2000). When 
we stimulated cells with TPA while blocking the proteasome, a strong increase in high-
molecular weight ubiquitin staining following ACTG1 immunoprecipitation (Figure 3C) was 
observed, and ACTG1 staining confirmed the presence of 50 – 100 kDa modified ACTG1 
species (Figure 3D) specifically in TRIM3 expressing cells, and not in ΔRBCC-TRIM3 or 
mock-transfected cells (mock 1 ± 0.14, ∆RBCC-TRIM3 0.91 ± 0.13, TRIM3 4.75 ± 0.77, 
n = 3, * p < 0.05) (Figure 3E). We observed a similar increase in 50 - 100 kDa modified 
ACTG1 species in cultured hippocampal neurons treated with TPA and MG132 for 4 h, 
specifically for wildtype neurons, and not in Trim3-/- neurons (Figure 3F). The discrete 
banding pattern of these high-molecular weight ACTG1 species is consistent with ubiquitin 
modifications consisting of one or more ubiquitin moieties. 
TRIM3 protein and Actg1 mRNA co-localize in mRNP particles 
It was previously reported that poly-ubiquitylation of ACTG1 occurs co-translationally at 
Lys-18, which is buried in the protein core and inaccessible once the protein is fully 
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synthesized (Zhang et al., 2010). In that respect it is interesting to note that TRIM3 is found 
in mRNP particles (Chapter 3) as these might co-deliver TRIM3 and Actg1 mRNA to 
synaptic sites, allowing TRIM3 to poly-ubiquitylate ACTG1 during local translation. In 
contrast to Actb mRNA however, Actg1 mRNA was not previously reported to be present in 
mRNP particles. To test whether Actg1 mRNA is available for local translation, we 
immunoprecipitated mRNP particles from hippocampal synapse-enriched fractions using 
antibodies against TRIM3 or PURA and quantified the levels of different mRNAs using 
quantitative real-time PCR. We found that Actg1 and Actb mRNAs were both present in all 
immunoprecipitates and at similar levels, whereas a negative control transcript (Slc1a3) was 
detected at ~10 times lower levels (Figure 3G). The same results were obtained when mRNP 
particles were immunoprecipitated from Trim3-/- protein fractions using the PURA antibody, 
suggesting that TRIM3 itself is not required for the incorporation of Actg1 mRNA into mRNP 
particles. 
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Figure 3 TRIM3 poly-ubiquitylates ACTG1. (A - B) HEK293 cells were transfected with TRIM3 or 
ΔRBCC-TRIM3. After 44 hours cells were incubated for four hours in the presence of MG132. Cells 
were then lysed and ACTG1 was immunoprecipitated from the lysates, resolved on SDS-PAGE and 
Western blotted. Blots were first stained for poly-ubiquitin (A), and then stripped and re-stained for 
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ACTG1 (B). Under basal conditions, only unmodified ACTG1 was detected, but no higher molecular 
weight poly-ubiquitylated forms of ACTG1. (C-E) HEK293 cells were transfected with TRIM3 or 
ΔRBCC-TRIM3. After 44 hours cells were incubated for four hours in the presence of MG132 and 
TPA. Cells were then lysed and ACTG1 was immunoprecipitated from the lysates, resolved on SDS-
PAGE and Western blotted. Blots were first stained for poly-ubiquitin (C), stripped and re-stained for 
ACTG1 (D). TPA induced a significant increase in high-molecular weight poly-ubiquitylated forms of 
ACTG1 (indicated with *) specifically in TRIM3 transfected cells, and not in ΔRBCC-TRIM3 or mock 
transfected cells (E) (means ± SEM, two-tailed t test, *p < 0.05, n = 3 per condition). (F) Hippocampal 
neurons from wildtype and Trim3-/- mice were cultured for 14 days in vitro. Cells were then treated 
MG132 and TPA for 4h and lysed. Lysates were Western blotted and stained for ACTG1. TPA induced 
the appearance of multiple high-molecular weight (50 - 100 kDa) bands (indicated with *) consistent 
with poly-ubiquitylation and specifically in neurons from wildtype mice and not from Trim3-/- mice. 
(G) Actg1 mRNA is present in TRIM3/PURA-containing mRNP granules. mRNP granules were 
immunoprecipitated with antibodies against TRIM3 or PURA from hippocampal lysates of wildtype 
and Trim3-/- mice. mRNA was isolated from immunoprecipitates, reverse-transcribed into cDNA and 
used for real-time qPCR. Actg1 and Actb mRNA were detected at equal levels in all precipitates, 
whereas the negative control mRNA Slc1a3 was ~10-fold lower detected. 
 
Conditional Actg1 knockout mice show enhanced fear memory 
We finally wanted to establish whether and how a change in gamma-actin levels in neurons 
can affect hippocampus-dependent learning and memory. We therefore generated a forebrain 
specific ACTG1 knockout mouse by crossing Actg1lox/lox mice (Perrin et al., 2010) with mice 
that express Cre-recombinase under the control of the CamKIIα (calcium/calmodulin-
dependent protein kinase II alpha) promotor, which is activated in most forebrain neurons 
from the first postnatal week on (Mantamadiotis et al., 2002; Tsien et al., 1996). All 
conditional knockout animals were live born at expected Mendelian ratios and were 
indistinguishable from heterozygous and wildtype littermates. We used western blotting to 
(i) validate brain region specificity of our gamma-actin knockout mice and (ii) test the 
specificity of the used gamma-actin antibodies. While the specificity of ACTG1 antibody 
clone 2-4 was demonstrated earlier using muscle specific ACTG1 knockout mice (Hanft et 
al., 2006), clone 2A3 has not been tested on knockout tissue. Both antibodies showed a 
significant reduction of gamma-actin in hippocampus, frontal cortex and olfactory bulb 
(ACTG1 clone 2A3: 32 ± 0.04 %, ACTG1 clone 2 - 4: 0.12 ± 0.04 %, **p < 0.01), at ratios 
expected for a conditional knockout targeting excitatory neurons (Figure 4A - B). Hindbrain 
(cerebellum, brain stem) SDS extracts showed normal gamma-actin levels for wildtype and 
knockout animals (Figure 4). Interestingly, we also observed a significant compensatory up-
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regulation of beta-actin in the forebrain of gamma-actin deficient animals, which is in 
accordance with previously published literature (Belyantseva et al., 2009). TRIM3 on the 
other hand is not affected by loss of ACTG1 and is equally expressed in all tested brain 
regions regardless of the genotype (Figure 4). To assess hippocampus dependent memory 
performance, we tested Actg1-cKO mice and wildtype littermates in a contextual fear 
conditioning paradigm. We found that Actg1-cKO froze significantly more when re-exposed 
to the initial context 24 h after conditioning (WT: 35.7 ± 10.3 %, Actg1-cKO: 61.2 ± 2.9 %, 
*p < 0.05). When we re-exposed the same animals again to the context after 72 h,  Actg1-
cKO mice still froze significantly more (WT: 31.1 ± 9.0 %, Actg1-cKO: 60.1 ± 7.3%, *p < 
0.05). Altogether, these data show that: (i) TRIM3 co-localizes and interacts with ACTG1 in 
hippocampal neurons, (ii) TRIM3 can poly-ubiquitylate ACTG1 at synaptic sites in an 
activity dependent manner, and (iii) ACTG1 is a crucial factor in hippocampus dependent 
learning and memory.  
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Figure 4 Forebrain-specific Actg1 knockout mice show enhanced contextual fear memory. 
(A - B) Forebrain specific ACTG1 knockout mice under the control of the CamKIIα promotor show a 
distinct and significant reduction of ACTG1 protein in hippocampus, frontal cortex and olfactory bulb 
(B), but not in cerebellum and brain stem. Loss of ACTG1 protein is compensated by ACTB and not 
by ACTA1 up-regulation in the forebrain. TRIM3, TUBB3 and GAPDH are unaffected by loss of 
ACTG1 (means ± SEM, two-tailed t test, *p < 0.01, n = 3) (C) Actg1-cKO mice show significantly 
enhanced freezing 24 h after fear conditioning and still freeze more when re-exposed to the conditioning 
context after 72 h (means ± SEM, two-tailed t test, 24h *p < 0.05, n = 11; 72 h *p < 0.05, n = 6/5).  
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Discussion 
In this chapter we demonstrated that TRIM3 and ACTG1 co-localize and interact in 
hippocampal synapses. TRIM3 is able to regulate ACTG1 amounts by poly-ubiquitylation 
and subsequent proteasomal degradation in a stimulus-dependent manner. We further showed 
that Actg1 mRNA is present in PURA / TRIM3 containing mRNP granules, allowing the 
possibility that TRIM3 ubiquitylates ACTG1 co-translationally. We finally demonstrated the 
importance of ACTG1 in learning by showing that a forebrain-specific Actg1 knockout 
mouse shows enhanced memory in a contextual fear memory paradigm. 
TRIM3 interacts with ACTG1 
Consistent with the finding from our substrate identification assay (Chapter 4) we were able 
validate ACTG1 as a TRIM3 interactor. By using immunoprecipitations of TRIM3 and 
ACTG1 we were able to show that TRIM3 interacts with ACTG1 and vice versa. We had 
earlier demonstrated that TRIM3 also interacts with PURA, but that this interaction is 
mediated by RNA, or by being part of the same mRNA transport granule (Chapter 3). To 
address the question of whether the interaction between ACTG1 and TRIM3 is direct, we 
treated synapse-enriched hippocampal fractions with RNase prior to immunoprecipitation. 
The interaction of ACTG1 and TRIM3 was still present after RNase treatment, indicating 
direct interaction. We further validated the interaction by overexpressing TRIM3 in HEK 
cells, followed by immunoprecipitation. TRIM3 is not endogenously expressed in HEK cells, 
making it unlikely that an observed interaction is RNA mediated, at least not by the same 
mechanism as in neurons. Indeed, we were able co-immunoprecipitate TRIM3 with ACTG1 
and vice versa, leading us to conclude that the interaction is indeed direct. However, HEK 
cells share some properties with neurons and express numerous neuronal proteins (Lin et al., 
2014; Shaw et al., 2002), allowing for the possibility that an unknown protein-protein 
mediator between ACTG1 and TRIM3 is involved. Immunoprecipitation of intact TRIM3 
complexes from HEK cells followed by BN-PAGE could certainly shed light on this matter. 
TRIM3 regulates ACTG1 by ubiquitylation 
We observed that when we overexpress TRIM3 in HEK cells, ACTG1 levels were 
significantly decreased. In accordance we found significantly more ACTG1 in hippocampal 
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neurons from TRIM3-/- mice. Interestingly, in HEK cells we also observed a significant 
decrease of ACTB when we overexpressed TRIM3, indicating that with an excess of TRIM3, 
or a lack of suitable substrate, specificity of the ubiquitylation reaction decreases. 
The detected changes in ACTG1 levels in neurons and HEK cells are likely caused by the 
presence or absence of TRIM3-mediated ubiquitylation. We found that TRIM3 was only able 
to ubiquitylate ACTG1 in HEK293 cells under conditions where protein synthesis was 
stimulated. A number of possible explanations may account for this finding. We had earlier 
hypothesized that TRIM3 ubiquitylates ACTG1 co-translationally at lysine 18 which is only 
accessible while in translation (Zhang et al., 2010). In our immunoprecipitation experiments 
for ACTG1 we transfected HEK293 cells at 60 - 80 % confluence and blocked the proteasome 
for four hours after 44 hours of transfection. At this moment in time cells were fully confluent 
and considering the relatively long half-life of actin of about 48 hours (Antecol et al., 1986) 
we may assume that there was little demand for new actin synthesis, and stimulation of 
protein synthesis would be required to reveal co-translational ubiquitylation. Indeed, we 
enriched for poly-ubiquitylated ACTG1 species when cells were stimulated with TPA while 
blocking the proteasome. TPA is a tumor promotor (Blumberg, 1988) and has effects on cell 
growth, gene transcription and proteins synthesis by activating among others protein kinase 
C (PKC) and the mTOR pathway (Carriere et al., 2011; Herbert et al., 2000; Kazanietz, 2000; 
Kazanietz et al., 2000). Only when blocking the proteasome and stimulating at the same time 
with TPA were we able to detect poly-ubiquitylated species of ACTG1, supporting our 
hypothesis that TRIM3 regulates ACTG1 co-translationally. However, due to the broad effect 
of TPA on cells, we cannot rule out other possibilities entirely. In some cases it is known that 
ubiquitylation is preceded by other post-translational modifications such as arginylation, 
acetylation and phosphorylation (Arnesen, 2011; Terman and Kashina, 2013). Since PKC 
phosphorylates actin (Carrascosa and Wieland, 1986; Walsh et al., 1981), the TPA-induction 
experiments might also indicate that only phosphorylated ACTG1 is targeted by TRIM3 for 
degradation. Similarly the Skp1-Cul1-F-box (SCF) ubiquitin ligase only ubiquitylates cyclin 
D1 when threonine 286 is phosphorylated (Lin et al., 2006). Also, TRIM3 itself has two 
known phosphorylation sites (Olsen et al., 2006) and it is possible that TPA-induced 
phosphorylation of TRIM3 enhances ubiquitylation of ACTG1. 
Co-translational ubiquitylation of ACTG1 by TRIM3 is further supported by the fact that we 
were able to detect Actg1 mRNA in TRIM3/PURA containing mRNA transport granules 
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from hippocampal neurons. Many mRNP granule proteins identified by Kanai et al. (2004), 
i.e. FMR1, DDX1, EF1A, EF2A and numerous hnRNP proteins, are involved in local 
translation (Chen et al., 2002; Lee et al., 2010; Nilsson and Nissen, 2005; Sidorov et al., 
2013; Torvund-Jensen et al., 2014). Moreover, many locally translated mRNAs such as Arc, 
Map2, CamKIIα and β-actin are known components of mRNP granules (Hirokawa, 2006; 
Mikl et al., 2011). Although Actg1 mRNA is often claimed not to be dendritically targeted, 
our findings are supported by a recent deep sequencing study showing that both Actg1 and 
Actb transcripts are present in the hippocampal neuropil, and are among the 2,550 mRNAs 
that can be identified with high confidence as dendritic/axonal transcripts (Cajigas et al., 
2012).  
Actg1-cKO and the role of ACTG1 in learning 
To test whether ACTG1 levels also affect learning we created a forebrain-specific Actg1 
knockout mouse. Recently generated global Actg1 knockout mice were found to be born at 
only one-third of the expected Mendelian ratio (Belyantseva et al., 2009), indicating that 
ACTG1 is at least partially important for normal development. Furthermore these mice had 
significantly reduced body weights and showed a high rate of premature death (Belyantseva 
et al., 2009). To limit systemic and developmental effects of ACTG1 deficiency we generated 
a forebrain-specific Actg1 knockout mouse (Actg1-cKO) employing CamKIIα promotor 
driven Cre expression. Actg1-cKO mice were viable and born at normal Mendelian ratios. 
We observed a significant reduction in ACTG1 protein levels in forebrain that was 
compensated by a significant upregulation of ACTB. We were not able to detect any alpha-
actin expression in brain, regardless of the genotype. This was unexpected, since CNS-
specific Actb knockout mice showed a strong up-regulation of both gamma-actin and of 
alpha-actin (Cheever et al., 2012), suggesting that in our case ACTB is either sufficient to 
compensate for loss of ACTG1, or that the sensitivity of our alpha-actin antibody was too 
low. 
We tested Actg1-cKO mice in a contextual fear memory paradigm and observed that they 
show enhanced contextual fear memory. Interestingly, Trim3-/- mice, which have increased 
ACTG1 levels, showed a similar enhanced contextual fear memory phenotype. This suggests 
that normal expression of both ACTG1 and TRIM3 is required to constrain plasticity within 
physiological boundaries, and that an increase as well as the loss of ACTG1 contributes to 
 TRIM3 ubiquitylates gamma-actin in an activity-dependent manner 
 125 
the manifestation of enhanced fear memory. An interpretation of these findings is currently 
difficult, for it is largely unknown how cytoskeletal rearrangements affect learning. Also, we 
do not yet know how LTP and spine densities, both of which are increased in Trim3-/- mice, 
are affected in Actg1-cKO mice. However, if we assume that changes in gamma-actin levels 
underlie both phenotypes, previously published data on the role of gamma-actin in 
determining the dynamic properties of the actin cytoskeleton are worth mentioning here. It is 
known that only two of the six known actin isoforms are expressed in neurons, β−actin and 
γ-actin (Rubenstein, 1990). Both isoforms readily co-polymerize to form filaments and it was 
recently demonstrated that the γ:β ratio dictates the stability of actin filaments. While high 
amounts of ACTG1 stabilize filaments, abundance of ACTB renders filaments more dynamic 
(Belyantseva et al., 2009; Bergeron et al., 2010). Our findings thus suggest that changing 
γ/β-actin ratio of actin filaments either way results in alterations in the dynamic properties of 
the actin cytoskeleton such that plasticity is enhanced. Determining actin polymerization and 
depolymerization rates in Trim3-/- mice and Actg1-cKO mice may help to better understand 
how these alterations correlate with structural and functional plasticity at the synapse. 
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General Discussion 
This study was aimed to elucidate the role of TRIM3 in hippocampal and cerebellar function 
by making use of a newly generated Trim3 knockout mouse. 
In the hippocampus, TRIM3 was found to be a synaptic ubiquitin ligase that targets ACTG1 
for proteasomal degradation. As a consequence Trim3-/- mice have increased levels of 
ACTG1 at synaptic sites, higher spine densities, increased long-term potentiation (LTP) and 
enhanced contextual fear memory consolidation compared to wildtype controls. 
Interestingly, forebrain specific deletion of Actg1 resulted in a similar enhancement of 
contextual fear memory, suggesting that normal expression of both ACTG1 and TRIM3 are 
required to constrain hippocampal plasticity within physiological boundaries. TRIM3 is also 
expressed in cerebellar granule cells (CGCs) and in neurons of the deep cerebellar nuclei, but 
not in Purkinje cells. The localization of TRIM3 in the molecular layer further supports a 
synaptic function in the cerebellum, in particular at parallel fiber to Purkinje cell synapses. 
Interestingly, we identified a different set of candidate TRIM3 synaptic substrates in the 
cerebellum compared with the hippocampus, suggesting different functions for TRIM3 in 
these brain regions. Determining the physiological and behavioral roles of TRIM3 and its 
substrates in the cerebellum will need further investigation. 
Here, I will discuss potential similarities and dissimilarities between TRIM3 function in the 
hippocampus and the cerebellum. I will regularly refer to published data on two other RING-
finger E3 ligases, TRIM2 and TRIM32, which are structurally closely related to TRIM3 and 
have partially overlapping expression patterns in the hippocampus and cerebellum. Studying 
potential functional complementarity and redundancy between these three proteins may thus 
help to understand some of the phenotypes that are associated with their deletion or 
overexpression. 
 
TRIM3 and brain morphology 
In adult mice TRIM3 is strongly expressed in hippocampus and cerebellum and cellular 
expression is highly localized to synaptic sites (El-Husseini, 1999; Hung et al., 2010) 
(Chapter 2). However, a direct effect of TRIM3 deletion in mice was not readily apparent, 
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and two independently generated Trim3-/- mouse lines were viable and of normal appearance 
(Cheung et al., 2010; Chapter 2). We performed detailed histological examination of brains 
of Trim3-/- mice and did not observe abnormalities. Overall hippocampal and cerebellar 
morphology and cytoarchitecture were unaffected after loss of TRIM3. It can therefore be 
concluded that TRIM3 is dispensable for normal brain development. Mice deficient for 
TRIM2, the closest relative of TRIM3, also presented with no apparent brain defects 
(Balastik et al., 2008). From the age of four months on, however, TRIM2 deficient mice 
developed seizures and showed strong progressive neurodegeneration of cerebellar Purkinje 
cells, neurons of the deep cerebellar nuclei, retinal ganglion cells and neurons in the spinal 
cord (Balastik et al., 2008). The same authors showed that TRIM2 targets neurofilament light 
chain for proteasomal degradation, and provided evidence that neurodegeneration in TRIM2 
deficient mice is likely caused by neurofilament accumulations in axons and subsequent cell 
death (Balastik et al., 2008). To test for such an age-dependent accumulative effect in Trim3-/- 
mice we also examined brain morphology at 8 months of age. Aged Trim3-/- mice did not 
exhibit seizures, nor was there any sign of neurodegeneration, leading us to conclude that 
loss of TRIM3 does not result in age-dependent morphological alterations as was reported 
for TRIM2 deficient mice. In this respect it is interesting to note that in the cerebellum TRIM2 
is uniquely expressed in Purkinje cells (Balastik et al., 2008) and TRIM3 in CGCs 
(Chapter 2), whereas in the hippocampus they are co-expressed in CA pyramidal neurons. 
Despite abundant TRIM2 expression in the hippocampus, TRIM2 deficient mice show no 
hippocampal degeneration, suggesting that TRIM3 might compensate for TRIM2 when both 
are expressed in the same cells. However, TRIM2 and TRIM3 are also co-expressed in 
neurons of the deep cerebellar nuclei, which do show age-dependent degeneration in TRIM2 
deficient mice. Thus, functional redundancy between TRIM2 and TRIM3, if any, does seem 
to depend on the cell type in which they are expressed and possibly on subcellular localization 
and on the specific protein substrates that are targeted for proteasomal degradation. 
Additional research on double mutant mice and cell type-specific mutants should be able to 
resolve this issue. 
At the synapse morphological level it was reported that TRIM3 overexpression in 
cultured rat hippocampal neurons leads to a decrease in spine head width, but did not have 
an effect on spine density or spine length (Hung et al., 2010). To assess potential synapse 
morphological abnormalities in Trim3-/- mice in vivo, we used fluorescent confocal 
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microscopy. Three spine parameters were investigated: (i) spine head size, (ii) spine length 
and (iii) spine density. In contrast to Hung et al. (2010) we observed a significant increase in 
spine density in Trim3-/- mice, while spine length and spine head size were not affected. These 
discrepancies may be explained in different ways. First Hung et al. (2010) overexpressed 
TRIM3 whereas we studied the consequences of TRIM3 deletion. Both studies confirm a 
role for TRIM3 in spine morphogenesis, but reducing or increasing TRIM3 levels may have 
different consequences for how this translates into spine morphology. Moreover, 
overexpression of TRIM3 was performed in cultured embryonic neurons, whereas we used 
slice preparations of adult mouse hippocampi for spine analysis. In addition to being of 
different developmental stages these preparation also have very different dynamics and 
network properties. This for instance might mean that a decreased spine head size after three 
days of TRIM3 overexpression in cultured neurons represents an early stage of spine pruning, 
while in slice preparations the long-term consequences of such spine pruning are observed 
as reduced spine densities. Whatever the explanation, both our data and that of Hung et al. 
(2010) strongly suggest that TRIM3 is important for maintaining normal hippocampal spine 
morphology. 
 
TRIM3 and memory 
Because of the strong expression of TRIM3 in the hippocampus and cerebellum, we 
specifically assessed hippocampus- and cerebellum-associated behaviors, i.e. motor 
coordination (rotarod) and contextual memory (contextual fear conditioning) in Trim3-/- mice. 
To rule out that observed behaviors stem from generally altered aspects of basal behavior, 
such as activity or anxiety, we also tested Trim3-/- mice using open field, light-dark box and 
elevated plus maze tasks. Our analysis showed that motor coordination is not affected by loss 
of TRIM3. Latencies of Trim3-/- mice to fall off the accelerating rotarod were not different 
from those of wildtype mice. Also, overall locomotor behavior was not affected by loss of 
TRIM3. Trim3-/- and wildtype mice were equally active on the elevated plus maze, in the 
open field and in the light-dark box. The lack of any defect in activity and motor parameters 
confirms at the behavioral level that there is no significant neuronal degeneration and cell 
loss in the cerebellum (Chapter 2), as was observed for TRIM2 deficient mice (Balastik et 
al., 2008). 
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 When focusing on hippocampal learning and memory, we did identify one striking 
difference between Trim3-/- mice and wildtype controls. In a contextual fear memory task we 
observed enhanced memory acquisition, evidenced by higher freezing levels at two hours 
after conditioning. The levels of freezing were comparable to that of both Trim3-/- mice and 
wildtype mice at 24 h after conditioning, indicating that Trim3-/- mice have a specific 
enhancement of short-term memory. Having used a contextual fear conditioning paradigm 
without tone or light pairing, this behavioral abnormality is likely caused by the absence of 
TRIM3 in the hippocampus (Kim and Fanselow, 1992; Phillips and LeDoux, 1992), however, 
an involvement of the amygdala, where TRIM3 is normally also expressed, cannot be ruled 
out entirely. One might also question whether high freezing levels at two hours after 
conditioning are the result of increased fear memory consolidation or of higher anxiety levels. 
However, Trim3-/- mice and wildtype controls showed similar performance in the elevated 
plus maze, open field and light-dark box, indicating that basal anxiety levels did not differ. 
When inspecting closely the data obtained from the elevated plus maze, Trim3-/- mice tend to 
enter more often and spend more time in open arms, indicating slightly decreased anxiety. 
Interestingly Trim3-/- mice did spend significantly more time in the center area of the elevated 
plus maze. Although this is difficult to interpret, it is generally considered to be a measure of 
decision making (Carobrez and Bertoglio, 2005). Following this reasoning it appears that 
Trim3-/- mice took more time deciding, yet entered and explored open arms more often and 
longer, indicating decreased anxiety. In the light-dark box paradigm we observed a similar 
behavior. Although not significantly different, Trim3-/- mice showed a tendency to enter the 
light compartment more often, again arguing against increased anxiety as an explanation for 
the enhanced freezing levels of Trim3-/- mice at two hours after fear condition. Taken together 
it can be concluded that the enhanced fear memory consolidation of Trim3-/- mice is caused 
by the absence of TRIM3 in the hippocampus and not by higher activity and/or anxiety levels. 
This indicates that TRIM3 is a negative regulator of hippocampus dependent fear memory 
consolidation and that removing TRIM3 enhances learning and memory. 
 Based on the fear conditioning phenotype it is tempting to speculate that TRIM3 
might also be involved in regulating motor learning in the cerebellum. Preliminary data (not 
included in this thesis) indicate that Trim3-/- mice show reduced motor learning using the 
Erasmus ladder, a device designed to measure conditioning of motor responses to an auditory 
stimulus (Van Der Giessen et al., 2008). Trim3-/- mice were less capable of pairing the tone 
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with a correct motor response, indicating decreased motor learning. Importantly, the number 
of missteps was not different between Trim3-/- mice and wildtype controls, indicating again 
that basal motor performance was not affected. Although preliminary in nature, these findings 
show that in contrast to enhanced hippocampal contextual fear conditioning, Trim3-/- mice 
show reduced cerebellar motor learning. 
 
TRIM3 and synaptic plasticity 
The fact that hippocampal learning is enhanced in Trim3-/- mice, whereas cerebellar motor 
learning appears to be decreased, puts to question the nature of the underlying synapse 
physiological and molecular mechanisms. We observed increased hippocampal long-term 
potentiation (LTP) in slice preparations from Trim3-/- mice (Chapter 2). Basal synaptic 
transmission parameters were unaffected, and spontaneous excitatory and inhibitory synaptic 
responses appeared normal in Trim3-/- mice. In a previous study, Cheung et al. (2010) 
reported that Trim3-/- mice have reduced spontaneous inhibitory synaptic transmission in the 
cortex, which correlates with reduced GABA-A receptor gamma-2 subunit surface 
expression. According to our data this is not the case in the hippocampus. The specific 
enhancement of LTP and not basal transmission may thus provide a good explanation for 
increased short-term fear memory consolidation. Cerebellar motor learning on the other hand 
depends, among others, on long-term depression (LTD) at parallel fiber-Purkinje cell 
synapses (De Zeeuw and Yeo, 2005; Hansel and Linden, 2000), which are probably the site 
of TRIM3 expression in the cerebellum (Chapter 2). It is thus tempting to speculate that 
TRIM3 is a regulator of meta-plasticity, and that TRIM3 deletion increases LTP while 
decreasing LTD, resulting in an enhancement of memory processes that depend on LTP and 
an impairment of memory processes that depend on LTD. However, there may be many other 
explanations for the differences observed in hippocampal versus cerebellar learning. For 
instance, as discussed above the subcellular localization of TRIM3 may be different, i.e., 
post- versus presynaptic respectively, and the substrates involved may also be different. The 
latter issue will be discussed in the following sections. 
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TRIM3 and the cytoskeleton 
In chapter 4 we performed an open proteomics screen in order to identity TRIM3 
ubiquitylation substrates in the hippocampus and in the cerebellum. By using a unique 
combination of poly-ubiquitin affinity purification and immunoprecipitation with multiple 
anti-TRIM3 antibodies, and employing Trim3-/- tissue as a negative control, we were able to 
identify potential substrate proteins with high confidence. We were initially surprised to find 
a ubiquitously expressed protein like ACTG1 as the most likely substrate in the hippocampus, 
but subsequent studies presented in chapter 5 demonstrated that TRIM3 indeed binds and 
negatively regulates ACTG1 via ubiquitylation, making ACTG1 the likely cause for the 
memory phenotype we observed in Trim3-/- mice. Behavioral analysis of hippocampus-
specific Actg1-/- mice confirmed that ACTG1 indeed contributes to the formation of 
contextual fear memory, findings that will be discussed in more detail in the following 
sections.  
 The question of what the specific role of TRIM3 in the cerebellum is remains 
unanswered. From our findings we can, however, deduce that it likely differs from its role in 
the hippocampus. As aforementioned, TRIM3 is strongly expressed in the cerebellum (El-
Husseini, 1999). Yet, whereas its expression in the hippocampus is primarily post-synaptic, 
in the cerebellum we observed predominantly pre-synaptic expression (Chapter 2). 
Moreover, our substrate identification strategy identified a different set of potential TRIM3 
substrate proteins for cerebellum than for the hippocampus, including the intermediate 
filament protein vimentin (Chapter 4). It is thus interesting to speculate that all TRIM-NHL 
proteins (TRIM2, TRIM3 and TRIM32) target cytoskeletal proteins for proteasomal 
degradation, i.e., actin (TRIM32 in muscle cells), neurofilament (TRIM2 in cerebellum), 
gamma-actin (TRIM3 in hippocampus) and vimentin (TRIM3 in cerebellum). However, 
vimentin expression is generally thought to be limited to developmental stages and is not 
expressed in mature neurons (Yabe et al., 2003). This finding therefore needs to be 
considered with caution and requires further investigation. Finally, it would be interesting to 
see whether TRIM2 targets different cytoskeletal proteins in cerebellum and hippocampus 
explaining the lack of a neurodegenerative phenotype in the hippocampus as discussed above. 
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TRIM3 and mRNP granules 
Identifying TRIM3 as an E3 ligase that targets ACTG1 for proteasomal degradation did not 
come as a complete surprise. A study in heterologous cells demonstrated that ACTG1 is poly-
ubiquitylated co-translationally (Zhang et al., 2010). Non-coding sequences in Actg1 mRNA 
cause ACTG1 to be synthesized at a much slower rate than ACTB, allowing a normally 
buried lysine residue at the N-terminus to be exposed long enough to be ubiquitylated. For 
TRIM3 to be responsible for co-translational ACTG1 ubiquitylation, TRIM3 protein and 
Actg1 mRNA would need to be in close proximity. In this respect it is interesting to note that 
Kanai et al. (2004) found TRIM3 among a core set of 42 proteins that constitute a detergent-
resistant, RNase-sensitive neuronal transport granule that associates with motor protein 
KIF5. These so-called messenger ribonucleoprotein (mRNP) granules transport mRNAs 
towards synapses (Buchan, 2014). We confirmed the presence of TRIM3 in mRNP granules 
by showing that TRIM3 co-immunoprecipitates with PURA (Chapter 3), one of the major 
components of mRNP granules (Elvira et al., 2006), in an RNase-sensitive manner. We also 
established that Actg1 mRNA is present in mRNP granules that are immunoprecipitated with 
antibodies against either TRIM3 or PURA. Actg1 mRNA lacks the zipcode sequence that is 
known to target Actb mRNA to dendrites (Eom et al., 2003; Poon et al., 2006). However, a 
recent deep sequencing study showed that both Actg1 and Actb transcripts are present in the 
hippocampal neuropil, and are among the 2,550 mRNAs that can be identified with high 
confidence as dendritic/axonal transcripts (Cajigas et al., 2012). Our findings confirm that 
Actg1 mRNA levels in TRIM3- or PURA-positive immunoprecipitates are comparable with 
those of Actb. Thus, TRIM3 and Actg1 mRNA co-localize in mRNP granules that target 
mRNAs to dendritic spines for local translation, suggesting that TRIM3-mediated 
co-translational ubiquitylation of ACTG1 may occur at synaptic sites. 
We furthermore found that TRIM3 is not essential for dendritic trafficking of 
PURA-positive mRNP granules (chapter 3). We did however detect a significant increase in 
the maximum velocity and maximum distance traveled of a small sub-population of long 
distance PURA-positive granules. These long distance clusters traveled more than 5 µm and 
accounted for 26 – 30 % of all detected clusters. In this respect we must consider that mRNP 
granules are diverse in composition (Buchan, 2014; Erickson and Lykke-Andersen, 2011) 
and that not all PURA-positive granules would necessarily contain TRIM3 and vice versa. 
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This suggests that the 26 – 30 % long distance granules may possibly reflect the entirety of 
mRNP granules containing TRIM3. Co-expression or co-labeling of both PURA and TRIM3 
in neurons, followed by quantitative co-localization analysis would certainly shed light on 
that matter. 
Wilhelm and Vale (Wilhelm and Vale, 1993) brought four essential aspects of 
mRNP granules forward that needed to be addressed in order to precisely understand their 
function: (i) how mRNP particles assemble, (ii) how they are localized and transported via 
cytoskeletal motors, (iii) how they are anchored to local sites, and (iv) how local translation 
is then facilitated. Although Wilhelm and Vale had already speculated that recognition of 
local sites and anchoring would have to involve cytoskeletal (actin) elements, this matter has 
largely been unaddressed since then. Taking our findings that (i) TRIM3 is part mRNP 
granules, that (ii) without TRIM3 these granules travel faster and further, and that (iii) TRIM3 
strongly binds ACTG1, it is possible that TRIM3 not only regulates ACTG1 co-
translationally at synaptic sites, but also functions as recognition or anchoring molecule of 
actin filament protrusions of synapses. Thus, mRNP granules lacking TRIM3 may have a 
reduced ability to recognize synaptic sites, which in return would explain the longer distances 
travelled and the higher velocity. It would be interesting to test that hypothesis in our recently 
generated Actg1-cKO mouse. If indeed the binding of TRIM3 to ACTG1 serves as a synapse 
identifier or synapse anchor for mRNP granules, then tracking mRNPs in ACTG1 deficient 
cells should yield a similar result as tracking them in TRIM3 deficient cells. 
 
How do TRIM3 and gamma-actin affect spine morphology, synaptic plasticity 
and memory? 
Consistent with our finding that TRIM3 protein and Actg1 mRNA co-localize in mRNP 
granules trafficking to synaptic sites, our proteomic screen identified ACTG1 as high-
confidence TRIM3-interactor as well as the most TRIM3-dependent poly-ubiquitylated 
protein in hippocampal synapse-enriched fractions. Moreover, TRIM3-dependent 
poly-ubiquitylated forms of ACTG1 can be detected in hippocampal neurons after 
stimulation with TPA, a PKC activator that induces protein synthesis and synaptic plasticity 
(Carriere et al., 2011; Herbert et al., 2000; Kim et al., 2013), and ACTG1 levels are 
significantly increased in Trim3-/- neurons. Together, these findings demonstrate that TRIM3 
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regulates synaptic ACTG1 levels in an activity-dependent manner, most likely via ubiquitin-
dependent proteasomal degradation. Targeting a newly synthesized protein for degradation 
appears unintuitive at first glance. There are, however, a number of scenarios in which such 
an apparently wasteful procedure can be beneficial. First, TRIM3 may act as quality control 
of ACTG1. The incidence rate of misfolded protein is dependent on synthesis and folding 
rate (Dubitzky et al., 2011). Considering a sudden increase in ACTG1 translation after a 
stimulus, this would likely yield a larger amount of defective ACTG1, which can affect actin 
dynamics in any number of manners. Limiting the formation or promptly removing this pool 
of defective and/or non-functional ACTG1 may be highly beneficial. Examples of other 
quality control E3 ligases are Hel2, Ltn1 and Not4, all of which are known to be ribosome 
associated and to ubiquitylate proteins co-translationally (Panasenko, 2014). Second, it is 
possible that TRIM3 poly-ubiquitylates ACTG1 co-translationally and poly-ubiquitylated 
ACTG1 is then transiently incorporated into actin filaments. TRIM3 may possibly play an 
active role in this, as TRIM3 interacts with several actin-binding proteins, including myosin 
V (El-Husseini, 1999) and α-actinin-4 (El-Husseini et al., 2000), and is involved in actin-
based transport (Yan et al., 2005). TRIM3 may thus facilitate incorporation of poly-
ubiquitylated ACTG1 into F-actin. In the filament, poly-ubiquitylated ACTG1 may present 
another cross-linking opportunity for other synaptic proteins, allowing stabilization of 
postsynaptic proteins and thereby retaining a specific synaptic state (Kuriu et al., 2006; 
Renner et al., 2009). Upon de-polymerization of F-actin, prior incorporated poly-
ubiquitylated ACTG1 would then be released, recognized by the ubiquitin proteasome 
system, degraded and thereby removed from the available actin pool. A transient increase in 
ACTG1 levels due to local translation and degradation might temporarily change the dynamic 
properties of the actin cytoskeleton and create a window of opportunity for ACTG1 to 
contribute to activity-induced synaptic plasticity. Interestingly, enhanced LTP in Trim3-/- 
mice is confined to the early phase of LTP (i.e., the first 30 min after induction), which was 
previously demonstrated to also depend on protein synthesis (Fonseca et al., 2006a; Fonseca 
et al., 2006b). After 30 min LTP levels are normal again, suggesting that ACTG1 turnover 
may not be completely abolished in the absence of TRIM3 or that compensatory mechanisms 
normalize plasticity at later time points. 
 General Discussion 
 
 137 
 What might be the specific contribution of ACTG1 to actin dynamics in dendritic 
spines in relation to synaptic plasticity? To date the role of ACTG1 in synaptic plasticity is 
unknown. Our findings show that increased synaptic ACTG1 protein levels correlate with 
alterations in spine density, LTP and contextual fear conditioning and to our knowledge 
provide the first link of ACTG1 to plasticity, learning and memory. Moreover, forebrain 
specific, postnatal deletion in hippocampal neurons of Actg1 itself also causes fear memory 
deficits (Chapter 5). Although these findings do not provide definite proof that the plasticity 
and memory phenotypes in Trim3-/- mice are due to increased ACTG1 levels only, they do 
indicate that ACTG1 contributes to hippocampal plasticity and that TRIM3 is involved as an 
upstream regulator. In contrast to ACTB (Cheever et al., 2012), central nervous system 
specific deletion of ACTG1 does not result in detectable morphological or histological 
abnormalities (Cheever and Ervasti, 2013), indicating that ACTG1 has no major role in gross 
brain development. Several studies have hinted towards specific and unique roles for ACTG1 
in adulthood. For instance, whereas ACTG1 and ACTB are each dispensable for the normal 
development of auditory hair cells in the cochlea (Perrin et al., 2010), ACTG1 deficient mice 
cannot properly maintain hair cell stereocilia actin cores and suffer from progressive age-
dependent hearing loss (Belyantseva et al., 2009). The authors observed that ACTG1 
accumulates at sites of stereocilia core disruptions, and conclude that ACTG1 is required for 
the reinforcement of long-term stability of actin filaments and the remodeling and repair of 
stereocilia cores following mechanical stress-induced damage. One possible explanation for 
these findings is that ACTG1-containing filaments have different biochemical and 
biophysical properties than filaments lacking ACTG1. Recent studies seem to confirm that 
ACTG1 may indeed contribute to more stable actin filaments (Bergeron et al., 2010). 
Although polymerization rates of ACTB and ACTG1 were indistinguishable in the 
Mg2+-bound state, which is considered to be the physiologically most relevant state, turnover 
rates of ACTB in its Ca2+-bound state were considerably faster than those of ACTG1, 
indicating that in the presence of Ca2+ ACTB is more dynamic, and ACTG1 is more stable. 
Moreover, since ACTB and ACTG1 readily copolymerized, it probably is the 
ACTB / ACTG1 ratio in actin filaments that determines their stability in the presence of 
Ca2+ (Bergeron et al., 2010). By regulating local ACTG1 levels TRIM3 may thus play a 
crucial role in controlling actin stability during synaptic plasticity. Changes in actin stability 
would directly affect spine morphogenesis (Sekino et al., 2007) and synaptic AMPA receptor 
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recycling (Osterweil et al., 2005; Zhou et al., 2001) and anchoring (Allison et al., 1998; Kuriu 
et al., 2006), thus explaining the hippocampal spine density, LTP and memory phenotypes 
observed in Trim3-/- mice. 
 
Why at all have TRIM3 or ACTG1 
If Trim3-/- and Actg1-cKO mice show an enhanced ability to remember a painful and 
potentially threatening situation, why would there still be ACTG1 and TRIM3? 
In the case of ACTG1 this question can be addressed with a straightforward answer. 
The benefit of having ACTG1 largely outweighs the ability to remember better. Actins are 
structurally and functionally involved in nearly every aspect of cellular life (Perrin and 
Ervasti, 2010; Rubenstein, 1990; Rubenstein and Wen, 2014) and so it is not surprising that 
knocking actin isoforms out, has severe effects. A β-actin knockout in mice for example is 
embryonically lethal (Shawlot et al., 1998). γ-actin knockout mice on the other hand are 
viable, yet at a reduced rate (Belyantseva et al., 2009; Bunnell and Ervasti, 2010). In addition 
γ-actin knockout mice show delayed embryonic heart development, are smaller in size and 
develop skeletal muscle myopathy and progressive hearing loss (Belyantseva et al., 2009; 
Sonnemann et al., 2006). In addition to these published negative effects caused by the loss of 
ACTG1, it cannot be ruled out that the observed enhanced fear memory is not accompanied 
by other adverse effects, which can only be seen in different behavioral paradigms or at later 
phases in life of these mice. This finding, however, can be seen as a prolific foundation to 
base future hypotheses on. 
 In the case of TRIM3 the question of why it is there, is unarguably more 
complicated. Aside from its role in ACTG1 ubiquitylation TRIM3 may also target other 
proteins for degradation or serve other functions that we were unable to detect with our 
approach and are therefore unaware of. Given that we found Trim3-/- mice to be viable, 
healthy to an old age and in most aspects nearly indistinguishable from their wildtype 
littermates, we can assume that potential other functions are either of subtle nature or present 
in other physiological domains beyond the scope of this study. Our study revealed enhanced 
hippocampal LTP, increased hippocampal spine density and an enhanced fear memory 
consolidation in Trim3-/- mice. Reflecting theses points, it appears as if not having TRIM3 is 
solely beneficial and has no downsides. After all, a better memory is something that is 
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generally sought after. In regard to fear memory, however, better is probably only desirable 
to a certain degree. When a fear memory becomes disproportionate to the experienced event, 
it may be triggered by cues only faintly resembling the original setting. This inappropriate 
fear expression can interfere with daily life and may pose severe disadvantages when it comes 
to acquiring mating partners, food and other resources. In humans such misplaced expression 
of fear interfering with daily life would be placed within the group of anxiety disorders 
(Kandel et al., 2000; Michael et al., 2007; Reiss, 1991). 
 
In conclusion 
We discovered the ubiquitin E3 ligase TRIM3 to be an important factor in modulating 
synaptic plasticity. We demonstrated its role at molecular, synaptic physiological, synaptic 
structural and behavioral levels. The study presented in this thesis clearly demonstrates the 
importance of E3-ligases in synaptic function underlying aspects of learning and memory. It 
also provides a methodological framework towards target identification of similar synaptic 
E3-ligases. We implicated ACTG1 as an important TRIM3 target. The way TRIM3 is 
activated during plasticity processes and how ACTG1 is involved in structural plasticity 
would deserve attention in future studies. 
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Summary 
Animals and their behavior have been shaped by evolution to succeed in their respective 
natural environments. The ability to learn, memorize and retrieve information has proven to 
be an invaluable property in the success of most species living on earth today. The brain, be 
it as small as 20,000 neurons in honeybees or as large as 257 billion neurons in African 
elephants, is generally considered to be the organ that enables animals to learn about and 
interact with their environments. One brain region in particular, the mammalian 
hippocampus, is indispensable for many types of learning and has drawn the attention of 
thousands of researches over the last decades. As with all other brain regions, the primary 
functional building blocks of the hippocampus are neurons, which communicate via 
synapses. Synaptic transmission can vary in efficacy depending on various factors. This 
variation in transmission efficacy, often called synaptic plasticity, is accompanied by 
structural and compositional synaptic changes facilitated by an increase, decrease, 
displacement and rearrangement of numerous synaptic proteins. Synaptic plasticity is 
generally considered the basis of learning and memory. 
TRIM3, the subject of this thesis, is one such synaptic protein. It is a RING E3 
ubiquitin ligase that is expressed at synapses in the hippocampus and the cerebellum and was 
supposed to regulate ubiquitin-proteasome-mediated degradation of particular synaptic 
protein substrates. However, at the start of the research described in this thesis, its precise 
role and function in neurons and especially at synaptic sites had remained elusive. In order 
to understand the role of TRIM3 in hippocampal and cerebellar function, we made use of a 
newly generated Trim3 knockout mouse and investigated it in a multidisciplinary manner. 
Chapter 2 focuses on the descriptive characterization of TRIM3 and on the effect 
of its loss on brain morphology, learning behavior and synaptic function. We used 
immunohistochemistry, immunocytochemistry, sub-cellular fractionation and 
overexpression experiments to show that TRIM3 protein is highly expressed at synaptic sites 
of the hippocampus and cerebellum and that it is indeed an ubiquitin ligase. We found that 
knocking out Trim3 has no overall effect on gross brain morphology and cytoarchitecture, 
and that basal locomotor and anxiety-related behaviors are unaffected. Hippocampus-
dependent fear memory, however, was significantly enhanced in Trim3-/- mice, in particular 
short-term memory measured at two hours after conditioning. By using an 
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electrophysiological approach we showed that hippocampal LTP is enhanced in Trim3-/- 
mice, but that spontaneous activity of hippocampal pyramidal cells is indistinguishable from 
that of wildtype neurons. Finally, we showed that loss of TRIM3 causes an increase in spine 
density in hippocampal pyramidal cells. Together these findings support a role for TRIM3 in 
structural and functional hippocampal synaptic plasticity. 
Chapter 3 explores the possibility that the behavioral, electrophysiological and 
structural abnormalities of Trim3-/- mice described in chapter 2 are caused by deficits in the 
trafficking properties of messenger ribonucleoprotein (mRNP) particles. We used 
biochemistry to demonstrate that TRIM3 is part of PURA-containing mRNP granules in 
hippocampus. By co-immunoprecipitation and overexpression experiments we showed that 
TRIM3 interacts with PURA, one of the main protein constituents of mRNPs, but that the 
interaction is mediated by RNA and not by direct contact of TRIM3 and PURA. We further 
demonstrated that PURA abundance is unaffected by the presence or absence of TRIM3, 
making PURA an unlikely ubiquitylation substrate. We furthermore used time lapse imaging 
to analyze mRNP trafficking and mobility in cultured neurons, to find that TRIM3 is not 
essential for mRNP trafficking, but that the loss of TRIM3 does result in a small but 
significant increase in travelled distance and velocity of a small subpopulation of mRNP 
particles. 
Chapter 4 describes a novel strategy to identify TRIM3 ubiquitylation substrates. 
We applied Tandem Ubiquitin Binding Entities (TUBEs) affinity purification and 
immunoprecipitation with three different TRIM3 antibodies in parallel to Trim3-/- mice and 
wildtype controls. Using this universally applicable, two-pillared quantitative mass 
spectrometry based strategy we identified synaptic TRIM3 interactors on the one side and 
differentially ubiquitylated synaptic proteins on the other. We demonstrate the suitability and 
reproducibility of our approach and present γ-actin (ACTG1) as the most likely ubiquitylation 
substrate of TRIM3 in hippocampal synapses. 
Chapter 5 focuses on the validation of ACTG1 as a TRIM3 substrate in the 
hippocampus. By co-immunoprecipitating ACTG1 with TRIM3 and TRIM3 with ACTG1 
from hippocampal synaptic fractions and from HEK293 cells after TRIM3 overexpression, 
we were able to show that TRIM3 and ACTG1 interact directly. We further demonstrate that 
loss of TRIM3 leads to an increase in ACTG1 in hippocampal neurons, and that 
overexpressing TRIM3 in heterologous cells causes a decrease in endogenous ACTG1 levels. 
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This decrease is caused by ubiquitylation and subsequent proteasomal degradation mediated 
by TRIM3. Finally, the importance of ACTG1 in learning and memory is evidenced for the 
first time by generating a forebrain specific Actg1 knockout mouse. These mice are viable, 
and show similar memory deficits in a contextual fear conditioning paradigm as Trim3-/- 
mice. However, whereas Trim3-/- mice showed increased short-term memory at two hours 
after conditioning, conditional Actg1 mice do so at 24 - 72 hours after conditioning. Taken 
together our findings suggest that temporal control of ACTG1 levels by TRIM3 is required 
to regulate the timing of hippocampal plasticity. 
 Chapter 6 summarizes and discusses obtained data, placing TRIM3 and ACTG1 
into a working model in which TRIM3, by fine tuning the expression, degradation and 
potentially polymerization of ACTG1, keeps the acquisition, consolidation and later 
expression of a fear memory within physiological boundaries, allowing individuals to 
function and properly react to their environment. 
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